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Abstract
T cell activation may result in productive outcomes such as proliferation or 
IL-2 production. Alternatively, anergy or apoptosis may result from TCR 
engagement. One of the main objectives of this study is the investigation of 
what determines which of these outcomes occurs.
In order to examine T cell activation requirements, anti-CD3 monoclonal 
antibodies, the mitogen PHA and the superantigen SEB have all been 
utilised. The ability of human peripheral T  lymphocytes to respond to these 
stimuli was determined by measuring proliferation and IL-2 responses.
The role of costimulation was addressed using transfectants expressing the 
LFA3 or B7 cell surface molecules. T lymphocytes were found to require 
APC-dependent signals in addition to TCR engagement. B7 was 
demonstrated to be a potent costimulatory molecule capable costimulating 
resting and activated T lymphocytes and of providing third party 
costimulation for SEB responses. LFA3 appeared to predominantly function 
as an adhesion molecule although it costimulated PHA responses in resting T 
cells.
i
In addition to productive activation, the requirements for apoptosis of T 
lymphocytes was also examined. PHAwas demonstrated to induce time and 
dose dependent apoptosis in Jurkat T cells via a Fas-independent pathway. In 
contrast SEB-induced apoptosis in T lymphocytes was shown to occur via a 
Fas-dependent pathway. Fas-L up-regulation was found to be intimately 
linked to SEB-induced apoptosis. Additionally Fas-resistant cell lines which 
were also resistant to SEB-induced apoptosis were also observed. 
Interestingly, Fas ligation was also shown to costimulate anti-CD3 induced 
proliferation.
One of the main conclusions presented is that more than one signal is 
required both for productive T cell activation to result in proliferation and 
IL-2 production and for apoptosis of human peripheral T lymphocytes to 
occur.
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CHAPTER ONE. 
INTRODUCTION.
1.1 T lymphocytes in the immune response.
The eukaryotic immune system is a complex network of multiple cellular and soluble 
mediators which protect the host from disease. The cells involved include T and B 
lymphocytes; T lymphocytes play a pivotal role in the efficient functioning of the 
immune response providing both help for B lymphocytes as well as direct cytotoxic 
functions. The soluble mediators produced by activated T cells attract and activate B 
lymphocytes and macrophages promoting the elimination of pathogens. T cells are 
critical for the development of cytotoxic responses to virus-infected cells, malignant 
cells and the response to foreign antigens.
In order to mount an immune response a T lymphocyte must first proceed from a 
resting to an activated state progressing through the cell cycle to proliferate and 
expand. Activated T cells are then capable of the lymphokine secretion and cell lysis 
required for their effector role.
T cells are broadly divided into two classes based on their mutually exclusive 
expression of the cell surface glycoproteins CD4 and CD8. The function of CD8+ 
cytotoxic T cells is to eliminate virally infected cells or tumour cells while CD4+
f
cells are known as T helper (Th) cells because they provide help in the form of 
cytokines to B cells to assist in the production of antibodies. There is a level of 
overlap however in that CD4+ T cells can also be cytotoxic. Murine CD4+ Th cells 
can be divided into two distinct subsets, Thl and Th2 cells based on their pattern of 
cytokine production (Mossman and Coffman 1989). Thl clones secrete 
predominantly interleukin (EL)-2 and interferon (IFN)Y and promote cellular 
immunity whereas Th2 clones secrete IL-4, IL-5 and IL-10, providing help for B cell 
differentiation and humoral responses in the form of antibody production.
One of the most prominent features of the T cell system is the generation of diversity 
by random somatic gene rearrangement of the T cell receptor (TCR) for antigen. This 
diversity supplies the variety of receptors needed to recognise an almost infinite array 
of foreign antigens. However, the process of gene rearrangement results in T cells 
which also have the capacity to react to self antigens. It is therefore critical to 
regulate this process, by having control points during development in order to 
eliminate potentially harmful self-reactive T cells.
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The central question of self-tolerance in the immune system is how to maintain a 
repertoire of cells which have the ability to recognise a myriad of foreign antigens 
while at the same time ensure that cells which are self-reactive are either removed or 
prevented from being activated. The consequences of such inappropriate activation 
could lead to autoimmune damage of the host as is thought to occur in a number of 
diseases. These include rheumatoid arthritis, multiple sclerosis and insulin-dependent 
diabetes melitus (IDDM). The increasing awareness of autoimmune pathology of 
such diseases highlights the necessity to fully characterise the way in which a normal 
immune system operates. The importance of efficient functioning of the immune 
system is underscored by the observation that immunomodulatory intervention is 
seen as the way forward for the treatment of a large number of diseases.
Unrestricted tumour growth and metastasis may occur if cytotoxic T cells do not 
recognise and eliminate cancer cells. It will be interesting to elucidate the molecular 
basis of immune recognition and the manner in which a T cell interacts with tumour 
cells. The differences that occur between a cell which is recognised as foreign or 
virally infected by the immune system and eliminated and a cancerous cell which 
avoids detection may provide strategies for targeting and destroying tumour cells in 
the treatment of cancer.
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When the immune system is confronted by an antigen it must either recognise the 
antigen as foreign and destroy i t , or recognise at as self and ignore it. The aim in the 
immunoregulation of transplant rejection is to change the aggression of alloreactive 
T cells into passive bystanders which do not attack the transplanted organ. The 
mechanisms that control T cell recognition and rejection of foreign antigens are of 
prime importance in strategies for suppression of the immune system to control graft 
rejection. Therefore an understanding of how the immune system remains tolerant to 
self antigens will aid transplant technology.
The underlying immunopathology in patients who are HIV+ has become 
increasingly obvious recently with the discovery that CD4 T cells are being rapidly 
deleted. This has been proposed to be due to dysregulated apoptosis (Ameisen and 
Capron 1991) resulting in immunocompromised patients and eventually leading to 
death. It will be interesting to determine the role played by apoptosis in T cell 
homeostasis. An understanding of the factors that regulate T cell function will 
facilitate the study of human disease.
2
It has thus become apparent that T lymphocyte activation needs to be tightly 
orchestrated to protect against development of autoimmunity. Each T cell clone 
produced needs to be tested for self reactivity and autoreactive T cells inactivated or 
eliminated. The requirement for clonal expansion of antigen-specific cells provides 
the immune response with a crucial control point at which to address the problem of 
self-nonself discrimination. The control of T cell activation is the central subject of 
this thesis and the essential features which influence this process will now be 
outlined.
1.2 Antigen Recognition - the Antigen Presenting Cell.
T cells recognise antigen displayed on the Major Histocompatibility Complex (MHC) 
of Antigen Presenting Cells (APCs), which include dendritic cells, macrophages and 
activated B cells. The MHC molecules are a group of highly polymorphic cell surface 
glycoproteins that present antigen, which has been processed into peptides, for 
recognition by T cells. In general CD4+ T cells recognise antigen associated with 
MHC class II whereas CD8+ T cells recognise MHC Class I bound antigen, although 
exceptions to this have been identified. The crystal structure of the MHC class I
i
molecule HLA-A2 revealed a peptide binding groove formed by two a  helices lying 
on a p pleated sheet (Bjorkman et al 1987). A similar structure has been identified for 
class II molecules (Brown et al 1993).
It has been demonstrated that peptide plays a critical role in stabilising Class I 
structure (Townsend et al 1989). The peptides bound by class I molecules are usually 
8-10 amino acids in length and in most cases are derived from cytosolic or nuclear 
proteins (Townsend and Bodmer 1989, Yewdell and Bennick 1992) possibly through 
the action of proteasomes, macromolecular multicatalytic proteases abundant in the 
cytosol and nucleus (Monaco 1992). These peptides are delivered to the secretory 
pathway via the transporter associated with antigen processing (Townsend and 
Trowsdale 1993), which is formed by two MHC encoded gene products.
Class II MHC differs from class I MHC in that it binds peptides more promiscuously, 
and the bound peptides are longer, usually 15-20 amino acids. Peptides are important 
in regulating surface expression of class II molecules (Germain and Hendrix 1991)
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but are unnecessary for stable association with the a  and P chains. Instead, Class II a  
and p chains assemble as oligomeric complexes with a third polypeptide the Invariant 
chain, a non-polymoiphic non-MHC -encoded protein, that is essential for proper 
assembly and transport of class II dimers (Peterson and Miller 1990, Anderson and 
Miller 1992, Lamb et al 1991, Lotteau et al 1990, Bakke and Dobberstein 1990, 
Neefjes and Ploegh 1992 , Guagliardi et al 1990). An invariant chain peptide is 
responsible for this stable association (Romaglioni and Germain 1994). Another 
MHC-encoded Class II protein DM has also been demonstrated to play a vital role in 
processing of Class II antigens, by enhancing peptide binding to Class II (Sherman et 
al 1995).
Thus, a complex network of protein associations ensures that antigens are processed 
and presented on the surface of APCs and are available for recognition by the T cell 
receptor on T lymphocytes.
1.3 Antigen recognition - the T lymphocyte.
The T cell receptor (TCR) is a multi-subunit receptor for antigen recognition 
composed of an antigen binding heterodimer (oc/p) with structural diversity, 
complexed with the CD3ySe chains and the £ family of hetero- and homo-dimers 
(TCR£-£,£-t| and £-y) (Marrack and Kappler 1987). The a  and p chains determine 
the antigen specificity of the receptor, binding to a complex formed between 
antigenically derived peptides and the cell surface proteins encoded by the MHC 
genes, whereas the £ and CD3 chains mediate signalling.
T cells are characterised by the expression of various lineage-specific cell surface 
molecules. In addition to CD3 other molecules such as CD2, CD4 and CD8 which 
are all members of the immunoglobulin superfamily, play a role in T cell activation. 
The two co-receptors CD4 and CD8 are modulated on the surface of thymocytes and 
expression is mutually exclusive on mature T cells as a result of thymic selection.
CD4 and CD8 bind to non-polymorphic regions of MHC class II and MHC class I 
antigens respectively.
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1.4 Signalling through the TCR.
Signalling through the TCR/CD3 complex has been proposed to take place through 
an apparatus composed of one signal-transduction module consisting of a ££ dimer 
or another involving the CD3e chain (Howard et al 1992). Cross-linking of chimaeric 
proteins that contain the cytoplasmic domains of £ or £ induces increased tyrosine 
phosphorylation of distinct groups of proteins, consistent with the existence of 
multiple signalling pathways. Anti-CD3 antibodies can signal through either signal 
transduction module whereas anti-CD2 appears to signal exclusively through a 
module involving £.
Triggering of the TCR/CD3 complex initiates multiple signal transduction pathways 
(Figure 1.1 page 7), which include generation of intracellular second messengers, 
activation of protein kinases, synthesis or phosphorylation of nuclear factors, 
functional activation of nuclear factors and stimulation of gene transcription 
(Berridge and Irvine 1994, Klausner and Samelson 1991, Rudd et al 1994).
The major TCR- linked signalling pathway appears to be activation of intracellular 
protein tyrosine kinases (PTKs) which is essential for all subsequent activation events 
(Klausner and Samelson 1991). The TCR itself however has no intrinsic TK activity 
but T cells express three src-related PTKs; p56lck p59fyn and p60yes (Rudd et al 
1984). These PTKs possess a characteristic structure that includes a unique N- 
terminal region, src homology regions 2 and 3 (SH2 and SH3 domains), a catalytic 
tyrosine kinase domain (SHI domain) and a regulatory C-terminal motif. The CD4 
and CD8 molecules were initially found to associate with p56^cK and subsequently 
p59fyn was found to interact with the TCR£ chain and the CD3y5e chains through its 
N-terminal region. TCR crosslinking has been shown to lead to the rapid activation of 
c-fyn. In addition a fourth PTK, Zap-70, which is a member of the syk family of 
TKs is also implicated in TCR signal transduction ( Samelson and Klausner 1992, 
Rudd et al 1994). Therefore it has become apparent that a variety of PTKs are 
crucially involved in T cell signalling.
The kinase activity coupled to TCR£/CD3 -CD4 leads to phosphorylation of 
downstream targets such as phospholipase C y (PLCy) and possibly Mitogen 
Activated Protein (MAP)-2 kinase (Park et al 1991, Rudd et al 1995).
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Phosphorylation of PLC y by an as yet unidentified PTK leads to the hydrolysis of 
phosphatidyl inositol 4,5, bisphosphate (PIP2) and the formation of inositol 1,4,5 
triphosphate (IP3) and 1,2-diacylglycerol (DAG) which act as second messengers in 
the signalling pathway (Perlmutter et al 1993, Berridge and Irvine 1984, Imboden and 
Stobo 1985).
IP3 causes release of calcium (Ca2+) from intracellular stores leading to a transient 
increase in intracellular Ca2+ concentration followed by extracellular Ca2+ influx 
which can be mimicked by ionophores such as ionomycin (Weiss et al 1984, Weiss 
and Imboden 1987). Calcium ions then bind to a small protein - calmodulin which 
acts as a regulatory subunit for other enzymes essential for T cell activation such as 
the threonine/serine phosphatase - calcineurin. The importance of calcium signalling 
is evidenced by the inhibition of T cell activation using cyclosporin A (CsA see 
Figure 1.1 page 7), CsA blocks T cell activation by binding to cyclophilin which 
inhibits the ability of calcineurin to dephosphorylate its substrate (Mueller et al 1989, 
Fmman et al 1992). The calcineurin pathway is known to control activation of the 
transcription factors NF-AT and NFkB. These events in association with a second 
signal lead to the production of cytokines that mediate T cell effector function (Wolff 
et al 1992).
Cytokines pl^y essential roles in the regulation of the growth, differentiation and 
functional activities of immune cells. The pleiotropic effects of cytokines are 
mediated through binding to specific high affinity receptors on the cell surface. One 
of the most crucial cytokines produced by T lymphocytes is IL-2 (Fraser et al 1993).
Phosphorylation and dephosphorylation appear to be integrally involved in T cell 
activation. PKC phosphorylates the CD3y chain of the CD3/TCR complex on serine 
(Cantrell et al 1985) which appears to play an essential role in the induction of the IL- 
2 gene expresssion by the CD3/TCR complex (Valge et al 1988). Protein tyrosine 
phosphorylation is also a proximal and obligatory cellular response to cytokine 
receptor occupancy. Phosphorylation and dephosphorylation of NFkB or NF-AT 
induces or represses target genes such as EL-2. The signal transduction of most if not 
all cytokine receptors is critically dependent on asssociation with the Janus Kinase 
(JAK) family of PTKs (Rudd et al 1995).
Active PKC can stimulate the cellular proto-oncogenes p74raf and p21ras, second 
messengers common to multiple different signal transduction pathways
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Figure 1.1 Schematic diagram  of signalling pathways in a T lvmphocvte.
Some of the pathways involved in T cell signalling leading to production of IL-2 from 
CD4+ T lymphocytes are shown. TCR signalling leads to activation of a number of 
tyrosine kinases (PTK) such as p561ck, p59fyn and p70 zap. CD4 and CD8 (not shown) 
interact with p561ck Phosphorylation of PLC leads to the hydrolysis of PIP2 and the 
formation of DAG and IP3. TCR signalling appears to be calcium dependent as CsA 
inhibits activation whereas CD28 signalling appears to be Ca independent and resistant to 
CsA.
Ag = peptide antigen presented on MHC class II molecules, PTK = protein tyrosine 
kinase, PLC = phospholipase C, DAG = diacylglycerol, CsA = cyclosporin A, PIP2 
= phosphatidyl inositol 4,5 bisphosphate, PIP3 = inositol 1,4,5 triphosphate , PKC = 
protein kinase.
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(Downward et al 1992). p21ras activation can regulate cell cycle progresssion 
(Downward et al 1992) triggering a serine threonine kinase mediated signal 
amplification cascade culminating in the activation of MAP-kinase (Kamitz and 
Abraham 1995) which regulates the expression of mitogen responsive genes by 
phosphoiylating specific transcription factors. Many cytokines trigger rapid increase 
of activated Ras which is evidence supporting a crucial role of this molecule in T cell 
signalling.
Activation of the two src-related PTKs, p56lck and p59fyn is regulated by the protein 
tyrosine phosphatase CD45 and TCR mediated signalling crucially requires the 
phosphatase activity of this molecule (Mustelin et al 1989, Mustelin et al 1992).
CD45 is expressed on the cell surface of all haematopoietic cells and their precursors 
with the exception of platelets and erythrocytes.
It can therefore be seen that rather than one pathway of TCR signal transduction there 
exists in T cells a complex web of coupling and signalling molecules and of kinases 
and phosphatases.
1.5 T cell interaction with APCs.
i
It has become apparent that in addition to the TCR/MHC there are multiple receptor- 
ligand interactions that occur between the T cell and the APC. Many are adhesive 
such as that between LFA1(CD1 la/CD18) and ICAM-1-3, or between LFA3 and 
CD2, which reinforce the contact between the two cells (Springer 1987, Springer 
1990) while others serve to transduce additional signals to the T cell (Bierer and 
Burkoff 1991). It is difficult to distinguish between an adhesive compared to a 
stimulatory signal, for example CD2 ligation may mediate or enhance T cell 
activation, suggesting that the signals from the CD2 adhesive interaction with LFA3 
are integrated with TCR signals (Springer et al 1990). One of the difficulties in the 
study of T cell activation has been resolving whether an interaction is merely 
adhesive or provides a function which contibutes to activation signals. Interactions 
which provide additional signals independent of those produced via TCR engagement 
are termed costimulatory.
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1.6 Costimulation of T cell activation.
The interaction which takes place between the T lymphocyte and an APC is 
increasingly being seen as cmcial for T cell effector function. Moreover, following 
the discovery that ligation of the TCR in the absence of a functional APC lead to 
functional inactivation of a T cell clone (Quill et al 1987, Jenkins et al 1987) it was 
hypothesised, that in addition to MHC/peptide interaction with the TCR, other 
accessory cell dependent signals were required to costimulate T cell activation 
(Mueller et al 1989). These experiments suggested that signals from accessory cells 
were required in addition to TCR engagement to facilitate T cell effector function in 
agreement with a two signal model of T cell activation first proposed by Bretscher 
and Cohn (1970). Signal 1 is via the TCR while signal 2 (the costimulatory signal) is 
thought to be dependent on accessory cells.
Attempts to elucidate the nature of the costimulatory signal has led to the conclusion 
that the interaction between the CD28 molecule expressed on T lymphocytes and its 
ligand B7-1 generates such a signal.
f
1.7 The CD28 family of receptors.
The first ligand demonstrated for B7-1 was the CD28 molecule which is a 44Kd 
homodimeric glycoprotein conserved between human and mouse and which belongs 
to the immunoglobulin superfamily. This molecule was first identified in studies with 
anti-T cell mAbs as a differentiation antigen expressed on CD4+ and on some CD8+ 
T cells (Hansen et al 1980). CD28 is also present at detectable but at low levels on 
CD4+CD8+ thymocytes and expression is enhanced by activation in vitro (Turka et 
al 1990).
A second receptor for B7-1 has also been identified, CTLA-4 (cytolytic T 
lymphocyte associated antigen 4), which was cloned from a subtraction library 
derived from cytotoxic T cells (Brunet et al 1988). CTLA-4 is induced transiently at
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low levels on activated CD4+ and CD8+ T cells and its presence is restricted to the 
memory population of these cells (Linsley et al 1992, Freeman et al 1992). There is a 
high homology between the mouse and human genes for CTLA-4, in addition CTLA- 
4 has homology with the CD28 gene and maps to the same chromosome (Haiper et al 
1991, Dariavach et al 1988 and Lafage-Pochitaloff et al 1990). Surprisingly, despite 
low level expression, CTLA-4 binds to B 7-1 with 20 times higher affinity than 
CD28 (Linsley et al 1991a), which suggested that this molecule may play a vital role 
in T cell function and may influence the interaction between CD28 and B7-1. In 
addition knock-out mice lacking CTLA-4 develop lymphoadenopathy and massive 
tissue destruction and die by 3-4 weeks, supporting a critical role for CTLA-4 in T 
cell activation (Tivol et al 1995, Waterhouse et al 1995).
1.8 The B7 family
The B7-1 molecule, originally identified on the surface of activated B cells using the 
monoclonal antibody (mAb) BBl(Yokochi et al 1982), is a 44-54 kD glycoprotein 
also known as CD80. Much evidence now exists that B7-1 binds to CD28 providing 
costimulation to T cells promoting activation resulting in proliferation and IL-2 
production (I^oulova et al 1991, Gimmi et al 1991).
It was first postulated that there might be a CD28/CTLA-4 ligand in addition to B7-1 
when it was demonstrated that the functional interaction of CD28 with its ligand was 
less efficiently blocked by B7-1 antibodies than by CTLA-4- Ig, a chimaeric 
construct (Boussiotis et al 1993, Lenschow et al 1993, Wu et al 1993A). With the 
discovery that B7-1 deficient mice had very few obvious immune defects and that 
despite lacking B7-1, activated B cells still bound CTLA-4 came the search for a 
second ligand for CD28 (Freeman et al 1993). Simultaneously two groups reported 
the cloning of B7-2 (CD86), an additional ligand for CD28 (Freeman et al 1993, 
Azuma et al 1993a). When the human B7-1 and B7-2 cDNA sequences were 
examined only 25% sequence identity in the extracellular region was found, (Azuma 
et al 1993, Freeman et al 1993a and b) although there are indications of structural 
similarities (Freeman et al 1993b). B7-2 was shown to bind CD28 and induce the 
CD28 specific signal (Lenschow et al 1993, Engel et al 1994, Freeman et al 1993b). 
Therefore there is an additional complexity in the CD28/B7 interaction and ligation 
of CD28 by either B7-1 or B7-2 results in CD28 signalling.
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Studies on the expression of B7-1 and B7-2 have revealed that both are co-expressed 
on professional APCs, dendritic cells, activated B cells and macrophages but not on 
resting T or B cells or non-haematopoietic cells, B7-1 has also been shown to be 
found on some activated T cells (Sansom and Hall 1993, Azuma et al 1993b). 
Although the stimuli that induce B7-1 and B7-2 expression are similar, B7-2 is 
induced more quickly than B7-1, and is usually expressed at much higher levels 
(Linsley et al 1994) suggesting perhaps that these molecules serve different functions. 
The expression of both molecules is induced by LPS, IL-2, IL-4 or signals through 
surface immunoglobulin, CD40 or Class II MHC (Nabavi et al 1992, Hathcock et al
1994). In contrast, B7-1 and B7-2 have been demonstrated to have different binding 
determinants for CTLA-4 and to have differential kinetics for CTLA-4-Ig binding 
(Linsley et al 1994).
However, to date a distinct role for B7-1 compared to B7-2 is controversial, although 
differential roles for B7-1 and B7-2 have been suggested by the demonstration that 
administration of anti-B7-l antibody resulted in reduced disease severity in EAE 
whereas the use of B7-2 antibody increased disease severity (Kuchroo et al 1995). 
Additionally recent reports have shown that B7-1 preferentially acts as a inducer of 
Thl cells whereas B7-2 induces Th2 cells (Freemann et al 1995, Kuchroo et al 1995). 
These data suggest a role for B7-1 in determining which group of cytokines is 
produced in an immune reaction by influencing the development of either Thl cells 
or Th2 cells from a ThO precursor. Interestingly in autoimmune diabetes in the 
nonobese diabetic (NOD) mouse model the opposite was seen (Lenschow et al
1995). Mice treated with anti-B7-2 mAb did not develop the disease whereas anti- 
67-1 administration accelerated the development of the disease. These studies 
demonstrated that B7-1 and B7-2 have distinct regulatory roles during the 
development of autoimmune diseases and therefore may play different roles in 
costimulation of T cell activation. The conflicting results in these two diseases may 
reflect the stage at which the antibodies interact with the disease process and the 
involvements of different patterns of cytokine production. Clearly, an understanding 
of how these interactions regulate the disease process will contribute to our 
understanding not only of the disease itself but also autoimmunity and the process of 
T cell activation.
Recent evidence has shown that B7-1 molecules are capable of inhibiting T cell 
activation (Sethna et al 1994). Constitutive expression of B7-1 on resting B cells in
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transgenic mice resulted in a defect in T cell-dependent antibody production and 
treatment with anti-B7-l restored the capacity of these mice to respond, 
demonstrating that the deficient antibody responses are directly attributable to the 
expression of B7 (Sethna et al 1994). These results suggest that in addition to 
costimulating productive outcome of TCR engagement B7-1 may also have negative 
effects on T cell activation. The B7 family thus plays an important role in regulation 
of T cell function while modulation of B7 expression may influence the outcome of T 
cell activation.
1.9 Function of the CD28/B7 interaction.
The functional outcome of CD28 interaction with B7 has been the subject of intense 
study. Anti-CD28 mAbs were found to augment the expression of the IL-2 receptor 
(CD25) a  chain and to enhance production of cytokines from T lymphocytes 
including IL-2, IFNy, TNFa and IL-4 (Thompson et al 1989, Lindsten et al 1989). 
Costimulation appears to occur at the transcriptional level of the IL-2 promoter, 
causing an increase in IL-2 via accumulation and stabilisation of IL-2 mRNA and 
direct upregulation of the IL-2 enhancer (Linsley et al 1991b). Thus T lymphocyte 
function is critically dependent on the interaction between B7 and CD28.
Antigen and accessory cell-dependent priming for IL-4 and IFNy production was 
shown to be critically dependent on CD28 costimulation as assessed using inhibition 
by CTLA-4-Ig, thus suggesting that CD28 costimulation pathway can also play a role 
in the development of Th cells (Seder et al 1994). Thl cells predominantly produce 
EL-2 and IFNy whereas Th2 cells secrete IL-4, IL-5 and IL-10. The factors that 
govern the Th subset differentiation are not completely understood, however a critical 
role for IL-4 in induction and expansion of the Th2 response and for IFNy in 
promoting a Thl profile has been shown (Swain et al 1990, Maggi et al 1992). Since 
IL-4 and IFNy are produced by activated and partially differentiated T cells the initial 
factors that favour IL-4 or IFNy secretion remain uncertain. However it has recently 
been demonstrated that CD28 may play an important role in the differentiation of the 
Th2 subset in humans (King et al 1995). This places CD28 as an important molecule 
in the development of specific T cell responses resulting in either the predominance 
of a Thl or Th2 response leading to production of a particular group of cytokines.
This is crucial to the host defence mechanism in diseases such as Leishmaniasis
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where regulation of a favourable versus deleterious outcome is mediated by the initial 
group of cytokines produced.
The two signal model for T cell activation can therefore be viewed as the ability of 
CD28 to deliver biochemical signals that synergise with TCR derived signals to 
mediate T cell responses.
1.10 Intracellular responses to CD28
In agreement with the two signal model of T cell activation, the signalling pathway 
coupled to CD28 appears to be different to the TCR/CD3 signalling pathway. The 
major pathway by which CD28 signals is resistant to CsA and consequently 
independent of calcium signals (June et al 1987).
T lymphocyte proliferation and IL-2 production was blocked using herbimycin A, a 
PTK inhibitor (Vandenburghe et al 1992) which suggested that PTKs and tyrosine 
phosphorylation are essential for CD28 induced responses. CD28 activates a 
signalling pathway that results in the appearance of a nuclear protein complex. This 
complex in turn interacts with a CD28-specific response element in lymphokine gene 
regulatory regions corresponding to their transcriptional activation (Fraser et al 1991, 
1992).
Phosphorylation of a specific tyrosine residue in the intracellular domain of CD28 
creates a binding domain for PI-3 kinase (Page et al 1994). Formation of products of 
PI3 kinase and association of active PI-3 kinase with CD28 have been reported by 
several groups (Ward et al 1993, Stein et al 1994, Ueda et al 1995). In addition 
blocking of proliferation and IL-2 production dependent on CD28 costimulation was 
demonstrated using wortmannin, a specific inhibitor of PI3 kinase. These results 
however are controversial and Lu and colleagues (1995) have shown no effect of this 
inhibitor which may indicate the involvement of other signalling pathways in CD28 
costimulation. It appears that the state of activation of the T cell may account for 
this discrepancy as CD28 has the capacity to couple to multiple signalling pathways 
depending on the overall state of T cell activation (Sansom et al 1995).
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In addition to PI-3 kinase signalling CD28 costimulation has also been found to 
induce the sphingomyelin (SM) signalling pathway. T cell proliferation is under the 
strong influence of this pathway which has similarities to the phosphoinositide signal 
transduction pathway (Kolesnick et al 1994). The SM pathway is initiated by the 
enzymatic hydrolysis of the phosphodiester bond of SM by a specific SM-directed 
phospholipase C, generating ceramide and phosphocholine. Two forms of 
sphingomyelinase (SMase) have been identified, a neutral SMase is distinguished 
from an acidic isozyme by Mg2+ dependence and DAG independence. Ceramide 
serves as the second messenger of the SM pathway and is known to induce 
proliferation, differentiation, or both in some cells (Olivera et al 1992). Recently, 
CD28 has been demonstrated to trigger A-SMase activation in resting as well as in 
activated T cells (Boucher et al 1995). CD3 triggering did not elicit ceramide 
production by A-SMase indicating that this lipid messenger system is a distinct 
costimulatory pathway. Additionally over-expression of recombinant A-SMase was 
shown to substitute for CD28 in the NFkB pathway (Boucher et al 1995). Therefore 
the SMase signalling pathways appears to be critically important in transducing 
signals received through CD28.
Several immediate targets for ceramide action have been identified. A serine/ 
threonine kinase termed Ceramide-activated Protein Kinase has been characterised 
(Mathias et at 1991) which has been shown to phosphorylate and activate 
recombinant human Raf. Other targets include a cytosolic serine /threonine 
phosphatase and the £ isoform of PKC (Lozano et al 1994).
Another immediate consequence of CD28 ligation is phosphorylation of the Protein 
Tyrosine Kinase Itk (August et al 1994). CD28 signalling has also been shown to 
cause a sustained down-regulation of IkBa, an inhibitor of the c-rel family of 
transcriptional factors, which allows the nuclear translocation of c-rel (Lai and Tan
1994). This is suggested to cause sustained upregulation of IL-2 gene expression 
supporting the hypothesis that CD28 plays a crucial role in IL-2 production and T cell 
activation.
A recent report demonstrated that TCR and CD28 signals are both required for full 
activation of two mitogen activated protein kinases, JNK1 and JNK2 which are 
involved in phosphorylation of the c-jun activation domain and activation of the 
transcription factor API (Su et al 1994). Studies from several laboratories have 
revealed a crucial role for AP-1 in T cell activation. Thus it appears that TCR and
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CD28 signalling may be integrated at the level of JNK rather than by eliciting 
different transcriptional factors that integrate at the level of the promoter.
These data add considerable weight to the ability of CD28 signals to act as a prime 
costimulator of T cell activation. Co-operation between the CD3 and CD28 pathways 
is essential in order to mount an effective T cell response. Co-ordination of signals 
may be one way in which the immune response regulates T cell activation.
1.11 Function and signalling capcacity of CTLA-4.
The function of CTLA-4 on T cells is still under investigation, but unlike CD28, 
CTLA-4 expression is not constitutive and only occurs after T cell activation by 
TCR/CD3 and CD28 ligation (Guinan et al 1994, June et al 1994, Linsley and 
Ledbetter 1993). It has been shown that CTLA-4 co-operates with CD28 to enhance 
T cell proliferation (Linsley et al 1991a, Linsley et al 1992, Damle et al 1994). 
However, others have suggested that CTLA-4 might inhibit CD28-induced functions 
either by competing for B7-1 or B7-2 or by generating a negative regulatory signal 
(Walunas et al 1994, Jenkins 1994). Studies with CD28 deficient mice have 
demonstrated much reduced proliferative responses (Green et al 1994a), CTLA-4+ T 
cells from these mice do not benefit from costimulation by B 7-1+ accessory cells in 
the presence of phorbol esters suggesting that this interaction does not promote 
proliferation. In addition, CTLA-4 knockout mice have recently been generated and 
CTLA-4 demonstrated to be critically important for down-regulating T cell activation 
and maintaining lymphocyte homeostasis (Tivol et al 1995, Waterhouse et al 1995)
On balance the CTLA-4/B7 interaction does not appear to transduce a positive 
costimulatory signal and may in fact interfere with CD28 signals. It thus appears that 
ligation of CD28 may costimulate T cell activation while engagement of CTLA-4 
may be involved in regulation of T cell effector function. CTLA-4 may therefore play 
a crucial yet still unclear role in T cell signalling. In support of a differential function 
of CD28 versus CTLA-4 it has been shown that CD28 engagement by B7-1 
downregulates CD28 synthesis and function at approximately the same time as 
CTLA-4 expression increases (Linsley et al 1993). Furthermore, it was demonstrated 
that crosslinking of CTLA-4 together with the TCR and CD28 results in profound 
inhibition of IL-2 production and proliferation (Krummel et al 1995). It is thus 
suggested that crosslinking of CTLA-4 in the absence of CD28-mediated
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costimulation can induce deletion of previously activated T cells, indeed a mAb to 
CTLA-4 has recently been generated which induces apoptosis in previously activated 
T cells (Gribben et al 1995). It can be hypothesised from these studies that CD28 and 
CTLA-4 do not carry out redundant functions and that CTLA-4 may modulate CD28 
dependent responses.
The signalling capacities of CTLA-4 are relatively unknown although an association 
between CTLA-4 and PI3 kinase has been observed (Schneider et al 1995). However 
no such association was observed by other investigators (Stein et al 1994).
Integration of costimulatory signals from CD28 and inhibitory signals from CTLA-4 
may therefore determine the outcome of TCR engagement The role of CTLA-4 thus 
might be to regulate T cell responses by terminating IL-2 production and thereby 
promoting the generation of memory T cells in order to mount a more effective 
secondary response to infection. These studies warrant fresh investigation of the 
signals induced by engagement of the CTLA-4 molecule perhaps looking at the SM 
pathway and ceramide production.
The temporal patterns of expression of B7/CD28/CTLA-4 suggest that the biological 
activities of B7 - CD28/CTLA-4 costimulation are modulated during the 
development of immune responses. Perhaps therefore there is an additional 
complexity to the idea of the two signal hypothesis in that regulation of the 
expression by T cells of CD28 and CTLA-4 may modulate T cell responses. In 
addition regulation of expression of B7-1 and B7-2, by the APC and also due to local 
environment, may add to the complexity of immune response generated by the T 
lymphocyte. Together these data suggest that CD28/CTLA-4 is the major, if not the 
only receptor family of APC-derived signals that costimulate TCR signals and 
control proliferation. The interaction of the CD28/B7 families is therefore a prime 
mediator of the outcome of T cell activation and regulation of this interaction may 
influence the development of the immune response.
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1.12 Mechanisms of self tolerance
The establishment of a T cell repertoire which reacts to and eliminates foreign 
pathogens but remains unreactive or tolerant to self-antigens is essential in order to 
maintain a functioning immune system. Two distinct mechanisms of T cell tolerance 
have been defined and studied. First, clonal deletion is considered the principal 
mechanism of selection occurring during maturation of thymocytes in the thymus 
(Kappler and Marrack 1987). In contrast hyporesponsiveness (anergy) and Activation 
Induced Cell Death (AICD) are considered to be the mechanisms responsible for 
tolerance induction of mature peripheral T lymphocytes. Both functional inactivation 
and deletional mechanisms are now thought to contribute to central and peripheral 
tolerance (Cohen et al 1992).
1.12.1 Central tolerance: Elimination in the Thymus.
Mechanisms that regulate cell death and survival are essential for normal 
development and-maintenance of homeostasis. The major mechanism for elimination 
of self-reactive thymocytes is by programmed cell death (PCD) in the thymus 
(Jenkinson et al 1989, Kappler and Marrack 1987). The most common 
morphological expression of such programmed cell death is apoptosis. The 
characteristics of apoptosis include ; cell shrinkage, blebbing of the plasma 
membrane and nuclear collapse. Fragmentation of the nuclear chromatin at 
intemucleosomal sites occurs via activation of an endogenous nuclease (Kerr 1971, 
Wyllie 1994). During the apoptotic process, the cytoplasm of affected cells 
condenses, the plasma membrane becomes convoluted and condensation of the 
nucleus occurs. At the final stage of apoptosis, the cells themselves are fragmented 
(apoptotic bodies) and are phagocytosed by neighbouring macrophages and 
granulocytes (Raff 1992, Wyllie 1980). This ensures that the apoptotic cell contents 
do not remain in the immune system which may lead to inflammation and tissue 
damage. This contrasts with necrosis which can lead to inflammation (Barr and 
Tomei 1994).
PCD occurs when a cell activates an internal programme of suicide as a result of 
either external or internal signals, apoptosis is therefore often termed death from the 
inside out. External signals include an array of pathological conditions such as
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irradiation, heat shock and toxic substances. PCD has been observed in most if not 
all multicellular organisms and it occurs in a variety of processes from embryonic 
development to neurological homeostasis and lymphocyte maturation. Apoptotic 
death has also been shown to be highly conserved throughout evolution from plants, 
Caenorhabditis elegans and Drosophila to mice and humans. Just as cells induced to 
proliferate activate a programmed series of biochemical events leading to cell 
division, cells induced to die activate a distinct program of biochemical events 
leading to apoptosis.
During thymocyte ontogeny the genes of the TCR undergo rearrangement, thereby 
generating a large number of clonally diverse cells (Kappler and marack 1987, von 
Boehmer 1992). PCD is induced in immature T cells which have failed to express a 
functional TCR (selection by default) and T cells which express a high affinity TCR 
with potential self reactivity (negative selection) (von Boehmer 1992, Schwartz
1989). These cells are then eliminated from the thymus by engulfment by 
macrophages.
Concurrent with gene rearrangements, developing thymocytes also modulate the 
expression of a number of molecules on their cell surface, one of the first molecules 
newly expressed on human thymocytes is CD2 (Fox et al 1985). These CD2+ CD3* 
CD4* CD8"Cp28" cells expand, rearrange their TCR genes and progress to an 
intermediate stage of development where they express low levels of TCR and CD3. 
The vast majority of thymocytes use the TCR a  and P chains, acquiring other 
accessory molecules, including CD4, CD8, and CD28 at this stage (Lanier et al 
1986). Thymocytes which express a TCR with low affinity for self-MHC/peptide 
complexes survive (positive selection) and migrate from the thymus to begin life as 
mature peripheral T cells. Both positive and negative selection are thought to occur at 
this stage after which surviving thymocytes increase expression of CD3 and CD28, 
but lose either CD4 or CD8 before export into the periphery.
Positive selection in the thymus is thought to involve engagement of the TCR on 
immature CD3l°+ CD8+ CD4+ thymocytes with self MHC products expressed on 
the surface of thymic epithelial cells. It has been suggested recently that the overall 
avidity of the TCR complex and co-receptor molecules such as CD4 and CD8 
determine whether a T cell is positively selected or undergoes PCD due to default and 
negative selection (Penninger and Mak 1994). This ensures that only those 
thymocytes expressing TCRs with sufficient but not too great an affinity for self
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MHC are given the signal for maturation and proceed to leave the thymus and seed 
the peripheral lymphoid organs (Kisielow et al 1988, Sha et al 1988). These cells are 
then capable of recognising foreign peptide presented by self-MHC on an APC. T 
lymphocytes which fail to express functional TCR or those with too high an affinity 
for self-MHC die by PCD and are removed from the thymus.
Successful engagement of the TCR with MHC class I molecules leads to 
differentiation into CD8+ CD4" T cells which are most often cytotoxic T cells, while 
engagement with class II leads to differentiation into CD4+CD8- T helper cells (Teh 
et al 1988). Signals mediated by CD4 and CD8 have also been shown to influence the 
specificity of the emerging thymocyte: upon MHC recognition by the developing 
thymocyte, TCR/CD3 mediated signalling is enhanced by co-ligation with CD4 or 
CD8 (Turka et al 1991). It has been suggested that the state of activation and 
differentiation could render thymocytes susceptible to positive or negative signals 
(Russell et al 1991). Therefore thymic development depends on the expression of 
molecules other than TCR for selection of T cells capable of responding to antigen.
It is well established that thymocytes are highly susceptible to PCD and most of the 
death of unwanted T cells seen in thymic deletion has been shown to occur via 
apoptosis. Triggering of cell surface receptors such as CD3/TCR with anti-CD3 
mAbs has been shown to lead to PCD in immature T cells (Smith et al 1989). This 
provides evidence for a dual outcome of TCR engagement resulting in a proliferative 
response when costimulated or in death when costimulation signals are not provided. 
Ionomycin alone strongly induced death via apoptosis in immature thymocytes 
(Smith et al 1989) which suggested that an increase in intracellular calcium alone was 
sufficient to induce the cell suicide response. Further evidence that clonal deletion of 
autoreactive cells involves apoptosis was reported in the neonatal mouse thymus 
(MacDonald and Lees 1990). A significant population of CD4+ T cells bearing 
autoreactive TCR were found in these mice and when placed in culture a large 
proportion die. Death was prevented by inhibitors of macromolecular (RNA and 
protein) synthesis implying that this was an active metabolic process. T cell death in 
the thymus therefore may occur via TCR engagement without costimulation via a 
calcium dependent metabolically active pathway.
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1.12.2 The role of costimulation in thymic deletion.
The role of CD28 as a costimulus in the thymus remains controversial. CD28 is 
expressed on mouse and human thymocytes and B7-1+ T cells have been observed in 
sections of human thymus (Yang et al 1988, Gross et al 1992). A potential role for 
CD28 signal transduction was suggested by the demonstration that B7-1 is expressed 
on thymic stromal cells (Turka et al 1990, Vandenberghe et al 1993). A possible 
model of thymic selection was proposed in which CD4 or CD8 enhance TCR/CD3 
signalling upon co-ligation by an MHC molecule. If CD28 is ligated by a B7-1 
expressing stromal cell, this could lead to proliferation and positive selection. In the 
absence of CD28 signalling the enhanced TCR/CD3 signals might lead to apoptosis 
and negative selection. However in vitro studies using CTLA-4-Ig to study thymic 
negative selection in mice have not supported a role for B7-1/CD28 (Jones et al 1992, 
Page et al 1993). In addition negative selection as assessed by deletion of self- 
reactive T cells bearing particular Minor lymphocyte stimulating (Mis) antigen 
determinants proceeded normally in CD28 deficient mice (Shahinian et al 1993). 
However in vivo studies indicated that, consistent with the medullary location of B7-
I expression, CD28 may indeed have a role in negative selection (Punt et al 1994). 
IL-7, which is abundantly expressed in thymus where it drives T cell gene 
rearrangement, has been shown to induce T cell B7-1 expression (Yssel et al 1993), 
which might support the idea of CD28 costimulation in the thymus.
The different consequences of TCR signalling in CD4+CD8+ thymocytes depending 
upon the presence or absence of costimulatory signals, provides another model for 
the basis for the difference between positive and negative selection processes.
Positive selection may be initiated when the TCR is engaged in the absence of 
costimulation, whereas negative selection may occur as a result of a high affinity 
TCR interaction in the presence of a costimulatory signal (Punt et al 1994). The 
nature of the cell presenting antigen to an immature thymocyte may also determine 
whether positive or negative selection takes place as not all cells which express class
II MHC in the thymus are also capable of costimulation. This is similar to the 
requirement for costimulation in order for T cell proliferation to occur in the 
periphery. Costimulatory signals and cell to cell interactions are therefore important 
throughout T cell development. T cells are thus programmed with the information 
they need to make the decision to live or die depending on their surroundings.
20
1.12.3 Peripheral Tolerance: Anergy
The existence of a multitude of diseases with an autoimmune pathology lays 
testimony to the prevalence of autoreactive T cells in the periphery. The functioning 
of a normal immune system depends on silencing these autoreactive T cells and 
preventing their expansion. The ability to prevent activation of autoreactive T cells 
may be a routine function of a normal immune system, maintained by limiting 
exposure of professional APCs to self antigen or by presenting self antigen on 
inefficient APCs in a way that functionally inactivates these T cells.
An in vitro mpdel of T cell tolerance was first described in which IL-2 driven 
proliferation of CD4+ T cell clones, responding to peptide antigen and syngeneic 
APCs, was blocked if the APCs were pretreated with a chemical fixative (Jenkins and 
Schwartz 1987). Instead of stimulating proliferation in the presence of specific 
antigen, these fixed APCs induced the T cells into a state of proliferative 
unresponsiveness termed anergy. This led to the suggestion that the APCs lacked the 
capacity to provide costimulation to drive a proliferative response, supporting the two 
signalling model of T cell activation first proposed by Bretscher and Cohen (1970), 
who hypothesised that T cells, in addition to signal 1 (TCR engagement), also 
required signal 2 (costimulation) in order that T cell activation takes place.
Peripheral tolerance in vivo was first observed by demonstrating 
unresponsiveness to the Mis antigen (Ramensee et al 1989). Most murine T cells that 
express the Vp6 TCR gene segment are reactive against Mis-la antigens, therefore 
by using an anti Vp6 mAb the fate of Mis-la specific T cells were able to be 
monitored in Mis-lb mice. These mice were made specifically unresponsive to Mls- 
la because the antigen was expressed on resting B cells, which are not professional 
APCs. The induced unresponsiveness in this system was shown to be due to clonal 
inactivation or anergy and not deletion since VP6 cells were still present in the 
periphery. The anergic cells in Mis-lb mice expressed IL-2 receptors but did not 
produce IL-2, in contrast to VP6 cells from naive mice. In agreement with this model, 
presentation of antigen by MHC expressed on non-lymphoid cells which do not 
function as professional APCs has been shown to result in the functional inactivation 
of T cell clones (Lo et al 1990, Burkly et al 1990). These cells do not express B7-1 
or B7-2, thus they cannot trigger CD28 signalling. Therefore tolerance in the
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periphery may be mediated by presentation of antigen on non-professional APCs 
which are incapable of providing costimulation via CD28.
A number of models of T cell anergy have now been described (Hewitt et al 1992, 
Lamb et al 1983), including the induction of T cell unresponsiveness by modulating 
surface CD3 with an anti-CD3 mAb in the absence of costimulatory signals (Davis et 
al 1989). This generated an initial increase in Ca2+ concentration which failed to 
induce T cell activation. This again indicates the potential for multiple outcomes of 
TCR engagement depending on the presence or absence of costimulation. Therefore 
there is considerable evidence which shows that in the absence of costimulation, 
engagement of the TCR results in a state of unresponsiveness in the T cell, 
characterised by failure to activate the IL-2 gene and proliferate in response to further 
antigenic challenge. Anergy can thus be considered to be an important mechanism in 
maintaining self tolerance and in regulating the magnitude of responses to foreign 
antigen.
It has also been proposed that differential tolerance induction occurs in naive and 
memory T cells, the latter being shown to be much more susceptible to anergy 
induction than naive T cells (Davis and Lipsky 1993). T cell clones which are further 
differentiated than memory cells were also shown to be particularly sensitive to 
inactivation by tolerising signals. The sensitivity to tolerance induction may play a 
crucial role in limiting the capacity of memory cells to respond to self antigens after 
presentation by non-professional APCs. This suggests that there are multiple 
pathways of anergy induction, each acting at different stages of T cell development 
providing the immune system with fail-safe mechanisms to prevent self-reactivity.
1.12.4 The involvement of CD28 in peripheral tolerance.
Ectopic expression of MHC molecules on non-lymphoid cells, which do not express 
B7-1 or B7-2, can induce anergy in T cell clones (Lo et al 1990, Burkly et al 1990) 
which lead to the suggestion that lack of costimulation via CD28 may lead to 
tolerance induction in the periphery. Furthermore, the involvement of CD28- 
mediated signalling in prevention of anergy has been demonstrated using a mAb to 
murine CD28 (Harding et al 1992). Evidence from studies on human T cells has 
shown that blocking the interaction between CD28 and B7-1 when T cells are 
presented with alloantigen in a mixed leukocyte culture, leads to hyporesponsiveness
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to the alloantigen (Tan et al 1993). Blocking was carried out using either anti-CD28 
mAb fragment or CTLA-4-Ig, a chimaeric immunoglobulin fusion protein 
containing the extracellular domain of CTLA4. These experiments demonstrated the 
importance of the CD28/B7 interaction in T cell proliferative responses.
Interestingly it has been shown that T cells receiving a tolerising signal from the 
superantigen Staphylococcal enterotoxin B (SEB) downregulate expression of CD28 
(O’Hehir et al 1990). Ligation of CD28 as has been discussed earlier results in the 
upregulation of IL-2 (Thompson et al 1989, Fraser et al 1991). Thus the loss of CD28 
will render this costimulatoiy pathway inactive, therefore emphasising the role 
played by CD28 in prevention of functional inactivation of T lymphocytes. 
Expression of B7 and CD28 may therefore be critically involved in regulating the 
response to autoantigens.
It has been recently demonstrated that hyporesponsiveness resulting from TCR 
engagement stems from a selective defect in the early signal transduction initiated by 
TCR crosslinking (Dubois et al 1994). Furthermore it was shown that tyrosine 
phosphorylation and calcium mobilisation were both deficient in anergic cells while 
diminished inositol phosphate hydrolysis has also been shown in these cells (Dubois 
et al 1994). The AP-1 complex may also be a unique target for T cell clonal anergy 
(Kang et al 1992). CD28 signalling results in activation of AP-1 and it can therefore 
be concluded that CD28 costimulation is intimately involved with the prevention of 
anergy.
The importance of the B7-1-CD28/CTLA-4 pathway for peripheral tolerance has also 
been demonstrated in vivo. Blocking CD28-B7-1 interactions inhibits rejection of 
human pancreatic islet grafts in mice (Lenschow et al 1992) and CTLA-4-Ig 
treatment resulted in prolonged donor specific unresponsiveness to the xenogeneic 
islets. This suggests that blocking the CD28/CTLA-4-B7-1 interaction may provide 
an approach to the suppression of graft rejection in humans. These results emphasise 
the importance of CD28/B7-1 interactions in preventing the induction of anergy and 
in delivering a costimulus to drive productive outcome of TCR triggering resulting in 
proliferation of antigen-specific T cells and effector function. Therefore CD28 
costimulation is intimately linked with the maintenance of tolerance in the immune 
system preventing the harmful activation of self-reactive T cells which could result in 
autoimmunity and disease.
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1.12.5 Peripheral Tolerance : Activation Induced Cell Death 
(AICD)
Dysregulated apoptosis has been proposed to be involved in the pathology of a 
multitude of diseases including cancer, heart disease, neurological disorders such as 
Alzheimers and AIDS. The uncontrolled cell growth observed in tumours may be 
caused by cell populations increasing their rate of proliferation, or decreasing their 
rate of apoptotic cell death or both. Therefore maintenance of a balanced immune 
response in the periphery is critically dependent on apoptosis.
1.12.5.1. Apoptosis in T lymphocytes
A number of murine T cell hybridomas undergo apoptosis within a few hours of 
activation by specific antigens, mitogens, mAbs against the TCR or a combination of 
phorbol ester and calcium ionophore (Shi et al 1989, Ucker et al 1989, Shi et al
1990). The mechanisms of death seen involved de novo synthesis of RNA and 
proteins which suggested that the apoptosis proceeds via an active metabolic 
pathway. Activation induced apoptotic death of T cells in the peripheiy has been 
demonstrated (Liu and Janeway 1990. Newell et al 1990). In addition, activated 
murine and human T cells expressing either ct/p or y/5 TCR undergo apoptosis when 
they are incubated with anti-CD3 mAb or PHA (Russell et al 1991, Janssen et al 
1991, Owen-Schaub et al 1992). Thus, evidence has accumulated that AICD via 
apoptosis is not limited to immature thymocytes and transformed T cells 
(hybridomas) but can be similarly triggered in mature peripheral T cells.
During primary activation both human and murine mature T cells change from an 
AICD resistant to AICD sensitive phenotype over a period of several days 
(Wesselborg et al 1993, Russell et al 1991). In the thymus however, elimination of T 
cells occurs within hours of first exposure to the deleting epitope (Murphy et al
1990). A characteristic of peripheral clonal deletion of mature T cells is that a 
transient phase of proliferation precedes cell deletion and ligand-specific 
hyporeactivity of persisting cells. Regulating the time needed to convert from a 
resistant to a sensitive phenotype may be one way in which T cells can undergo a 
primary activation without risking elimination. It is only during the second encounter 
with antigen that responding T cells are at risk of deletion through AICD.
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Consequently, AICD provides a mechanism for clonal deletion in the peripheral 
immune system and is therefore important in the maintenance of cell tolerance.
1.12.5.2 Susceptibility to apoptosis: activated versus resting 
cells
Data from numerous experimental systems have suggested that previously activated 
T cells are predisposed to the induction of apoptosis when given a second signal 
through the TCR. CD8+ CD57+ T cells can be induced to die via AICD following 
ligation of CD2 by certain combinations of anti-CD2 mAbs (Rouleau et al 1993). 
Signals mediated through CD3 allow these cells to enter cell division whereas signals 
via CD2 result in proliferation or apoptosis depending on the conformational changes 
imposed on the CD2 molecules and on the activation state of the cells. It appeared 
from these studies that once the cells have entered the cell cycle they become 
extremely sensitive to apoptosis. It can therefore be hypothesised that T cells are 
predisposed to apoptosis while undergoing cell division, perhaps by being driven to 
proliferate by the .addition of growth factors such as IL-2. Additionally, it has also 
been shown that pre-exposure of T cells to IL-2 renders these cell more susceptible to 
the induction of apoptotic death (Lenardo 1991). Interestingly, crosslinking of the 
TCR where IL-2 gene expression is prevented programs T cells at different stages of 
development for apoptosis in response to IFNy(Groux et al 1993). This is different to 
the death induced by cytokine deprivation as engagement of the TCR is necessary to 
induce death as well as inhibition of cytokines. This indicated that IL-2 production 
may be necessary for prevention of apoptosis. These results emphasise the complex 
nature of the T cell signalling response and that it is influenced by many factors. At 
some stages IL-2 may protect the cell from induction of apoptosis whereas at others 
IL-2 production may drive the T cell towards apoptotic death.
HIV-infected cells are more sensitive to apoptosis than are uninfected cells 
(Kobayashi et al 1990). An apoptotic mechanism of cell death after HIV infection has 
been suggested (Ameisen and Capron 1991) and it has also been demonstrated that 
mouse splenic T cells pretreated with anti-CD4 antibodies die by apoptosis. CD4+ T 
cells from HIV-infected individuals are primed in vivo for suicide via apoptosis, 
upon TCR activation by both superantigen and MHC II-restricted antigen (Groux et 
al 1992). Crosslinking of gpl20 on human CD4+ T cells followed by signalling 
through the TCR results in AICD (Banda et al 1992). The relevance of apoptosis to
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the aetiology of HIV infection has been substantiated by the demonstration of 
elevated levels of Fas/APO-1 on peripheral blood T cells of HIV infected individuals 
(Katsikis et al 1995). This results in the more rapid induction of apoptosis on these T 
cells.The role of Fas in mediating apoptosis of T lymphocytes is becoming 
increasingly more apparent.
1.13 The Fas Receptor.
The Fas antigen was first identified using a mAb which recognised myeloid cells, T 
lymphoblastoid cells or diploid fibroblasts and induced a cytolytic activity in cells 
expressing this antigen (Yonehara et al 1989). Another antibody termed APO-1 was 
also described which recognised activated or malignant T lymphocytes (Trauth et al
1989) and lead to death of tumour cells. Derived amino acid analysis of Fas cDNA 
indicated that it is identical to APO-1 and that both are members of the NGF/TNF 
superfamily which includes TNFRs, NGFR and CD40 (Itoh et al 1991, Oehm et al 
1992).
The mature Fas antigen is a 36 kD glycoprotein, comprised of 319 amino acids 
whose N-terminal 157 amino acids is extracellular while the C- terminal 145 
intracellular region is cysteine rich. Additional features include a membrane spanning 
region of 17 amino acids which place Fas as a Type I membrane protein. Staining of 
mouse thymocytes with an anti-Fas antibody indicated that these cells expressed the 
Fas antigen and were rapidly killed upon intraperitoneal administration of the anti- 
Fas antibody (Ogasawara et al 1993). Therefore Fas was demonstrated to be involved 
in cell death in vivo. Furthermore, expression of the cDNA for Fas in murine T cell 
lymphomas or fibroblasts resulted in susceptibility to apoptosis when ligated by a 
mouse anti-Fas antibody (Itoh et al 1991). Death was mediated by an endonuclease 
that preferentially digests intemucleosomal DNA (Itoh et al 1991), thus the peptide 
encoded by the Fas cDNA transduces the apoptotic death signal into cells. Together 
these results led to the hypothesis that Fas is intimately associated with apoptotic cell 
death in T lymphocytes.
The death signal is mediated by a segment at the carboxyl terminal of the Fas 
molecule that exhibits high homology with that of human TNFR1 (Itoh et all 991,
Itoh et a ll993) which can also transduce an apoptotic signal into cells (Tartaglia et al
26
1991). Specific mutational analysis (Itoh and Nagata 1993) defined a critical 68 
amino acid portion of Fas required for apoptotic signal transduction. A point 
mutation within this region was sufficient to abolish the ability of Fas to mediate 
apoptosis. This region has been called the death domain and has been demonstrated 
to be homologous to a molecule discovered in Drosophila termed reaper (Golstein et 
al 1995). Reaper is a 65 amino acid peptide, the expression of which is both 
necessary and sufficient for developmental cell death in Drosophila. The homology 
between reaper and the death domain of Fas suggested a common mechanism of PCD 
from drosophila to mammals indicating the importance of this process.
The Fas antigen has been shown to be encoded by the gene for the 
lymphoproliferative (Ipr) mutation in MRL mice(Watanabe-Fukunaga et al 1992). 
This is an autosomal recessive mutation which results in a phenotype which includes 
formation of multiple autoantibodies and accumulation of large numbers of non- 
malignant CD4 - CD8" T lymphocytes in the lymph nodes and spleen of affected 
mice. All strains of mice that bear the Ipr/lpr gene are predisposed to the 
development of this lymphoproliferative autoimmune disorder (Cohen and Eisenberg
1991). It is thus possible that Fas is involved in the development of autoimmunity 
seen in these mice. A comparison of the Fas gene from Ipr mice with that of wild 
type mice indicated an insertion of an early transposable element into intron 2 of the 
Fas gene (Adachi et al 1993). In addition two other mutations have been identified, 
Ipr08 and gld which cause similar complex disorders of the immune system. In all 
three cases an unusual type of T cell accumulates in the periphery which expresses 
the Thy-1 antigen and polyclonal a  and p TCRs but lacks both CD4 and CD8, and 
expresses a number of cell surface molecules more often found on B cells such as the 
B220 antigen. The lpr°8 mutation results in a Fas antigen which is unable to 
transduce the apoptotic signal inside the cell. The mutated site of lpr°8 has been 
shown to occur in the cytoplasmic death domain of Fas. Furthermore it has been 
shown that Ipr mice are resistant to AICD (Russell et al 1993, Bossu et al 1993). This 
suggested the involvement of Fas in autoimmune disease perhaps due to a loss of 
tolerance in the periphery. Consequently it is suggested that the Fas antigen plays a 
role in the development of peripheral tolerance mediated perhaps by its intrinsic 
involvement in T lymphocyte apoptosis. A defect in the Fas antigen may therefore 
result in aberrant apoptosis leading to autoimmunity and disease.
SLE is a human autoimmune disease which has characteristics very similar to those 
seen in MRL Ipr/lpr mice. It has been postulated that due to accelerated apoptosis in
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SLE increased amounts of nucleosomes are released into the extracellular milieu. 
(Emlen et al 1994). This may provide a continuous source of nuclear antigens to 
drive the autoantibody response in SLE hence contributing to disease aetiology. 
Additionally in both Ipr mice and SLE patients apoptosis of T lymphocytes is 
accelerated in vitro (Van Houten and Budd 1992) which suggests that they may have 
been primed in vivo for apoptosis but due to a defect in their ability to undergo Fas- 
induced apoptosis, they are prevented from dying in vivo. It is hypothesised that 
failure to undergo apoptosis in response to Fas ligation generates a population of cells 
that are predisposed to undergo apoptosis when the environmental conditions are 
altered such as in vitro culture. Any deviation from the balance between 
lymphogenesis and lymphocyte death may endanger an individual by causing hypo- 
or hyper-immune responses, as evidenced by the consequences of altered lymphocyte 
death in SLE and Ipr mice.
1.14 Fas Ligand (Fas-L).
It has previously been suggested that Ipr and gld are mutations encoding an 
interacting pair of molecules involved in T cell development (Allen et al 1990).
Using a CTL line which had cytotoxic activity against wild type but not Ipr mice 
Rouvier et al (1993) suggested the presence of a ligand for Fas on the surface of these 
cells. A cDNA for the Fas ligand (Fas-L) was isolated using these cells and structural 
analysis carried out (Suda et al 1994) which revealed that the Fas-L was a type II 
membrane protein homologous to members of the TNF family. This includes TNFa, 
TNFp, LT and the ligands for CD40, CD27 and CD30. The murine gene for Fas-L 
has been mapped to Chromosome 1 (Takahashi et al 1994) where the gld mutation is 
localised and the gld mutation shown to abolish the ability of Fas-L to bind Fas. This 
indicated that gld mutation lies within the Fas-L gene and this mutation and Ipr 
encode a ligand and receptor involved in mediating cell death. When recombinant 
Fas-L was expressed in COS cells apoptosis was induced in Fas-expressing target 
cells (Suda et al 1994). Northern blot analysis of rat tissues indicated that Fas-L 
mRNA is expressed abundantly in the testis, moderately in the small intestine and 
weakly in the lungs. The limited expression of Fas-L RNA suggested perhaps that 
expression of this gene is tightly regulated in order to control Fas-L mediated 
apoptosis. These results indicate the importance of the Fas/Fas-L interaction in T cell 
cytotoxicity.
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A direct role for Fas-L in T cell mediated cytotoxicity is supported by two studies 
suggesting that Fas is the major target for CD4+ mediated cytolysis (Stalder et al
1994) and that a component of CD8+ cytotoxic T lymphocyte (CTL) killing involves 
Fas-L (Rouvier et al 1993). The importance of Fas engagement in CD4+ CTL 
mediated cytotoxicity is further substantiated by the failure of both cloned and 
normal CD4+ CTL to lyse B cell blasts from Ipr mice (Stalder et al 1994). The direct 
involvement of Fas in the apoptotic pathway induced by CD4+ Thl and CD8+ 
cytotoxic T lymphocytes has also been demonstrated (Ju et al 1995). Additionally, 
Fas-L is expressed on freshly isolated natural killer cells (Arase et al 1994), which 
exhibit Fas-mediated cytotoxicity against Fas-expressing target cells. These studies 
emphasise the importance of the Fas/Fas-L interaction in mediation of cytotoxic 
killing and that, together with perforin-mediated cytotoxicity this is a major 
mechanism of T cell death.
1.15 The function of the Fas/Fas-L interaction.
There is conflicting evidence as to whether negative selection of autoreactive T cells 
is impaired in Ipr mice and whether the presence or absence of negative selection of 
T cells in the thymus determines whether lymphoproliferation occurs in the lymph 
nodes. The current consensus is that negative and positive selection is normal in Ipr 
and gld mice (Sidman et al 1992). In contrast it has been demonstrated that AICD of 
mature T cells does not occur in Ipr or gld mice in vitro (Russell et al 1993, Russell 
and Wang 1993). Furthermore, when SEB is injected into wild type mice, mature T 
cells expressing SEB-reactive Vp8 TCR chain initially proliferate, then die by 
apoptosis. This process could not be seen or was severely retarded in Ipr mice (Scott 
et al 1993) supporting the hypothesis that Fas expression is intimately linked with the 
apoptotic process.
A model for the involvement of the Fas system in the clonal deletion of autoreactive 
T cells has been proposed (Suda and Nagata 1995). APCs express the autoreactive 
peptide as a complex with MHC on their surface. The peptide/MHC complex 
interacts with the TCR on autoreactive T cells, which activates the cells and induces 
the expression of Fas and Fas-L. Such autoreactive T cells then kill each other 
through Fas-Fas-L interactions. The defect in Fas in Ipr mice results in the failure of 
T cells to undergo AICD leading to a build up of T cells specific for self antigen. This
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in turn leads to an accumulation of aberrant T cells in the mutant mice resulting in an 
enlarged spleen and large lymph nodes.
In conclusion it has been established that Fas-L binds to Fas and induces apoptosis. 
Lpr and gld mutations result in the development of lymphadenopathy and are loss of 
function mutations in Fas and Fas-L respectively. Thus it appears that the Fas/Fas-L 
interaction is intimately involved in the apoptotic process that occurs during the 
maturation of T cells and hence the maintenance of T cell tolerance in the periphery. 
Recently it has been demonstrated that stimulation of Fas receptor is essential for 
TCR-activation death induced in T cell hybridomas, Jurkat T leukaemia cells and 
previously activated T cells (Dhein et al 1995, Ju et al 1995, Brunner et al 1995).
TCR stimulation in all these cells was shown to induce expression of both Fas and 
Fas-L. Death in these systems has been shown to be mediated via Fas/Fas ligand 
interactions. Additionally, elimination of self-reactive B cells has also been shown to 
be dependent on Fas (Rathmell et al 1995). Together these studies established Fas as 
an important mediator of death in T cells at various activation states and also 
suggested its involvement in tolerance of both T and B lymphocytes. Fas-L is thus 
the prime mediator of the peripheral deletion of T cells and maintenance of peripheral 
tolerance. Therefore the interaction between Fas and Fas-L is critical in the 
development of T cell repertoire and immune cell homeostasis.
1.16 Fas signalling.
Despite an explosive interest in apoptosis and its importance in the maintenance of 
cellular homeostasis in many organisms, relatively little is known about the 
biochemical basis of this process. However in the last few years pieces of the jigsaw 
are being located although a complete picture is still a long way off.
Similar to TCR stimulation, Fas-initiated transmembrane signalling in Jurkat T cells 
has been demonstrated to involve the rapid activation of PTK resulting in tyrosine 
phosphorylation of cellular proteins (Eischen et al 1994). Blocking this protein kinase 
activation using inhibitors such as herbimycin A, genistein or staurosporine inhibited 
Fas -induced DNA fragmentation. Fas and TNFR share a 70 amono acid intracellular 
death domain that transduces the signal for cell death (Tartaglia et al 1993, Itoh and 
Nagata 1993). This conserved sequence does not contain any intrinsic kinase or
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phosphatase domains and it is therefore assumed to be coupled to separate signalling 
elements. Recently, three groups reported the isolation of genes encoding proteins 
that associate with the cytoplasmic domains of Fas or TNFR1, which were termed 
TRADD, FADD, and RIP (Hsu et al 1995, Chinnaiyan et al 1995, Stanger et al
1995). These proteins when transiently over-expressed in cells, all induce apoptosis, 
supporting a functional relationship to cell death. Apart fom their associating 
domains these proteins are unrelated and only one of the proteins RIP has been found 
to contain a kinase domain. Their exact role in Fas-dependent cell death has yet to be 
elucidated. Recently, a Fas activated serine threonine kinase (FAST) has been 
identified (Tian et al 1995) which is rapidly activated during Fas-mediated 
apoptosis.The activation of this kinase has been postulated to be involved in 
triggering the downstream events involved in apoptosis and to be one of the 
molecules activated during ceramide production.
The signal generated by Fas is transduced by a SM-ceramide turnover-mediated 
signalling pathway in a manner similar to CD28 and TNFa (Cifone et al 1993). 
Direct measurement of enzyme activity in Fas-stimulated U937 promyelocytic cells 
as well as other tumour cell lines and Fas transfected murine cells showed SMase 
activity. All Fas sensitive cells tested could be induced to undergo apoptosis after 
exposure to ceramide. Additionally Fas-ligation generated ceramide in Jurkat T cells 
and in a mastocytoma cell line transfected with Fas (Gulbins et al 1995). In these 
cells Fas ligation also activated Ras which was found to constitute a critical 
component of the apoptotic pathway. Ras is activated upon TCR ligation (Downward 
et al 1990) and has been demonstrated to lead to apoptosis in immature thymocytes 
(Green and Scott 1994). This therefore demonstrates the involvement of similar 
second messenger pathways in proliferation and apoptosis and indicates the 
interlinked nature of cell survival and cell death.
The involvement of calcium signalling in apoptosis and generation of the death signal 
is contentious. TCR/CD3 stimulation of mixed lymphocyte cultures or hybridoma T 
cells was able to induce Fas-based cytotoxicity (Vignaux et al 1995). The induction 
of Fas-mediated cytotoxicity was shown to be Ca2+ dependent whereas execution of 
cytotoxicity was not. The induction was sensitive to macromolecular synthesis 
inhibition in line with the demonstration of increased Fas-L expression (Vignaux et al
1995). The CD28 pathway and the Fas death pathway are therefore similar in their 
downstream signalling via the SM pathway and minimal dependency on calcium 
signalling.
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Fas also contains a negative regulatory element, a "salvation” domain at the carboxy 
terminus that structurally is not present in TNFR1 (Itoh and Nagara 1993). A recent 
report documented evidence that the 15 amino acid carboxyl terminus of Fas 
associates with a protein phosphatase that had previously been identified in basophils 
(Sato et al 1995). Cells that are resistant to Fas-L killing expressed this phosphatase 
whereas susceptible cells did not and resistance could be conferred by introducing the 
phosphatase into sensitive cells. This demonstrates the involvement of 
phosphorylation in mediating not only TCR signalling but also apoptosis once again 
demonstrating the similarity between the cell death and cell survival pathways.
The Fas/Fas-L pathway thus plays a vital role in apoptosis of T lymphocytes and the 
maintenance of a tolerant T cell repertoire. The signalling pathways mediating Fas- 
induced apoptosis remain the focus of intense study as does that role the Fas/Fas-L 
interaction might play in functions other than death.
1.17 Superantigens and the T cell response.
One of the major obstacles to studying clonal expansion and regulation of normal T 
cell function is the low frequency of antigen specific naive cells. Much has been 
learnt about the development of the T cell repertoire and immune effector functions 
by the study of superantigens (SAgs). These are a group of molecules which 
stimulate T cells at a higher frequency than normal peptide antigen. T cell receptors 
are composed of five variable elements, Va, Joe, Vp, Dp jp all of which contribute to 
the specific interaction of T lymphocytes with conventional peptide antigens 
presented in the context of MHC molecules (Herman et al 1991). There are 
potentially billions of possible combinations of these variable elements, and so the 
frequency of responding T cells to a given conventional antigen is very low. SAgs 
stimulate such large numbers of T cells because they stimulate virtually all T cells 
bearing particular v p  elements and are therefore a useful tool in the investigation of 
T cell function.
MHC class II proteins are the specific receptors for Staphylococccal enterotoxins 
(SEs) and other foreign SAgs (Buxser et al 1981). The requirement for class II MHC 
products for SEB binding has been demonstrated (White et 1989). Unlike
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conventional antigens , SEs do not require processing prior to their presentation by 
class II MHC. Metabolically inactive cells are able to present SEs to T cells while 
unable to present other intact protein molecules, these antigens are therefore useful 
for studying the role of accessory cell molecules in T cell activation.
SEB administration to neonatal mice has been shown to lead to the elimination of 
virtually all T cells bearing Vp3,8.1, 8.2, and 8.3. while in vitro, it has been 
demonstrated that T cells bearing these V0s were stimulated by SEB (Callahan et al
1989). Thus SEB can stimulate a dual outcome in T lymphocytes resulting in either 
proliferation or death. Upon challenge with SEB, a powerful immune response occurs 
in vivo in mice, within 1-2 hours high semm levels of IL-2 and TNF are released. 
Apoptosis and/or anergy induction has been proposed to reflect exhaustive 
differentiation, a consequence of vigorous T cell responses in vivo (Webb and Sprent
1990). It has been shown that both CD4+ and CD8+ Vp8+ T cells proliferate 
vigorously in vivo in response to SEB (MacDonald et al 1991). Lymph nodes from 
Balb C mice previously injected with SEB failed to respond to subsequent challenge 
by SEB in vitro as assessed by IL-2 production. These data lend weight to the 
observation that a differential outcome of TCR signalling by the same trigger may 
occur at different stages in an immune reponse depending on the maturation state of 
the T cell and its environment.
Interestingly, SEB induced anergy was not inhibited by anti MHC class II 
monoclonal antibodies (Hewitt et al 1992). The binding site for SEB lies on the side 
of the TCR remote from the peptide/MHC binding site. This study showed that a 
TCR of defined antigen specificity is able to interact with SEB in the absence of 
MHC class II antigens. Mutational and structural analysis of SEB suggests that the 
TCR and the MHC are brought into close proximity during SAg engagement 
(Kappler et al 1992, Swaminathan et al 1992). It has also been demonstrated that 
mutations within the p chain of class II MHC but not the a  chain result in a unique 
pattern of SEB recognition by VP8+T cells (Deckhut et al 1994). This supports the 
idea that there is a functional interaction between the a  chain of the TCR and the p 
chain of the MHC, providing further evidence for the formation of a tertiary complex 
between the TCR and peptide held in the groove of the MHC.
It has been proposed that TCR-CD3 down-regulation is involved in the induction of 
anergy (Hewitt et al 1992). Consistent with this, treatment of cells with SEB reduced 
TCR levels in a dose dependent manner. The capacity of the cells to increase
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cytosolic free Ca2+ concentration in response to subsequent exposure to SEB was 
proportional to CD3 levels (Hewitt et al 1992). This proposal has been substantiated 
recently by the demonstration that SEB induces TCR downregulation by increasing 
internalisation of the TCR into endocytic vesicles (Niedergang et al 1995). The result 
of TCR downregulation may be the uncoupling of the TCR from the signal 
transduction machinery or may result in lower levels of signalling to the cell. This 
may be why tolerised cells can be rescued by giving them a higher threshold of 
second signal or by the addition of IL-2. This however does not appear to be the 
universal mechanism of anergy induction but may serve as a model for the 
investigation of downstream signalling defects in maintenance of tolerance.
SAg mediated T cell anergy may be due to the differentiation of SEB reactive virgin 
T cells into anergic memory cells and/or the activation and subsequent deletion of 
virgin T cells. Naive and memory T cells are thought to be differentially stimulated 
by SAgs. Memory T cells are deficient in their ability to produce IL-2 after 
stimulation with SEB. The activation requirements of memory T cells are more 
stringent than those of naive T lymphocytes. This may reflect downregulated TCR 
level, however other factors such as expression of CD45 isoforms, CD28 regulation 
and the expression of Fas/Fas-L may influence memory versus naive T cell 
responses.
Neonatal tolerance induction with SEB results in non-responsiveness to subsequent 
challenge in vivo or in vitro in wild-type MRL +/+ mice but loss of tolerance 
induction has been observed in Ipr Apr mice resulting in a proliferative response of T 
cells when challenged in vitro (Zhou et al 1994). The primary defect in these mice 
appears to be loss of tolerance rather than clonal deletion. This substantiates the 
hypothesis that Fas plays a role in peripheral T cell tolerance and highlights the the 
importance of apoptosis in maintaining immune homeostasis.
Therefore, studies with SEB have allowed more precise dissection of the fate of 
antigen-responsive T cells by virtue of the magnitude of the immune response 
induced. The need for proliferation in order for death to occur in the periphery has 
been observed with SEB and other antigens and is reinforced by the observation that 
treatment with IL-2 enhances apoptosis (Leonardo et al 1991). The interactions of 
both CD28 and Fas with their respective ligands are vitally important in the immune 
system via T cell activation and the maintenance of a fully functioning T cell 
response which recognises and eliminates deleterious antigens but does not respond
34
to and damage self antigens. It has also become apparent that life and death of a T 
cell are intimately associated as are the molecules that promote growth and survival 
responses.
1.18 Genetics of the ceil survival programme.
The consistency of the morphological and biochemical pattern of apoptosis within 
different cell types and species during normal development and as a response to 
external stimuli, suggests a common cause of cellular mortality. This idea is 
supported by the concept of an endogenous program responsible for death and the 
presence of gene products that are positive and negative regulators of apoptosis.
1.18.1 Bcl-2 family : modulation of the death signal
Bcl-2 provides the strongest evidence for a shared mammalian pathway of cell death 
by its ability to block a wide variety of cell death models. The bcl-2 gene was 
discovered as a result of its translocation to the H chain gene locus in most human 
follicular B cell lymphomas (Tsujimoto and Croce 1986). The survival of quiescent 
lymphocytes in the mouse is dependent on the expression of the bcl-2 gene 
(Nakayama et al 1993). Animals deficient in the bcl-2 gene have T cells with an 
increased susceptibility to undergo PCD when placed in culture. Bcl-2 expression is 
topographically restricted to the tissues characterised by apoptotic cell death and has 
been shown to prevent apoptosis via an antioxidant pathway at sites of oxygen free 
radical generation (Hockenberry et al 1990,1993). Excess production of reactive 
oxygen intermediates results in DNA strand breakage and membrane blebbing which 
match some of the hallmarks of apoptosis.
Bcl-2 exists as part of a higher molecular weight complex associating with a 21 kd 
protein partner bax (Oltvai et al 1993). Bax shows extensive homology with bcl-2 
forming homodimers and heterodimers with bcl-2 in vivo. When bax is in excess cell 
death is accelerated and the death repressor activity of bcl-2 is countered, but when 
bcl-2 is in excess cell death is repressed. Bax is encoded by six exons and 
demonstrates a complex pattern of alternative RNA splicing that predicts a 21kd
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membrane and two forms of cytosolic proteins. The complexity of the RNA splicing 
pattern regulates bax activity and localisation.
Another bcl-2 related gene, bcl-x has also been identified (Boise et al 1993). This 
gene makes protein products that either prevent or cause cell death depending on how 
the mRNA is processed. A larger transcript (bclxl) encodes a bcl-2 related protein 
product that can inhibit cell death induced by growth factor withdrawal when over- 
expressed in an IL-3 dependent cell line. Alternative splicing of bcl-x transcripts can 
generate a smaller transcript bcl-xs, that encodes an internal truncated version of Bcl- 
x protein that prevents overexpression of bcl-2 from inducing resistance to apoptosis. 
Thus a clear picture of a family of bcl-2 like genes is emerging. These genes are 
likely to be sequential members of a single death/survival pathway or regulators of 
parallel pathways.
The dynamic bcl-2 -bax pattern is reminiscent of that observed with the Myc family 
of proteins. The c-myc protein is known to associate with several intracellular 
proteins including Max (Blackwood and Eisenman 1991). The c-myc proto-oncogene 
product has been implicated in cell cycle progression (Green et al 1994b) and has 
also been shown to promote apoptotic death (Evan et al 1992). Ligation of the TCR 
on T cell hybridomas resulting in apoptosis is inhibited by the addition of anti-sense 
oligodeoxynucleotides which inhibit c-myc expression. (Green et al 1994b) In these 
proteins varied dimerisations between the partners determine the final activity of the 
myc-max complex. Importantly it has been shown that a mutant interfering with the 
function of the myc-max heterodimer inhibits the induction of apoptosis by TCR 
ligation. (Green et al 1994b) This similarity between bcl-2 bax and myc-max 
indicates that competing dimerisation among similar proteins may be a common 
mechanism for regulating cellular survival and growth.
With regard to Fas, transfectants expressing this antigen alone were killed by anti-Fas 
antibody, while overexpression of bcl-2 resulted in a partial inhibition of the Fas- 
mediated death, suggesting that the regulated expression of bcl-2 and Fas may control 
the PCD (Itoh et al 1993b).In addition bcl-xl has been demonstrated to repress cell 
death and functions with bcl-2 in a common pathway to regulate cell death (Chao et 
al 1995). In summary, it appears that the bcl-2 family of genes plays an important 
role in the regulation of T cell survival during an immune response and the interplay 
of death promoting and death enhancing factors may control the outcome of T cell 
activation.
36
1.18.2 p53 regulation of cell survival
Cell death can be developmental^ controlled by the expression of novel genes that 
induce the death signal at a specific stage of differentiation in response to defined 
physiological stimuli. Gene products may exert their effect through either repression 
of apoptosis or failure to correctly induce the cell death program. Wild type p53 
appears to function as an oncosuppressor by leading to inhibition of G1 cyclin- 
dependent kinases, thereby halting cell cycle progression. Under conditions where 
DNA repair is necessary , the cell is blocked in the G1 phase allowing time for repair 
to reach completion prior to cell division. If irreparable DNA damage exists, the cell 
becomes committed to the apoptosis pathway and is deleted from the system. Mutant 
p53 is an anti-apoptotic oncoprotein which may allow escape from this surveillance 
mechanism and generation of a malignant phenotype.
1.18.3 The involvement of the transcription factor nur 77 in 
apoptosis
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Elucidation of some of the genetic elements involved in T cell function has been 
aided by the use of CsA, a potent immunosuppressive agent used clinically to control 
allograft rejection, graft versus host disease and some autoimmune diseases. CsA is 
known to block a Ca^+ mediated T cell activation pathway and has also been 
demonstrated to inhibit anergy. The prinicipal inhibitory reaction of CsA is the result 
of impaired lymphokine production by T cells, especially EL-2. Anti-CD3-induced 
PCD in the thymus has been blocked by CsA (Shi et al 1989) while recent data 
suggest that CsA may enhance apoptosis in mature antigen-reactive T cells (Vanier 
and Prud’homme 1992). This suggests that there are differential requirements for 
calcium signalling in the thymus compared to the periphery. Low doses of CsA 
inhibit anergy induction while higher doses were needed to enhance T cell deletion 
in mice injected with SEB (Vanier and Prud’homme 1992). The mechanism by which 
CsA can interfere with anergy is not clear, however it is known that CsA blocks T 
cell activation by binding to cyclophilin which inhibits the ability of calcineurin to 
dephosphorylate its substrate, NF-AT.
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CsA blocks apoptosis by inhibiting the TCR- mediated activation of nur 77 
transcription factor in T cells. This effect is mediated by blocking the DNA binding 
activity of the nur 77 protein rather than its de novo synthesis (Yazdankakhsh 1995). 
Nur 77 is a member of the steroid/thyroid receptor superfamily and has been shown 
to be necessary for the induction of apoptosis in T cell hybridomas (Woronicz et al 
1994). Apoptotic signals delivered through the TCR in immature T cells and a T cell 
hybridoma also require the expression of nur 77 (Liu et al 1994).
Interestingly nur 77 knockout mice have been generated and apoptosis been 
demonstrated to be normal in these mice (Lee et al 1995). Recently a new gene has 
been cloned from an apoptotic cell line (Okabe et al 1995). This gene is called 
Transcriptionally inducible nuclear receptor (TINUR). and expression was induced 
by cross-linking the TCR complex. TINUR has the characteristics of an immediate 
early gene,was found to be a member of the NGFl-B/nur 77 family and to bind the 
same DNA sequence as nur 77. Consequently, defects in this gene rather than in nur 
77 may influence apoptotic death and the existence of this gene may explain the 
normal apoptosis found in nur 77 knock out mice.
Therefore factors which are involved in transcription may also plays a role in T cell 
apoptosis leading to the conclusion that T cell activation and apoptosis are intimately 
linked at the nuclear level resulting in the intrinsic capability of a cell to decide 
between life and death.
1.19 The involvement of cysteine proteases in PCD.
One of the approaches that has provided the most insight into the mechanism of cell 
death has been the analysis of the nematode Caenorhabditis elegans. During normal 
development, certain cells of this worm are predestined to die, of the 1090 somatic 
cells formed during the development of this organism 131 undergo PCD (Wang et al 
1994). Two genes ced-3 and ced-4 are required for this PCD. Ced-3 shares functional 
and sequence similarity with a mammalian cysteine protease, IL-lb- converting 
enzyme (ICE) (Yuan et al 1993). Both ICE and ced-3 contain the conserved 
pentapeptide sequence QACRG surrounding a cysteine residue that is known to be 
essential for ICE function. ICE is a cysteine protease that converts the IL-lb 
precursor to the active protein (Yuan et al 1993, Thomberry et al 1992). Transfection
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of the gene for ICE or ced-3 into rat fibroblasts has been shown to induce PCD 
(Miura et al 1993).
Another member of the ICE family was isolated recently (Wang et al 1994). This 
gene was originally identified from a cDNA expressed mostly during early mouse 
embiyonic development and down-regulated in adult brain and called NEDD-2 
(Kumar et al 1992). It was renamed Ice and ced-3 homologue (Ich-1) and mRNA for 
this gene was found to be alternatively spliced into two different forms. One form 
Ich-IL contains sequence homology to ICE and ced-3, whereas the other species 
named Ich-ls, terminates 21 amino acids after the pentapeptide QARCG. Expression 
of these two species was found to have opposite effects on cell death. Overexpression 
of Ich-1 L induces PCD while overexpression of Ich-lS suppressed cell death induced 
by serum deprivation. These results suggested that Ich-1 plays an important role in 
positive and negative regulation of PCD in vertebrates. The control of RNA splicing 
seen here is reminiscent of that seen in the bcl-x and myc systems, this may reflect 
the use of alternative gene splicing as a general mechanism for regulation of PCD.
Ced-9, a negative, regulator of ced-3 and ced-4, has also been found, which is 
structurally and functionally homologous to mammalian bcl-2. Human bcl-2 is able 
to function in cells from worms and insects as well as mammals. The fate of 
eukaryotic cejls may therefore reside in the balance between the opposing pro- 
apoptotic effects of an ICE/CED-3 protease and an upstream regulating bcl-2 and its 
homologues.
One of the substrates for an ICE/CED-3 protease during apoptosis is poly (ADP- 
ribose) polymerase (PARP), an enzyme that appears to be involved in DNA repair, 
genome surveillance and integrity. The protease (apopain) that is responsible for 
cleavage of PARP has been identified and shown to be derived from a proenzyme, 
identified as CPP.32 (Nicholson et al 1995). This proenzyme is related to ICE and 
CED-3. The Ca2+ endonuclease that is implicated in the characteristic 
intemucleosomal cleavage of apoptosis has been shown to be regulated by poly ADP- 
ribosylation. Inhibition of apopain mediated PARP cleavage attenuates apoptosis in 
vitro demonstrating the importance of this protease in apoptosis. Sequence 
relationship between CPP-32 and CED-3 suggests that CPP-32 may be the human 
equivalent of CED-3. Cowpox vims encodes a gene crm A that encodes a serine 
protease inhibitor that can bind to and inactivate ICE (Ray et al 1992).A similar 
protease has also been identified (Tewari et al 1995), Yama/CPP-32, which shows
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far greater sensitivity to crm A than apopain. Expression of crmA can prevent 
apoptosis induced by ICE (Miura et al 1993). Expression of a baculovirus gene p35 
prevents PCD in C. elegans, mammals and Drosophila (Hengartner 1994). This again 
suggests the universality of a death program and hints at the evolutionary 
development of a cell survival program in order for multi-cellular organisms to 
maintain homeostasis.
1.20 Aim of this project.
It has become apparent that TCR interactions alone are not sufficient to allow T cell 
proliferation, therefore an understanding of the molecular interactions generated 
during a T cell response is of considerable interest. Consequently, one aim of this 
project was to establish some of the costimulation requirements of T cell activation. 
Previous work has indicated that cell-cell interactions may be critical to T cell 
function, therefore to address this issue the relative roles of the interactions of LFA3 
and B7-1 with their respective ligands CD2 and CD28 was examined. Much use has 
been made of antibodies to CD28 and CD2 to investigate the roles played by these 
molecules in costimulating an immune response. A much more physiological 
approach and,one which will be used here is the use of specific ligands such as LFA3 
and B7-1 to trigger CD2 and CD28 respectively. Transfectants expressing either 
LFA3 or B7-1 have been established which will be used to study the costimulation 
requirements of T lymphocytes. In addition to proliferation, the costimulation 
required for EL-2 production will also be examined, again using LFA3 and B7-1 
transfectants in order to establish the interactions necessary for production of this 
cytokine.
Previously, the exact function of APCs in T cell stimulation has not been fully 
elucidated and so it was interesting to examine the role of presentation in T cell 
activation using the SAg SEB, presented by transfectants expressing MHC class II 
HLA DR4 molecules. HLA-DRtransfectants co-expressing MHC class II and either 
B7-1 or LFA3 were utilised to study the requirement for T cell costimulation. One of 
the criteria proposed to test the ability of a molecule to costimulate T cell responses is 
its capability to costimulate from a cell distinct from the one providing the TCR 
stimulus (third party costimulation). Both B7-1 and LFA3 were tested for this ability 
using SEB as the TCR stimulus.
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The factors which influence the outcome of TCR engagement are poorly understood, 
in addition to proliferation , engagement of the TCR may result in anergy and /or 
apoptosis. In order to investigate the effects of negative encounters with antigen, T 
cell apoptosis was studied. In addition the signals required to turn a potentially 
apoptotic stimulus into a signal to proliferate were examined as was the role played 
by APCs.
It is known that Fas ligation results in apoptotic death of T lymphocytes. However, 
the expression of Fas-L during the death process has not been examined. Hence, one 
question to be addressed is the regulation of Fas-L expression during AICD and what 
factors modulate this expression. The significance of the role played by Fas-L 
expression was also an attractive focus of study.
In summary the main questions to be addressed are , the role of costimulation during 
T cell encounters with antigen, the function of APCs during T cell activation, what 
determines negative outcomes of T cell ancounters with antigen, such as apoptosis, 
and the role of Fas/Fas-L expression during T cell apoptosis.
The underlying hypothesis is that engagement of the TCR results in different 
outcomes and the question to be addressed is what controls these outcomes. The 
results of triggering the TCR was the central subject of this thesis. The fate of a cell 
upon engagement of the TCR was investigated in order to elucidate what determines 





2.1.1 Preparation of solutions and tissue culture reagents 
GIu-Free medium for CHO transfectants
To 400ml of autoclaved distilled deionised H2O, the following were added;
DMEM (10X, Gibco BRL 12501-011) 55ml
FCS 50ml
Penicillin /streptomycin (Gibco BRL 15140-114) 5ml
(10000IU/ml)/10000pg/ml
Sodium bicarbonate (Gibco BRL 25080-060) 28ml
Sodium pyruvate (Gibco BRL 31870-025) 5ml
Nucleosides (100X) 5ml
RPMI/10% FCS.
The following were added to 400ml of RPMI (Gibco BRL 31870-025), 
FCS 50ml
Penicillin/Streptomycin 5ml
Glutamine (200mM, Gibco BRL 25030-024) 5ml





The nucleosides listed were made up to 50 mis using filter-sterilised H2O and used at 
1:100 dilution.
L-Methionine sulfoxamine (Sigma M-5379)
Stock 18mg/ml was made in Glu-Free medium and used at 1:100 dilution.
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Hvgromvcin (Sigma H-7772)
stock at 25mg/ml in PBS and used at 1:100 dilution.
Phosphate buffered saline (PBS. Oxoid).
5 tablet s were added to 500ml distilled deionised H2O and autoclaved.
Glutaraldehvde (Sigma G-6257)
25% aqueous solution 
used at 1:1000 = 0.025%.
G418. Geneticin G418-sulphate (Gibco-BRL 1181-031)
Stock 50mg/ml in PBS, used at 1:100 dilution.
Tris acetate EPTA (TAEiQXl 
Tris base 24.22g (0.4M)
Sodium acetate, 2.05g (0.05M) '
NA2EDTA 1.86g(0.01M)
these reagents were made up to 500ml using deionised distilled'H2O,
Diethyl Pvrocarbonate (DEPC) -treated H?Q.
500pl of DEPC was added to 500ml dH20, mixed and left at room temperature 
overnight, followed by autoclaving.
Solution D (RNA extraction buffer)
Guanidinium thiocyanate (Sigma G-6639) 250g
0.75M Sodium Citrate pH7.0 17.6ml
10% (w/v) N- lauiylsarcosine(sodium salt) 26.4ml
The above were dissolved in 293 ml sterile DEPC-treated water at 65°C and stored at 
4°C. For use, solution D was prepared by adding 72|il 6 mercaptoethanol to 10ml 
stock solution and stored for up to a week at 4°C.
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Prehvbridisation solution










SSPE was made using NaCl (175.3g), NaH2P04 (27.6g) and Na2 EDTA (7.4g) and 
making volume up to 1000ml using distilled H2O.
Salmon sperm DNA was prepared in distilled H2O by shearing several times through 
a 19-gauge needle, followed by denaturation by boiling for 10 minutes. The solution 
was cooled on ice for 2-3 minutes and could be stored at -20°C until required for use.
50X Denhardt’s solution was prepared by addition of l%w/v ficoll, 1% w/v PVP and 
l%w/v BSA to distilled deionised H2O,followed by filter sterilisation and storage in 
aliquots at -20C until required (see Maniatis).
SSC (20X)




pH was adjusted to 7.0 using HC1 and final volume made up to 1000ml using H2O.
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2.2 Suppliers of Reagents
Most laboratory reagents were supplied by Sigma (Poole, Dorset), however a list of 
other suppliers is given below.
2.2.1 Suppliers.
Tissue Culture Reagents
The following reagents were all purchased form Gibco BRL (Paisley, UK).
RPM I1640,
Dulbecco’s Minimal Essential Medium (DMEM),
Iscove’s medium,
AIM-V serum free medium,




Phosphate-buffered saline tablets Oxoid (Bristol, UK)
Lymphoprep Nycomed Ltd. (Birmingham, UK)
Heparin (Monoparin) CP Pharmaceuticals Ltd. (Wrexham, UK).
Hygromycin and ionomycin Calbiochem (Nottingham U.K). 
rIL-2 Glaxo.
CsA was a generous gift from Sandoz.




M-MLV reverse transcriptase GIBCO (Paisley UK)
Taq DNA polymerase NBL, Promega Ltd (Southampton UK).
pd(T)12-18, RNAguard RNase inhibitor and an Ultrapure dNTP set Pharmacia 
Biosystems Ltd.
X HHI DNA markers Gibco BRL 
pX174 DNA markers NBL
Water-saturated phenol (AquaPhenol) Appligene (Co. Durham, UK).
Biodyne B was supplied by Pall (UK)
DE81 discs and chromatography paper (3MM) Whatman Scientific (Maidstone, UK). 
Gene Clean II Kit Bio 101 (Stratech)
Prime-a-gene kit. from Promega 
Radiochemicals
[3H] thymidine and [51 Cr] Amersham International pic (Amersham UK).
[a-32P] dATP ICN Flow (High Wycombe, UK).
Optiscint HiSafe from Wallac Ltd. (Milton Keynes, UK).
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2.2.2 Suppliers: contact numbers.
The following list is not comprehensive but gives telephone numbers of suppliers 
most often used for laboratoiy reagents.
Amersham International pic (Aylesbury, UK) 0800 515 313
Boehringer Mannheim UK (Lewes UK)
Calbiochem Novabiochem UK Ltd(Nottingham, UK)
Dynal UK Ltd (Bromborough UK)
0800 521 578 
0800 622 935 
0151 3461234
Gibco BRL Life Technologies LTd (Paisley, UK) 0141 814 6100
Hybaid Ltd (Middlesax, UK) 0181 614 1000
NEN Dupont (Stevenage, UK) 01438 734 865
NBL Northumbria Biologies Ltd (Northumberland UK) 01670 739 297
Nycomed UK Ltd (Birmingham, UK) 0121 742 2444
Pharmacia Biotech Ltd (St Albans, UK) 01727 814 000
Promega Ltd (Southampton, UK)
Sigma (Poole, UK)
01703 760 225 
01202 733114
Stratagene Ltd (Cambridge, UK) 0800 585 370
Whatman Labsales Ltd (Maidstone, UK) 01622 692022
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2.3 Methods.
2.3.1 Monoclonal antibodies used.
The following antibodies were used as either staining reagents or blocking reagents at 
lOfig/ml.
OKT11 (anti-CD2), OKT3 (anti-CD3), L243 (anti HLA-DR), TS2/9 (anti-CD58), 
HB8784 (anti-CD25), aU from the ATCC (Rockville, MD, U.S.A.); 9.3 (anti-CD28) 
obtained from Dr P Linsley (Bristol-Myers Squibb, WA, U.S.A.); UCHT1 (anti- 
CD3) and UCHM1( anti-CD14) received from Dr P Beverly (ICRF, London, U.K.); 
BB1 (anti- B7-1) obtained from Dr E. Clark (University of Washington, WA,
U.S.A.); 15.2 (anti CD54) and 38 (anti-LFAl) received from Dr N. Hogg (ICRF, 
London, U.K.); BU12 (anti-CD19) obtained from Dr I. McLennon (University of 
Birmingham, U.K.); CH11 (anti-Fas, TCS Biologicals, U.K.); M3 (anti-Fas) 
received from Dr D.Lynch (Immunex, WA U.S.A.) was used at 3pg/ml.
i
2.3.2 Maintenance of cells.
All cells were cultured at 37°C and 5% C02 in a humidified incubator while 
manipulations were carried out in a sterile environment using a laminar flow hood.
Transfectants
Chinese hamster ovary (CHO) K1 cells were transfected with human cDNAs 
encoding LFA3, B7-1 and HLA DR A and HLA DRB1 DR4/DR B1 * 0401 as 
described previously (Sansom et al 1993). Double transfectants were also made co­
expressing HLA-DR and B7-1(DR4/B7-1) and triple transfectants expressing DR , 
B7-1 and LFA3 (DR4/LFA3/B7-1).
Cells were routinely screened and sorted for expression of cell surface molecules by 
FACS analysis and were tested for mycoplasma using a commercially available 
ELISA detection system (Boehringer Mannheim). Transfectants were comparable for 
levels of expression of surface molecules.
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Transfectants were routinely grown in Glu-Free medium. Selection of LFA3 was 
based on G418 at 500ng/ml. DR4/B7-1 and DR4/LFA3/B7-1 were grown under 
selection with hygromycin at 250p.g/ml. L-methionine sulfoxamine was used to select 
for expression of Class II on DR positive transfectants.
Removal of CHOs from plastic culture flasks was carried out as follows: medium 
was aspirated from flasks and cells washed with PBS. Having aspirated the PBS, 
tiypsin-EDTA was added (Gibco BRL 45300-027,2ml to a 75cm2 flask or 3ml to a 
125cm2 flask) and incubated at 37°C for 5 minutes. When the cells were detached 
medium was added to a final volume of 10ml and excess cells removed from the 
flask. Fresh medium and appropriate selection were added. Transfectants were 
normally passaged every two to three days or when cells became confluent.
T cell cultures.
Jurkat cells were grown in a 1:1 mixture of RPMLIscoves (10% FCS, Glutamine, 
Pen/Strep) and were passaged every two to three days. To ensure optimal growth 
cells were kept below 1 X10 6 /ml.
PBMCs and purified T cells were cultured in RPMI containing'10% FCS . T cell 
lines were cultured in above medium or AIM V -semm free medium and 
supplemented with recombinant IL-2 (rIL-2 at 20 International units (IU) /ml) every 
2-3 days as necessary.
2.3.3 Purification of PBMCs and T cells from blood.
All blood samples were taken from healthy volunteers. Heparinised blood was 
separated on a Lymphoprep (1.077) density gradient by centrifugation at 420g for 30 
minutes. The layer of mononuclear cells recovered from the gradient, which 
constitutes Peripheral Blood Mononuclear Cells (PBMCs), was washed three times in 
RPMI/10% FCS.
To purify T lymphocytes from PBMCs, cells were allowed to adhere to plastic petri- 
dishes for 1 hour at 37°C in RPMI/10% FCS. Non-adherent cells which include T 
cells were pipetted off into a fresh tube. These cells were incubated with mAbs to 
monocytes (UCHM1, anti-CD14, 500|il lOpg/ml), B cells (BU12, anti-CD19, 1:10
49
dilution of ascites) and activated T cells (L243, anti-HLA-DR, 500fil lOpg/ml) for 1 
hour at 4°C on a rotator. Having been washed with RPMI/10% FCS, the labelled 
cells were incubated with sheep anti-mouse IgG coated magnetic beads for 1 hour at 
4°C and then removed using a magnet (Dynal). The resulting T cell population was 
greater than 95% CD3 positive as assessed by FACS analysis.
2.3.4 Production of SEB responsive T cell lines.
T cell lines were established by incubating PBMCs with l-5pg/ml SEB for 4 days 
followed by addition of rIL-2 (20IU/ml). In order to remove dead cells and debris, 
cells were layered onto a lymphoprep gradient, centrifuged and live cells recovered. 
These were restimulated every 12-14 days using SEB pulsed DR4/B7-1 transfectants 
as APCs (see below) added at a ratio of 3:1 (T cells :transfectants). Cell lines were 
maintained for 8-10 weeks. The specificity of these cells was tested by determining 
reponses to SEB using a proliferation assay.
t
2.3.5. Preparation of transfectants for use in proliferation assays
Transfectants were tiypsinised, counted and washed twice with PBS to remove traces 
of FCS which interferes with the fixative. Cells were fixed for 2 minutes with 0.025% 
(v/v) glutaraldehyde (Sigma G-6257) in PBS. This was followed by washing twice in 
FCS containing medium to remove excess glutaraldehyde. MHC class II expressing 
cells to be used as APCs were trypsinised and counted. These cells were incubated 
with SEB at appropriate concentration in medium at 37°C for 3-4 hours followed by 
washing with PBS as above and fixation with glutaraldehyde.
2.3.6 Proliferation assay
2.3.6.1 Principle of assay.
As a cell divides it progresses through the cell cycle, duplicates its DNA and divides 
by mitosis. Addition of a radiolabelled nucleotide to the culture which is then 
incorporated into the cells as the DNA is replicated, can indicate whether the cells are 
dividing or not. Having washed away unincorporated radiolabel, these cultures are
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then harvested on to glass-flbre filter-mats where the radiolabelled DNA is trapped. 
Incorporation of radioactivity is measured using a P counter. Proliferation was 
therefore evaluated by measuring tritiated thymidine incorporation of dividing cells.
2.3.6.2 Assay.
Cell counting was carried out using a haemocytometer. T cells (5 XIO^) and APCs 
(2.5 Xl()4) were dispensed into flat bottomed 96 well microtitre plates in a final 
volume of lOOpl. Plates were incubated at 37°C usually for 3 days or as indicated for 
individual experiments. Tritiated thymidine incorporation was measured at indicated 
times by adding l|lCi of tritiated thymidine(5 Ci/mmol specific activity in 
RPMI/10% FCS) for the last 8-18 hours of culture followed by harvesting onto 
filtermats (Skatron) using a semi-automatic Skatron Cell harvester and counted by 
liquid scintillation counting using a p counter. The results are expressed as mean 
counts per minute (cpm) for triplicate cultures.
I
2.3.7 Cryogenic storage of cell stocks.
In order to maintain stocks all cells used were routinely frozen.'Having been 
passaged, cells were washed in medium and resuspended in 20% FCS, 10% DMSO, 
which acts as a cell preservative. Cells were aliquoted into freezing vials (Nunc) at 
(lxlOfyml). Vials were placed at -80°C, which allows cells to freeze slowly (at 
approximately 1°C per minute) followed by storage at -190°C in liquid nitrogen.
To recover from frozen, cells were brought to 37°C by immersing under warm 
running water. This must be done as quickly as possible to prevent‘the formation of 
ice crystals in the cells which could lead to cell lysis and death. Cells were washed in 
FCS containing medium, resuspended in the appropriate medium and placed into 
culture.
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2.3.8 Bioassav for IL-2 using CTLL-2
2.3.8.1 Principle of assay
The ability of T cells to produce IL-2 was measured by taking advantage of a murine 
cytotoxic T cell line, CTLL-2, which depends on IL-2 for its survival. This cell line 
can only proliferate in response to exogenous IL-2. Measurement of the proliferation 
responses of CTLLs using tritiated thymidine incorporation was used to evaluate the 
amount of IL-2 produced in a given set of culture conditions. Supernatants were 
harvested from T cell cultures and used as sources of IL-2 in this CTLL-2 assay. In 
order to determine the amount of IL-2 in the supernatants a standard curve of titrated 
IL-2 concentration was determined and IL-2 measurements of sample supernatants 
were extrapolated from this.
2.3.8.2 Assay
CTLL-2 cells were routinely cultured in RPMI/10% FCS supplemented with human 
rIL-2 (10-15 IU/ml) in upright 75cm2 flasks. Cells used for the bioassay were taken 
three days after feeding and washed twice with complete medium by centrifuging the 
cells at 420g for 5 minutes. The bioassay was only performed using cells which were 
> 80% viable. Viability was determined by staining cells with the exclusion dye 
Trypan Blue which is only taken up by dead cells. Live cells exclude it and can then 
be counted. Percentage viability was calculated as follows
Number of cells excluding dve X 100 = % viability.
Total number of cells
Cells were resuspended in RPMI/10%FCS to a final concentration of 1 X10 5 
cells/ml and aliquoted at 5 X 1()3 /well in 50 pi volume. A titration of IL-2 standard 
(NIBSC) was carried out using serial twofold dilutions starting at 20IU/ml down to 
0.019 IU/ml. Test samples were also diluted (usually by two or ten fold) in triplicate. 
The negative control was culture medium without exogenous IL-2. Each of the 
controls and samples were aliquoted in triplicate (50pl) in 96 well microtitre round 
bottomed plates. Assay was incubated at 37°C for 18 hours. Proliferation was 
measured by adding 0.5pCi of tritiated thymidine to each well for 4 hours. The cells 
were harvested on to glass fibre filtermats and counted by liquid scintillation 
counting in a B counter.
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2.3.9 IL-2 ELISA.
A solid phase Enzyme Immunoassay (Medgenix) was used to quantitate IL-2 in 
culture supernatants from proliferation assays. Several standards are provided from 
which a standard curve of concentration of IL-2 versus O.D. 450/490 was generated. 
These standards in IU/ml are as follows: 0, 0.9, 2.3, 7.5, 15, 30.
The assay was carried out according to manufacturer’s instruction in duplicate wells, 
100pi of each standard or sample being dispensed in the appropriate well of a 
microtitre plate coated with IL-2 antibody. The absorbance at 450nm and at 490nm 
was read and a standard plot generated from which amounts of EL-2 in sample 
supernatants were extrapolated.
2.3.10 £lC r release cvtotoxicitv assay : bioassav for determining Fas-L expression.
2.3.10.1 Principle of assay
This assay is based on the principle that live cells incorporate 51 Cr labelled sodium 
chromate, which are used as target cells. The chromate becomes protein bound and 
converts to dichromate. 51Cr release reflects protein leakage from dying cells and 
released dichromate cannot be retaken up by surviving live cells. When cytotoxic 
killing occurs the target cells are lysed and release the radiolabel into their culture 
medium which can be harvested and counted. This gives a measurement of % 
cytotoxicity when compared to cells induced to release all their label which is set at 
100% cytotoxicity.
2.3.10.2 Method
Fas sensitive Jurkat target cells were counted (5 XIOfy, washed, resuspended in FCS 
containing medium and labelled with lOOfll of lmCi Na^l Cr in 500|il for 2 hrs at 
37°C. Cells were washed three times in medium followed by incubation for 30 mins 
in medium at 37°C to allow any further chromium leach out into medium which was 
then washed off. Labelled cells were used at 5x10^ /well in a 96 well round bottomed 
plate. Effector T cells (either unstimulated or stimulated with PMA and ionomycin or 
with SEB) were incubated with the labelled Jurkats for 16-18 hours at 37°c. M3, anti-
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Fas blocking antibody was used at 3|Xg/ml and the Fas-Fc was used at 1/10 dilution. 
The 51Cr release results are for triplicate cultures.
The % specific release was calculated as follows:
% killing = experimental release - spontaneous release X 100 
maximum release - spontaneous release
Maximum release was determined by measuring the radioactivity released by adding 
NP40 (final concentration 1 % in a final volume of 200|il) to the labelled cells. 




The principle of flow cytometiy is that a single cell suspension-passes through a light 
beam emitted by a laser source. This light excites the fluorescent dyes used to label 
the cells leading to light amplification. Scattered or fluorescent light is collected. List 
mode data was collected for Forward Scatter (FSC), Side Scatter (SSC), fluorescence 
(FL)1 and (FL)2. Prior to data collection the nozzle head through which the labelled 
cells pass was aligned to maximise the detection of fluorescent events using a 
mixture of two latex beads coated with FITC of different intensities (Polysciences).
Analysis was carried out on a Becton Dickinson FACStar-plus equipped with a 
lOOmW 488nm air cooled laser and a Consort 32 computer. In addition for Hoechst 
staining a Becton Dickinson FACs Vantage equipped with a 50mW UV was used.
2.3.12 Analysis of expression of cell surface molecules.
Transfectants were trypsinised, washed and resuspended in primary antibody 
(10|ig/ml, 50pl/lxl()6 cells). PBMCs and T cells were washed in complete medium
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and resuspended in antibody as above. Cells were incubated with the primary 
antibody at 4°C for 45 minutes, washed with an excess of PBS, centrifuged at 420g 
and resuspended in secondary antibody, fluorescein isothiocyanate (FITC) 
conjugated anti-mouse polyvalent immunoglobulin, 1/50 dilution, (Sigma F-1010, 
lOOpl). After 45 minutes incubation at 4°C the cells were washed as above and 
resuspended in PBS, then analysed. Alternatively, cells were fixed with 1 % 
paraformadehyde/1% BSA and stored at 4 °C for up to one week prior to flow 
cytometry.
2.3.13 Analysis of DNA content for determination of apoptotic cells.
2.3.13.1 Principle
Morphological and biochemical analyses of apoptotic cell death have demonstrated a 
delayed loss of membrane integrity, accompanied by extensive degradation of DNA. 
In addition to loss of DNA, chromatin condensation occurs both of which can be used 
as a measure of cell death by analysing the DNA content of cells.
A quiescent cell which is not involved in cell division is often referred to as being in 
the Go state. If division is triggered, the cell first enters the G1 phase of the cell 
cycle, then the cell starts to synthesise new DNA during the (S) phase of the cell 
cycle until the DNA content has doubled. At this point DNA synthesis ceases and the 
cell is in G2 phase. Finally, the cell will enter mitosis (M) and divide. Cells in G2 and 
M phases of the cell cycle have double the DNA content of those in GO and Gl. Cells 
in S phase will have a DNA content lying between these extremes. Decreased uptake 
of the dye Propidium Iodide (PI), when used on fixed cells is an indication of 
apoptotic death when analysis of the cell cycle is determined. Measurement of the 
number of cells with reduced PI staining in the sub-GO region will represent the % of 
apoptotic cells induced by a particular treatment. If the DNA of 10,000 cells is 
measured and a histogram of number of cells against DNA content is plotted, this 
will reflect the state of the cell cycle (Figure 2.1). The appearance of cells with DNA 
content lower than that of Gl cells (subGo/Gl peak) in cultures treated to induce 
death, has been considered to be a marker of cell death by apoptosis. This reduced 
stainability represents both an decrease in DNA content (as a result of activation of 
the apoptosis specific endogenous endonuclease) and a change in conformation and 
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Figure 2.1 Diagram illustrating DNA histogram of the cell cvcle.
The DNA content of cells can be determined by using a dye such as propidium iodide 
which binds to nucleic acid and whose fluorescence is enhanced on binding. Cells in 
the G0/G1 region are resting or have just been triggered to enter the cycle and begin 
cell division, while cells in S or DNA synthetic phase are making new DNA. During 
this part of the cell cycle the DNA content of the cell increases until it has doubled, 
when this happens synthesis ends and the cell is in G2 phase. Cells in G2 therefore 
have double the DNA content of those in Gl or GO phase. When the DNA content of 
a given number of cells is measured by FACS analysis and a histogram of cell 
number against DNA content is plotted, this reflects the state of the cell cycle. Cells 
in the subGO phase contain fragmented and condensed DNA due to apoptosis, thus 
binding reduced amounts of the DNA binding dye. Therefore, a measure of apoptotic 




Briefly, apoptosis treatment was carried out by incubating cells with PHA (generally, 
5pg/ml) or SEB (generally, lpg/ml) or anti-Fas antibody (CH11 0.5 flg/ml) for 
appropriate time. Cells were washed in PBS, centrifuged at 420g and fixed in 80% 
EtOH in PBS at -20°C for times indicated. Cells were washed as before, resuspended 
in PBS (1ml) to which RNase A was added (final concentration 20pg/ml) and 
incubated at 37°C for 30 minutes in an incubator. Propidium iodide was added to 
cells (to final cone 10jig/ml) and incubated at room temperature for 15 minutes. Cells 
were given a final wash in PBS and stored in PBS at 4°C for up to one week prior to 
analysis.
2.3.14 Analysis of apoptotic cells using Hoechst 33342.(Dive et al 1992)
In addition to propidium iodide staining apoptotic cell death was determined by 
staining cells using the fluorochrome Hoechst 33342 (Ho33342). This dye is 
increasingly taken up as the amount of apoptosis increases therefore an increase in 
dye absorbance reflects increasing death.
A stock solution of Ho33342 (ImM in distilled water) was freshly prepared for each 
experiment. H033342 and propidium iodide were added to single cell suspensions 
such that their respective final concentrations were 10|iM and 32(iM. Ho33342 was 
added immediately prior to propidium iodide. Propidium iodide was used to 
discriminate between necrotic and apoptotic cell death. 10,000 cells were analysed 
using a FACS with UV laser excitation (lOOmW). Blue fluoresence (FL4 Ho33342 
staining) and red fluoresence (FL2, propidium iodide staining) were measured for 
each cell analysed with a flow rate of about 500 cells /  second. Cell debris was 
excluded by gating.
2.3.15 Agarose Gel Electrophoresis.
The standard method used to separate, identify and purify DNA fragments is 
electrophoresis through agarose gels. Horizontal submarine gel electrophoresis was 
used in this study for the analysis of both DNA and RNA.
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Agarose gels are made using TAE (section 2.1), heated in a microwave until melted 
and allowed to cool to approximately 60°C, when ethidium bromide was added to 
give a final concentration of 0.5|ig/ml., after which gel was poured into mold. 
Ethidium bromide contains a planar group which intercalates betweeen stacked bases 
of single- or double-stranded DNA or RNA causing the fluorescent intensity of the 
dye to increase, allowing visualisation of the DNA or RNA under a UV light 
source.The gel was then run in IX TAE buffer, DNA samples loaded in DNA loading 
dye (15% w/v Ficoll, 0.25% w/v xylene cyanol, 0.25% w/v bromophenol blue. The 
samples were electrophoresed at 100V, until the bromophenol blue dye was 
half/three-quarters of the way down the gel. The DNA was visualised using a UV 
transilluminator. Appropriate markers were used to allow sizing of DNA fragments.
X Hfil DNA cut with EcoRl (Gibco BRL 15612-013) or <J>X174 DNA digested with 
Hae III (NBL 031204). The molecular weights of marker in base pairs are as follows: 
<j>X174 1,353 1,078, 872, 603, 310, 281, 271, 234, 194, 118, 72.
X HHI fragments are: 23,130, 9,416, 6,557, 4,361, 2,322, 2,027, 564, 125.
2.3.16 RNA extraction (Chomczvnski and Sacchi 1987).
Cells were dissolved in Solution D (section 2.1.) (lOOpl/lx 10^ cells) in a microfuge 
tube. The following were added sequentially and mixed by inverting, sodium acetate 
(2M, pH4) 5 0 |il, phenol (Water saturated AquaPhenol) 500|il, chloroform: isoamyl 
alcohol (49:1 vokvol) 100|il. Cells were vortexed for 10 seconds and cooled on ice 
for 15 minutes after which they were centrifuged at 13,000 rpm for 10 minutes at 
room temperature. The top aqueous layer which contained the RNA was removed 
using a pipette, placed into a clean microfuge tube and an equal volume of 
chloroform: isoamyl alcohol was added. Having vortexed for 10 seconds, cells were 
centrifuged for 5 minutes as above and aqueous layer extracted once more with 
chloroform:isoamyl alcohol. The final aqueous layer was precipitated with an equal 
volume of isopropanol at -20°C overnight. RNA was centrifuged as above for 10 
minutes, pellet dissolved in Solution D(150pl) and precipitated with equal volume of 
isopropanol overnight at -20°C. RNA was centrifuged and pellet washed twice with 
70% (vol) ethanol and once with absolute ethanol. Final pellet was dried under 
vacuum for 15 minutes and pellet redissolved in DEPC treated water (50pl) and 
allowed to dissolve overnight at 4°C.
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RNA was quantified using Optical Density measurement at 260nm and 280nm. 
Integrity of 18s and 28s ribosomal RNA bands were checked by electrophoresis on a 
1.5% agarose gel. RNA was stained with ethidium bromide at 0.5(ig/ml and 
visualised using a U.V. source.
RNA is very easily degraded due to the presence of RNase on hands and in solutions, 
therefore gloves were worn during all manipulations involving RNA and reagents 
used were dedicated to RNA work only. When electrophoresis was to be carried out, 
gel tanks were washed with H2O2  and DEPC-treated water.
2.3.17 Reverse transcription.
RNA was reverse transcribed to form cDNA prior to amplification in the Polymerase 
Chain Reaction (PCR). In order to prevent cDNA formed from sticking, reactions 
were carried out in silanised eppendorf tubes. Approximately 500ng of total RNA 
was mixed with 50mM Tris-HCl (pH8.3), 75mM KC1, 3mM MgCl2, 10mM 
dithiothreitol, 0.5mM each of dATP, dCTP, dGTP, d’lTP, 1.5pM pd(T)12-18,30 
units RNAguard RNase inhibitor and 400 units M-MLV reverse transcriptase. The 
volume was made up to 30}il using DEPC treated H2O and the'tube placed in a water 
bath at 37°C for 60 minutes. The reaction was stopped by incubation at 95°C for 10 
minutes and put on to ice. PCR could be set up directly from this. Alternatively the 
cDNA could be stored at -20°C until required followed by a 5 minute incubation at 
95°C and then onto ice.
2.3.18 PCR.
2.3.18.1 Principle
The principle of the Polymerase Chain Reaction is that specific DNA sequences can 
be amplified by the simultaneous primer extension of complementary strands of 
DNA. Amounts as small as 30-50ng of cDNA can be used as the template to 
exponentially produce as much as lmg of DNA. The reaction takes place in three 
steps , the first is a denaturation step at temperature of 90-95°C, this allows double 
stranded DNA to denature forming a template for priming. The enzyme used is the 
DNA polymerase Thermus aquaticus (Taq) DNA polymerase which extends the
59
primer sequence by using a complementary strand as a template. This takes place at 
the annealing temperature determined from the base sequence of the primers used. 
This is followed by a final incubation step at the extension temperature resulting in 
fully double stranded molecules . The result is the production of large amounts of the 
required fragment.
2.3.18.2 Method.
PCR was carried out in a final volume of 50pl containing 2|il of the cDNA reaction 
mix,
200pM each of dATP, dCTP, dGTP, dTTP, 
lpM 5’ and 3’ primers,
2.5 units Taq,
1.5mM MgCl2
IX buffer (supplied with the Taq polymerase).
i
In order to minimise evaporation the reaction was overlaid with 40|ll of mineral oil 
and amplification carried out in the Perkin-Elmer Cetus DNA Thermal Cycler. Thirty 
cycles were carried out as follows;
1 minute at 94°C,
1.5 minutes at 55°C
1.5 minutes at 72°C.
This was followed by 10 minutes at 72°C . Samples were stored at 4°C until ready 
to be visualised. PCR products were loaded onto a 1% agarose gel containing 
ethidium bromide and visualised using a uv transilluminator.
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2. .3.19 Primer Pairs
The following amino acid sequences are for 5’ and 3’ primers respectively.
Fas-L
GTTTGCTGGGGCTGGCCTGACT and GGAAAGAATCCCAAAGTGCTCC 
GAPDH
GGTGAA GGTCGGAGTCAACGG and GGT CATGAGTCCTTCCACGAT 
Bax
TCC GGG GAGCAGCCCAGG GGCGGG and GTCCCAAAGTAGGAGAGGAG
2.3.20 Generation of Fas-L cDNA probe.
Fas-L cDNA was expressed in the pcDNA3 eukaryotic expression vector 
(Invitrogen). In order to prepare a Fas-L probe a fragment of Fas-L specific DNA 
was first removed from the expression vector by restriction digest. 10|ig of Fas-L 
pcDNA clone 9 was digested with EcoRl. 30 units of enzyme was used and reaction 
carried out in a 30|il reaction volume at 37°C overnight as follows:
Reagents volume(|il) stock concentration




The fragment produced by restriction endonuclease digestion was electrophoresed on 
a 1% agarose gel and the relevant DNA fragment excised with a clean scalpel blade. 
The DNA fragment was purified according to manufacturer’s instructions using a 
Geneclean II kit (Bio 101), designed to purify DNA from lObase pairs to lkb in 
length. The DNA was resuspended at 25pg/ml
Probe labelling
In order to probe DNA for presence of Fas- L or bax sequences a radiolabelled probe 
was first made using the appropriate cDNA .The “prime a gene” labelling system 
(Promega),based on the method developed by Feinberg and Vogelstein (1983) was
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used. The following reagents were added together in a 50|il reaction volume in an 
eppendorf tube:
lOjil 5X labelling buffer,
2|il non-labelled dNTPs (final concentation 20pM each) 
lp l denatured DNA template (25 ng) (500ng/ml final),
2|il nuclease free BSA (400|ig/ml)
5 pi (<x-32p) dNTP 
5 units Klenow enzyme (lOOu/ml).
Reagents were mixed gently and incubated at room temperature for lhr.
Incorporation of radioactive label into the DNA was measured as follows: l|il of the 
reaction mix was spotted on to the centre of each of two 2.3cm discs of Whatman 
DE81 ion exchange paper. This paper is ionically charged so that DNA will bind to it 
but unincorporated nucleotides will not. One disc was washed three times, for 5 
minutes each wash, with 0.5M Na2HP04, rinsed in water, followed by two washes in 
70% ethanol and finally in absolute ethanol. Once dry, an accurate measurement of 
the percentage incorporation of label was made by counting the filters in a LKB 1209 
Rackbeta liquid scintillation counter, using OptiScint HiSafe scintillant. Percent 
incorporation was calculated using the formula
cpm washed disc X 100 = % incorporation,
cpm unwashed disc
The probe is then ready to use for hybridisation.
2.3.21 Southern blotting
2.3.21.1 Principle
Localisation of particular sequences within DNA fragments or genomic DNA is 
usually accomplished by the transfer techniques originally described by Southern 
(1979). Briefly, DNA is separated on an agarose gel followed by denaturation and 
transfer to a solid matrix such as a filter membrane. The relative positions of the 
DNA fragments remain unchanged during their transfer to the filter. The DNA
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attached to the filter is hybridised to a radiolabelled probe and autoradiography used 
to locate the positions of the band complementary to the probe.
2.3.21.2 Blotting
In order to probe for Fas-L or bax sequences, PCR product DNA samples were first 
electrophoresed on a 1.5% agarose g e l. The gel was then Southern blotted onto a 
Biodyne B membrane. Blotting was set up at room temperature for 3 hours using 0.4 
M NaOH as the transfer buffer (Figure 2.2). The blot was washed twice in 2XSSC 
and air-dried for 30 minutes. This can be stored wrapped in saran wrap at 4°C until 
ready to carry out hybridisation.
Filter was hybridised in prehybridisation solution (25ml) in a hybridisation bottle. 
The labelled probe was added to prehybridisation mix and the blot hybridised 
overnight at 65°C. The hybridisation mix was removed and the filter was washed 
twice in 2X SSPE, 0.1% SDS (25ml) at room temp for 10 minutes. This was 
followed by washing with IX SSPE, 0.1% SDS for 15 minutes at 65°C, then 
0.1SSPE, 0.1% SDS twice for 10 minutes. This is a high stringency wash used when 
cDNA probes were utilised. The blot was removed from bottle, wrapped in Saran- 
wrap and autoradiographed by exposing to X-ray film with an intensifying screen for 
times indicated.
2.4 Statistical analyses.
Statistical analysis was carried out using the Students unpaired t test for Figures 3.6 
and 3.8.
















Figure 2.2 Southern Blotting Apparatus.
Transfer of DNA from agarose gel to Biodyne B filter. Gel was placed upside down 
on top of a pre-wetted 3MM wick sitting on a clean glass plate. In order to prevent 
leakage the gel was surrounded by parafilm. A piece of Biodyne B membrane cut to 
size was placed on the gel followed by Whatman 3MM and 6 sheets of Quickdraw 
papers .A glass plate topped with a small weight was put on top to secure the 






3.1 Proliferation requirements of human T lymphocytes.
T lymphocytes play a cmcial role in the efficient functioning of the immune system.
In order to carry out their effector function, T cells must first become activated and 
proceed through the cell cycle to expand and produce cytokines. In this chapter T cell 
responses to various stimuli including anti-CD3, PHA and the superantigen SEB are 
explored. The ability of these reagents to stimulate human peripheral T lymphocytes 
will be examined. Also, the necessity for signals in addition to engagement of the 
TCR will be investigated to determine the role costimulation plays in T cell activation.
In order to examine the activation requirements of human peripheral T lymphocytes, 
measurements of the outcome of productive activation were defined as proliferation 
and the secretion of T cell associated cytokines such as IL-2.
3.1.1 TCR engagement bv anti-CD3.
Engagement of the TCR by antigen/MHC class II complexes can be mimicked by 
aggregation of the .TCR using immobilised anti-CD3 antibody. In order to define a 
useful dose, range the ability of PBMCs to respond to engagement of the TCR/CD3 
complex by cross-linked anti-CD3 mAb was examined initially. It can be seen (Figure 
3.1) that PBMCs responded vigorously to anti-CD3 antibody stimulation, proliferation 
increasing as the concentration of anti-CD3 increased. Therefore, proliferation of 
PBMCs in response to engagement of the TCR by anti-CD3 mAb occurred in a dose 
dependent manner. However, when T cells were purified from PBMCs no 
proliferation was seen in response to anti-CD3 stimulation (Figure 3.1). The removal 
of T cells from other cells in the PBMC population led to abrogation of the ability of 
the T cells to respond to anti-CD3 stimulation. This therefore suggested that 
endogenous accessory cells were present in addition to T lymphocytes in the PBMC 
population. One possibility is that these cells provided signals which were necessary 
for T cells to proliferate in response to TCR signalling. Therefore an accessory cell 
dependent costimulatory signal was required in addition to the signal provided by 
anti-CD3 engagement of the TCR in order for T lymphocytes to proliferate.
In an attempt to reconstitute the accessory cell-dependent factors required to costimulate 
TCR signalling the effects of two accessory molecules, LFA3 and B7-1, on costimulation 
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Figure 3.1 Anti-CD3 stimulation o f PBM Cs and purified T cells.
(A) freshly isolated PBMCs (1 x 10^) were stimulated with various concentrations of anti- 
CD3 for 3 days and proliferation measured.
(B) PBMCs (1 x 10^) or T lymphocytes (5 x 10* ) were stimulated with various 
concentrations of anti-CD3 for 3 days. The ability of LFA3 or B7-1 to costimulate 
proliferation was determined by addition of transfectants expressing these molecules (2.5 x 
lO^) to anti-CD3 stimulated T cells. Untransfected CHO cells (2.5 x 10^) were added as a 
negative control. Proliferation was assessed by ^H-thymidine addition (lp.Ci/well). Data 
are representative of 3 experiments.
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cDNAs for either LFA3 or B7-1 which expressed high levels of these molecules were 
used in these experiments (Figure 3.2). Anti-CD3 induced proliferation of purified T 
cells was not costimulated by the addition of LFA3 transfectants or by untransfected 
CHO cells (Figure 3.1). Binding of LFA3 to its ligand CD2 on T cells therefore was 
not capable of providing costimulation for TCR induced signals. In contrast, addition 
of B7-1 expressing cells to anti-CD3 stimulated T cells resulted in a proliferative 
reponse which increased as the dose of anti-CD3 increased from 0.1 to 1.0 flg/ml 
(Figure 3.IB). Therefore ligation of CD28 by B7-1 results in costimulation of anti- 
CD3 triggered signals leading to T cell proliferation. In addition B7-1 costimulated 
responses were more potent than those obtained from unseparated PBMCs. This 
demonstrated that engagement of the CD28 receptor on T cells by its ligand B7-1 
resulted in an important costimulating signal which synergises with TCR signalling.
B7-1 therefore replaced the costimulation that was removed when the PBMCs were 
depleted of accessory cells. The B7-1/CD28 interaction thus was necessary and 
sufficient to synergise with TCR signalling resulting in proliferation of T 
lymphocytes.
The interaction of LFA3 with CD2 on T cells was however unable to costimulate 
TCR signalling. This interaction is therefore predicted to act merely via adhesion and 
does not function as a costimulus of TCR signalling during anti-CD3 stimulation of T 
lymphocytes. ,
These results demonstrated the need for more than one signal for productive T cell 
activation resulting in proliferation. Such a signal can be provided by the interaction 
of B7-1 with CD28 resulting in T lymphocyte proliferation in response to anti-CD3 
triggering. It was thus concluded that CD28 signalling can synergise with TCR 
signalling costimulating proliferation of T lymphocytes and can replace the accessory 
cell dependent signals in PBMCs signals.
3.2 Stimulation of T lymphocytes with the lectin PHA.
3.2.1 Proliferation requirements.
T cell activation requirements were also defined by the use of the mitogenic lectin PHA, 
which is thought to be capable of stimulating T cell proliferation by directly binding to the 
TCR. PHA is a polyclonal stimulator of T lymphocytes and therefore the magnitude of this 
response would be expected to be much greater than that seen with peptide responses, so
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Figure 3.2 Phenotypic analysis of LFA3 and B7-1 transfectants.
Cells were stained with TS29 (anti-LFA3) and BB1 (anti-B7-l) and analysed by FACS 
using a Becton Dickinson FACStar Plus. 5,000 events were analysed. Antibodies were 
used at 10|ig/ml.
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this molecule is useful for in vitro investigation of T cell proliferation. Consequently, 
in order to further assess the costimulation requirements of T cell proliferation, 
responses to PHA were examined.
Initially a useful dose range for PHA stimulation was established by examining 
PBMC responses to concentrations of PHA from 0.1 to 10|ig/ml. Similar to anti-CD3 
stimulation, it was seen that PBMCs were capable of proliferating in response to PHA 
in a dose dependent manner (Figure 3.3). Next the ability of T lymphocytes removed 
from accessory cells to proliferate was examined. Purified T cells proliferated weakly 
in response to 5pg/ml PHA whereas T cells in the PBMC population responded 
vigorously at this dose (Figure 3.3), consistent with the presence of endogenous APCs 
in this population. Similar to anti-CD3 stimulated responses, PHA responses therefore 
were also dependent on accessory cell factors. To define the interactions necessary to 
costimulate PHA responses, LFA3 and B7-1 transfectants were used once again. 
These transfectants were added to PHA stimulated T lymphocytes. However, in 
contrast to anti-CD3, addition of either B7-1 or LFA3 transfectants restored the 
proliferation of purified T cells in response to PHA (Figure 3.3). Both LFA3 and B7-1 
were thus capable of costimulating PHA proliferation in T lymphocytes and 
substituting for accessory cell dependent functions.
These experiments once again indicated the requirement for signals in addition to that 
transduced via TCR engagement in order for productive T cell activation resulting in 
proliferation to occur. In addition the ability of endogenous APCs to costimulate T 
cell responses was again shown. These results also demonstrated that costimulation 
requirements differed between anti-CD3 driven and PHA-driven proliferation, both 
LFA3 and B7-1 being capable of stimulating PHA-derived signals to the TCR 
whereas B7-1 but not LFA3 costimulated anti-CD3 driven responses.
Preliminary results also showed the ability of the B7-2 molecule to costimulate PHA 
induced responses (Figure 3.4). Therefore both B7-1 and B7-2 were capable of 
costimulating PHA-induced proliferation and replacing endogenous APCs. These 
results also add weight to the concept that B7 molecules costimulate T cell signalling 
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Figure 3.3 Proliferation responses to PHA in PBM Cs and T lym phocytes
(A) Dose response of PBMCs (1 x 10^) to PHA (B) PHA (5pg/ml) was added to 
PBMCs (1 x 105) or purified T cells (5 x 10*). The effect of addition of LFA3 (2.5 x 
10^) and B7-1 (2.5 x 10^) to PHA stimulated T cells was also measured. Background 
proliferation is shown in T cells without stimulation . Proliferation was measured by 
tritiated thymidine incorporation. Data are representative of 4 experiments.
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Figure 3.4 B7-1 and B?^2 cQstimulation o f PHA-driven proliferation in T 
lymphocytes
PHA (5pg/ml) was added to purified T cells (5 x 10^). The effect of addition of B7-1 
or B7-2 cells(2.5 x 10^) to PHA stimulated T cells was measured. Background 
proliferation is shown in T cells without stimulation and with untransfected CHO 
cells . Proliferation was measured by tritiated thymidine incorporation. Data are 
representative of 2 experiments.
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3.2.2 IL-2 responses in PHA stimulated T cells
In addition to proliferation, production of IL-2 was also measured in PHA stimulated 
T cells.The amount of IL-2 produced in PHA-treated T cells was determined using an 
ELISA method. No IL-2 was produced in unstimulated or PHA-treated T cells, 
whereas both LFA3 and B7-1 were capable of costimulating IL-2 production from 
PHA-stimulated T cells. It was seen also that B7-1 was much more efficient than 
LFA3 at costimulating IL-2 response (Figure 3.5). Therefore in addition to 
costimulating PHA proliferation, LFA3 and B7-1 were also capable of costimulating 
IL-2 production from T lymphocytes. These data support the hypothesis that TCR 
engagement is insufficient for T cell activation and that other costimulatory factors are 
required for PHA-driven responses which may be mediated by LFA3 or B7-1 
interactions with their respective ligands on T lymphocytes.
These observations led to the hypothesis that costimulation requirements differ 
between PHA-induced and anti-CD3 -induced T cell proliferation. This may reflect 
differential initial signalling triggered by these molecules. In addition to signals 
transduced through CD3, PHA may result in signalling via the CD2 molecule which 
requires a further engagement provided by the LFA3 transfectant. It is also 
hypothesised that B7-1 may be capable of providing a signal that is independent of 
TCR-transduced signals. This adds weight to the importance of CD28 signalling 
acting to costimulate TCR activation. The interactions provided by accessory cells 
can therefore be replaced by either LFA3 or B7-1 interactions with their respective 
ligands in PHA-stimulated proliferation and IL-2 production. In contrast, B7-1 but not 
LFA3 costimulated CD3-driven responses and was also a more potent costimulator of 
IL-2 production during PHA responses. These results highlight the crucial role played 
by costimulation in T cell responses and the potency of the CD28 costimulation 
pathway.
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Figure 3.5 IL-2 production in PHA stim ulated T cells.
PHA (5|ig/ml) was added to T lymphocytes (5 x 10^) and the effect of addition o f LFA3 or 
B7-1 transfectants (2.5 x 10^) on IL-2 secretion was determined. IL-2 production was 
measured in International units (IU)/ml using an ELISA. Unstimulated T cells were 
cultured with medium alone. Data are representative of 3 experiments.
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3.3.Stimulation requirements for superantigen driven 
proliferation.
The stimuli used thus far to determine costimulation requirements of T lymphocytes 
were not dependent on the TCR interaction with MHC molecules on an APC. One 
group of antigens which are believed to depend on presentation by MHC molecules 
are superantigens such as SEB. It was therefore useful to examine this physiologically 
relevant MHC-dependent T cell response.
In addition, SAg responses are a function of their interaction with families of TCR V(5 
chains , generating a polyclonal response of much greater magnitude than for most 
nominal peptide antigens. This enables the study of a greater number of T cells than 
would be possible with peptide antigens.
Superantigens also do not require processing in order to be presented to T cells as they 
interact directly with MHC class II molecules and thus metabolically inactivated 
presenting cells are still capable of presenting SAgs to T cells. These cells do not 
divide and therefore do not incorporate radioisotope making them ideal for use in 
proliferation assays. Fixed CHO transfectants expressing class II molecules were thus 
used as APCs to present SEB in order to analyse the requirements of the T cell 
proliferative response to this antigen.
3.3.1 Proliferation responses to SAgs
Initially it was decided to look at the response of PBMCs to the SAg SEB and to 
define a useful working range of concentrations. It was found that PBMCs 
proliferated in response to SEB, proliferation increasing as the concentration was 
raised from 0.000lpg/ml to l.Opg/ml (Figure 3.6). Even at doses as low as 0.001 
fig/ml SEB, PBMCs were capable of proliferative responses. Therefore PBMCs 
proliferated vigorously at concentrations of SEB from 0.0001 to 1 |lg/ml. These cells 
thus had the capacity to respond to this superantigen. The ability of purified T cells to 
respond to SEB was also examined. It can be seen (Figure 3.6) that purified T cells 
alone do not respond to SEB by proliferating. The removal of T cells from other cells 










Figure 3.6 SEB stimulation of PBMCs and purified T lymphocytes.
Freshly isolated PBMCs (1x10^) or T lymphocytes (5x10^) were stimulated with SEB 
at indicated concentration for 5 days. Proliferation was measured by 3H thymidine 
incorporation. Data are representative of 3 experiments. Points shown are mean +/- 
standard deviation. * = p < 0.005, when compared to proliferation in the absence of 
SEB.
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This was similar to the responses demonstrated for anti-CD3 and PHA, again 
emphasing the importance of accessory cell dependent costimulation in T lymphocyte 
proliferation. The T lymphocytes used in these experiments had been depleted of cells 
expressing class II MHC molecules, therefore autopresentation by the T cells could 
not have taken place. Class II MHC positive transfectants (DR4) (Figure 3.7) were 
used to examine whether presentation of SEB on MHC molecules resulted in 
proliferation. SEB was pulsed onto these cells, which were used as APCs to present 
SEB directly to T cells, resulting in a very small proliferative response (Figure 3.8). 
This confirmed that SEB proliferative responses were dependent on MHC 
presentation by APCs. Thus, SEB responses were MHC-dependent and more 
physiologically relevant than the stimuli previously used.
3.3.2 Costimulation requirements of SEB responses.
The proliferative responses resulting from class II MHC presentation of SEB were far 
less potent than the T cell response to SEB seen in PBMCs, which suggested that 
additional signals provided by accessory cells were required. Consequently, it was 
decided to attempt to reconstitute these signals using ligands for CD28 or CD2 as 
before. In addition to class II expressing CHOs, transfectants co-expressing class II 
and either B7-1 or LFA3 were also available (Figure 3.7). This enabled examination 
of the ability qf the LFA3 and B7-1 molecules to costimulate SEB responses. The 
addition of SEB pulsed DR4/LFA3 or DR4/B7-1 cells to purified T cells resulted in 
significantly increased proliferation when compared to SEB pulsed DR4 cells alone 
(Figure 3.8). It was also seen that DR4/B7-1 costimulated responses were greater than 
DR4/LFA3 costimulated SEB reponses. Therefore LFA3 and B7-1 were capable of 
providing costimulation to SEB presented on an APC. This was in agreement with 
results demonstrated for PHA responses but differs from that seen with anti-CD3 in 
that LFA3 did not costimulate this response. Once again B7-1 costimulation appeared 
to be more potent than LFA3 costimulation confirming the importance of the 
interaction of B7-1 with its ligand CD28 on the T cell .SEB responses therefore 
required additional signal to TCR engagement to induce T cell proliferation. These 
signals could be provided by either LFA3 or B7-1, the latter being the more potent 
costimulatory molecule. It therefore appears essential that for productive T cell 



































Figure 3,7 Expression qf Class II and B7-1 and LFA3 on transfectants.
Cells stained with L243 (anti-MHC Class II), or BB1 (anti-B7-l) or TS29 (anti-LFA3) and 
analysed by FACS using a Becton Dickinson FACStar Plus. Panels are as follows: A DR4 
cells, B and C DR4/B7-1, D and E DR4/LFA3, F, G and H DR4/LFA3/B7-1. Antibodies 
were used at 10 p.g/ml.
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Figure 3.8 LFA3 and B7-1 costimulation of SEB responses in resting T lymphocytes.
Class II MHC positive transfectants (DR4) (2.5 x 10^) were used to present SEB at 
various concentrations to purified T cells. The effect of LFA3 or B7-1 was measured 
by presenting SEB on class II MHC transfectants co-expressing either LFA3 
(DR4/LFA3) or B7-1 (DR4/B7-1) (2.5 x 10^). Prolferation values for T lymphocytes 
with SEB and CHO cells are also shown. Proliferation was measured by ^H thymidine 
incorporation as before and values shown are cpm for triplicate cultures. Data are 
representative of 3 experiments. Points shown are mean +/- standard deviation. *= p < 
0.005 when compared to T cell proliferation in response to DR4 pulsed with SEB at 
appropriate concentration.
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In order to distinguish between the ability of LFA3 or B7-1 to function either as 
adhesion molecules promoting cell to cell contact or to provide costimulation, the 
ability of these molecules to costimulate SEB responses from a cell distinct from the 
APC was examined (see Figure 3.9). When SEB was presented by a separate class II 
MHC positive APC to trigger the TCR and LFA3 added on a separate cell it was seen 
that this molecule was not capable of enhancing proliferation of resting T cells in 
response to SEB (Figure 3.10). In contrast, the addition of B7-1 transfectants resulted 
in costimulation of the response elicited by SEB on class II MHC transfectants. Even 
at B7-1 cell numbers as low as 10^ a substantial enhancement in proliferation was 
seen demonstrating the potency of the CD28 signal. As the number of B7-1 cells 
added to the culture was increased the proliferation increased demonstrating that 
enhanced costimulation was occurring as the number of B7-1/CD28 interactions 
taking place increased. Therefore B7-1 was capable of costimulation from a separate 
cell to the one stimulating the TCR and thus provided third party costimulation of 
SEB responses. This molecule thus acts to costimulate T cell responses even when it 
is not located on the same cell surface as the MHC derived signal.
It has been demonstrated therefore that B7-1 costimulated PHA and anti-CD3 
responses in T cells removed from endogenous APCs. Additionally these results 
showed that LFA3 acted as a costimulatory molecule in the T cell responses induced 
by PHA, functioned as an adhesion molecule in SEB responses but did not 
costimulate CD3 responses or provide third party costimulation for SEB proliferation. 
In contrast, the ability of the B7-1 molecule to costimulate SEB responses from a cell 
distinct from the cell providing the antigen specific signal which engages the TCR 
has been clearly demonstrated. These results lend considerable weight to the ability of 
the B7-1/CD28 interaction to act as a costimulatoiy signal in T cell responses placing 
this interaction as the principle costimulatory encounter in productive T cell 
signalling. In addition, these results suggest that CD28 may not require co-association 
with the TCR and is likely to provide a distinct signal involved in T cell activation. 
CD28 signalling thus provided essential costimulation for T cell activation resulting in 
proliferation and IL-2 production.
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Figure 3. 9 Schematic diagram of third party costim ulation of T cell activation.
T cells were stimulated using SEB presented by MHC class II positive transfectants (DR4) 
and the ability of transfectants expressing either B7 (shown here) or LFA3 (not shown) to 
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Figure 3.10 Third party costimulation of SEB proliferation in resting T lymphocytes. 
Class II positive transfectants (DR4, 2.5 x 1()4) were pulsed with 1 pg/ml SEB and used to 
stimulate freshly purified T cells. The effects of addition of untransfected CHO cells or 
either LFA3 or B7-1 on a cell separate to the one engaging the TCR was determined. 
Increasing numbers of costimulator cells were added to the cultures. Proliferation was 
measured 18 hours after tritiated thymidine addition. Data are representative of 3 
experiments.
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3.4 SEB responses in SAg-specific T cell lines.
In order to determine whether there were differences between engagement of the TCR on 
resting versus activated T cells, SEB specific T cell lines were developed. These cells were 
phenotyped by FACS analysis and the profile of expression of a number of 
cell surface molecules on three representative SEB specific T cell lines is shown in 
Table 3.1. Class IIMHC expression was observed on these cells, consequently, SEB 
specific T cells were potentially capable of autopresentation of antigens. Having 
established some of the requirements for SEB-induced proliferation in resting T cells 
which do not express MHC it was interesting to examine the effect of SEB on 
previously actiyated T cells.
3.4.1 Proliferation requirements of SEB T cell lines.
To investigate the proliferation requirements of SEB T cell lines, SEB was added to 
the cells and proliferation responses measured. In contrast to PBMCs, addition of SEB 
alone did not stimulate proliferation in these cell lines (Figure 3.11). SEB T cells 
were thus incapable of proliferating in response to SEB alone, this population of cells 
had been depleted of professional APCs and consisted of T cells which expressed 
class II MHC but did not act as professional APCs. It was therefore interesting to 
investigate whether class II MHC presentation of SEB on APCs could result in a 
proliferative response of these T cells. Presentation of SEB by class II MHC 
expressing transfectants resulted in a proliferative response to SEB indicating that 
these cells were both SEB-specific and capable of a proliferative response to antigen 
(Figure 3.11). The responses to DR4/SEB were low compared to the responses from 
SEB stimulated PBMCs. It was therefore necessary to determine if augmented 
responses could be achieved by costimulation.
The ability of LFA3 and B7-1 to costimulate SEB responses was evaluated using 
DR4/LFA3 or DR4/B7-1 transfectants pulsed with SEB. The responses seen with 
DR4/LFA3 were not much greater than with DR4 alone (Figure 3.12). However it was 
shown that SEB presented by DR4/B7-1 transfectants induced a much greater proliferative 
response to SEB (Figure3.12). The response increased to 10 times that seen in DR4/SEB 
driven proliferation. B7-1 was therefore capable of potently costimulating SEB driven 
responses in previously activated T cells as well as in resting T lymphocytes. LFA3 was 
much less potent at costimulating SEB responses in
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Line 1 Line 2 Line 3
Antibodv MFI % cells MFI % cells MFI % cells
Negative 2.3 92.3 3.3 97.3 3.7 91.1
CD2 42.4 99.8 112.9 99.4 98.5 98.8
CD3 56.9 99.6 36.6 97.0 100.8 99.2
CD4 24.7 89.3 35.6 88.9 30.2 85.0
CD25 20.1 27.0 101.2 97.2 96.4 86.3
CD28 12.0 73.9 15.5 46.9 37.1 28.8
HLA-DR 26.3 37.0 63.7 71.0 93.2 37.0
CD95 25.9 97.6 28.3 98.1 35.7 96.5
Table 3,1.
Phenotypic analysis of T cells from 3 representative SEB-specific T cell lines. Cells 
(2xl()5/antibody) were removed from culture and washed in PBS. Cells were resuspended 
in antibodies shown for 45 minutes at 0°C, washed in PBS and detected with anti-mouse 
FITC conjugated Ig. Stained cells were analysed using a Becton Dickinson FACStar Plus 
for Mean fluorescence intensity (MFI) and percentage (%) positivity above a region set at 
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Figure 3.11 SEB stimulation of antigen specific T cells. SEB responsive T cells(lxl()5) 
were cultures with or without SEB (lpg/m l) alone or pulsed onto DR4 transfectants for 3 
days. Proliferation was measured using tritiated thymidine incorporation. Data are 









Figure 3.12 Costimulation of SEB proliferation in superantigen specific T cells. 
Superantigen at various concentrations was pulsed onto transfectants expressing 
Class II (DR4 2.5 x 10^) or co-expressing class II MHC and either LFA3 
(DR4/LFA3) or B7-1 (DR4/B7-1 2.5 x 10^). These cells were added to SEB specific 
T cells (5 x 1C)4) and cultured for 3 days. Proliferation was measured 18 hours after 





activated T cells, in contrast to its ability to enhance SEB responses in resting T cells 
by acting as an adhesion molecule.
Transfectants co-expressing DR4 and both B7-1 and LFA3 (Figure 3.7) were also used to 
examine costimulation of SEB proliferation in SEB responsive T cells. When 
DR4/LFA3/B7-1 cells were added to SEB stimulated T cells an increased response 
compared to responses demonstrated previously with DR4 or DR4/B7-1 was seen 
(Figure 3.13). The proliferation response was equivalent to proliferation induced by 
SEB in PBMCs. This demonstrated that DR4/LFA3/B7-1 transfectants provided the 
T cell lines with the necessaiy costimulation requirements to respond to SEB. This 
suggested that both adhesion and costimulation were necessary in order to produce 
optimum proliferation in response to SEB in activated T cells. Increasing the 
adhesive interactions may also facilitate enhanced B7-1/CD28 interactions.
Proliferation increased as concentration of SEB increased, therefore these antigen 
specific T cells were capable of proliferating to SEB in a dose dependent manner 
similar to PBMCs (Figure3.13).
The production of IL-2 was also evaluated using CTLL-2 bioassay. Addition of SEB 
directly to the T cell lines did not result in IL-2 production (Figure 3.13) which was 
consistent with the lack of proliferation induced by SEB in these cells. In contrast, 
when DR4/LFA3/B7-1 was added to these cultures, EL-2 was produced, which 
increased as the concentration of SEB increased from 0.1 to 1.0 (Xg/ml. Therefore 
SEB-specific T cells produced IL-2 in response to costimulated SEB signals in a dose 
dependent fashion which correlated with proliferation responses. These cells express 
IL-2 receptor (Table 3.1) and were therefore capable of proliferating in response to 
IL-2 produced. The signal generated by SEB alone when added to previously 
activated T cells was insufficient to generate proliferation or IL-2 production in these 
cells whereas the signals generated by presenting SEB using DR4/LFA3/B7-1 
transfectants was sufficient to allow proliferation of these cells and to enable 
production of IL-2.
It was also observed (Figure 3.13) that addition of SEB to some of the T cell lines 
resulted in proliferation while increasing the dose of SEB resulted in a decrease in 
proliferative responses. This suggested that engagement of the TCR by SEB alone in 
these cells may be resulting in an outcome other than proliferation, perhaps inducing 
anergy or apoptosis. Interestingly, addition of B7-1 or B7-1-2 transfectants to 
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Figure 3.13. Costimulation of SEB driven proliferation in SEB specific T cells.
SEB specific T cells (5 x 10^) were stimulated for 3 days by the addition of SEB at various 
concentrations either alone or pulsed onto DR4/LFA3/B7-1 transfectants (2.5 x 10^). 
Proliferation (A) was measured using thymidine incorporation while IL-2 production (B) 
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Figure 3.14 SEB effect on B7-1 and B7-2 stimulated proliferation of antigen specific T 
cells.
B7-1 or B7-2 transfectants (2.5 x 10^) were used to stimulate SEB specific T cells (5 x 
104) for 3 days. The effect of addition of SEB (lpg/m l) on B7-1- or B7-2- stimulated 
proliferation was determined. Proliferation was measured 18 hours after 3h  thymidine 
addition. Data are representative of 2 experiments.
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of SEB (Figure 3.14). It was therefore suggested that SEB either by binding directly 
to the TCR or by autopresentation on Class II molecules may be inducing death of 
antigen-specific T cells.
3.5 Discussion.
The proliferation requirements of human T cells in response to a variety of stimuli 
have been explored here. The removal of T cells from PBMCs resulted in the loss of 
the T cell proliferative response to anti-CD3, PHA and SEB demonstrating the 
requirement for accessory cell dependent factors to costimulate T cell activation 
signals. It was therefore concluded that T cell proliferation required costimulation in 
addition to engagement of the TCR, in agreement with the two signal model of T cell 
activation first proposed by Bretscher and Cohn (1970).
It has been shown that signals received by a T cell when the TCR is triggered with 
anti-CD3 antibodies required costimulation which was provided by accessory cell 
dependent molecules. B7-1 costimulated anti-CD3 proliferative responses equivalent 
to that seen in PBMCs. Therefore signal one was provided by triggering of the TCR 
by anti-CD3 antibody while signal two was provided by B7-1 ligation of CD28. CD28 
is thus capable of providing a signal distinct from that mediated through the TCR. 
Consequently„the B7-1/CD28 interaction plays a critical role in anti-CD3 stimulated 
T cell proliferation.
The interaction of LFA3 with CD2 on T cells was however unable to costimulate 
TCR signalling. Certain combinations of anti-CD2 mAbs can activate T cells alone 
(Moingeon et al 1989) which suggested that there were differences between ligand 
induced signals and those induced by antibodies. Mimicking CD2 ligation using 
LFA3 expressed on cell surface is a more physiologically relevant response, therefore 
implying that the natural ligand LFA3 is unable to costimulate TCR signalling. The 
interaction between LFA3 and its ligand CD2 on T cells is therefore predicted to act 
merely as a adhesive interaction and does not function as a costimulus of TCR 
signalling during anti-CD3 stimulation of T lymphocytes.
The use of anti-CD3 required a costimulus to induce proliferation in these cells which 
may also reflect the ability of anti-CD3 to induce anergy in these cells, although 
induction of anergy in peripheral blood T cells was not directly demonstrated. The 
ability of B7-1 to provide this costimulus is consistent with a role of this molecule in
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the prevention of T cell anergy. The induction of hyporesponsiveness by MHC 
presentation of antigen on non-lymphoid cells which do not express either B7-1 or 
B7-2 (Burkly et al 1990, Lo et al 1989) is in agreement with CD28 signalling 
abrogating T cell tolerance. Moreover, Harding and colleagues (Harding et al 1992) 
have elegantly demonstrated the prevention of unresponsiveness using anti-CD28 
monoclonal antibody. This is in agreement with a direct role for CD28 in the 
prevention of tolerance. These data further emphasise the role the CD28/B7 
interaction plays in T cell effector function.
The costimulation requirements of PHA driven responses differ from anti-CD3 
induced responses in that either LFA3 or B7-1 can provide the costimulation 
necessary for T cell proliferation and IL-2 production. One possibility is that PHA, in 
addition to signalling via the TCR may also bind to the CD2 molecule on T cells. 
Once this ligation takes place engagement of CD2 by LFA3 may result in sufficient 
signalling to facilitate T cell activation. In addition PHA may also bind to other cell 
surface molecules to strengthen the adhesive interaction as it was observed 
microscopically that PHA addition to T cell cultures resulted in cellular aggregation. 
The fact that pairs of antibodies are required to costimulate through CD2 (Moingeon 
et al 1989) is consistent with this observation. The ability of LFA3 to costimulate 
PHA proliferative responses differed from that seen with anti-CD3 stimulated cells 
which may refject the ability of PHA to signal through the CD2 complex. One 
interpretation was that concommitant complexing of two determinants on the CD2 
molecule, the first by PHA and the second by LFA3 together resulted in a productive 
CD2 signal leading to proliferation.
B7-1 was capable of providing costimulation for PHA responses, moreover this 
molecule was a more potent inducer of both proliferation and production of IL-2, 
which further emphasised the importance of the B7/CD28 interaction in facilitating T 
cell effector function. Therefore during PHA-mediated responses both LFA3 and B7- 
1 may provide the additional signals necessary for T lymphocytes to proliferate and 
produce EL-2. Once again the results of these experiments highlighted the importance 
of costimulation in T cell activation.
In order to examine MHC-dependent responses, the SAg SEB was used and as 
expected it was shown that T lymphocytes respond to this antigen in an MHC- 
dependent manner. This is a more physiological stimulus since peptide antigens are 
presented on MHC molecules on the surface of APCs, therefore the costimulation
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requirements for SEB proliferation were investigated. It was demonstrated that either 
LFA3 or B7-1 co-expression on a class II MHC positive APC was capable of 
costimulating SEB responses. Similar to responses seen in PHA-driven activation, 
B7-1 was a much more potent costimulatory molecule than LFA3. Therefore SEB 
responses were also dependent on costimulation which could be provided by LFA3 or 
B7-1 on the same cell on which antigen was presented. This is in agreement with data 
published by Damle and colleagues (1992) who demonstrated that SAg-primed T 
cells can proliferate efficiently by engaging B7-1. In contrast it has been 
demonstrated that SAg-induced T cell responses are not critically dependent on the 
interaction of CD28 with B7-1 (Damle et al 1993A). However, the discrepancy in 
these results may reflect the use of SEA rather than SEB in these studies.
Additionally, CTLA-4-Ig was used to block proliferation whereas the direct use of 
B7-1 ligand for CD28 was utilised here which is a more physiological test of the 
ability of the CD28/B7-1 interaction to costimulate responses. One possibility is that 
the B7-1/CD28 interaction can costimulate SAg responses but when this is blocked 
other interactions such as LFA3/CD2 or as yet unidentified interactions compensate 
to allow proliferation to occur. CD28 costimulation may therefore be the primary 
interaction but other pathways may compensate if required. Indeed a monocyte 
derived costimulatory factor has recently been identified which synergises with B7-1- 
dependent costimulation (Johnson and Jenkins 1994).
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It has been argued that one essential feature of a costimulatory molecule is its ability 
to provide signal two (the costimulus) from a cell separate from the one engaging the 
TCR and providing signal 1 (Jenkins et al 1988). To determine whether either LFA3 
or B7-1 meet these requirements SEB was presented on a cell distinct from the cell 
providing accessory molecule stimulation. B7-1 but not LFA3 was capable of 
costimulating from a separate cell from the one triggering the TCR. The LFA3 
molecule therefore appears to function as an adhesion molecule in SEB responses 
whereas B7-1 is suggested to provide a signal distinct from that induced via the TCR. 
Consequently, the CD28/B7-1 interaction provides signals which synergise with 
TCR-mediated signals to enable T cell activation to proceed. CD28 signalling may 
therefore be considered as being truly costimulatory and acting as signal 2 in the two 
signal model of T cell activation (Bretscher and Cohn 1970).
Recently, the ability of B7-1 to provide third-party costimulation has been looked at 
using a mouse system (Liu and Janeway 1992). Interestingly, the authors concluded 
that delivery of two signals from separate cells was substantially less efficient than
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their combined delivery by one cell. There may be several reasons for the difference 
between these results and the results demonstrated here, first, in the experiments 
carried out by Liu and Janeway, they used anti-CD3 to stimulate the TCR, while SEB 
was used here. Second, the levels of B7-1 expressed on the costimulator cells may 
differ between the two experimental systems thereby affecting the ability of the third 
party cells to costimulate. Third, the mouse system may differ from humans in its 
ability to receive third party costimulation. Interestingly, mouse T cells do not 
express class II MHC when activated in contrast to human T cells which upregulate 
class II MHC on activation. However some of the data shown are consistent with that 
of Liu and Janeway in that expression of both ligands on the same cell is a more 
potent stimulus for proliferation.
In order to determine whether proliferation requirements differed between resting and 
activated T cells, SEB responsive T cell lines were developed. B7-1 costimulated 
SEB- driven signals in previously activated T cells, while LFA3 did not costimulate 
SEB responses. These data add weight to the hypothesis that LFA3 does not function 
as a costimulatory molecule but merely acts to enhance adhesive interactions. LFA3 
and B7-1 together provided SEB-specific T cells with the interactions necessary to 
produce a proliferative response equivalent to that demonstrated for PBMCs. LFA3 
might act to strengthen adhesion between the T cell and the APC and enhance B7- 
1/CD28 interaction. Productive engagement of the TCR resulted in IL-2 production 
by SEB specific T cells which was dependent on B7-1 and LFA3 costimulation. IL-2 
production was not elicited in these cells by SEB alone, thus costimulation signals 
were required in addition to TCR stimulation to lead to T cell effector function.
The importance of the B7-1/CD28 interaction in T cell effector function has been 
highlighted by these results and the potency of this reaction leads to the suggestion 
that understanding the molecular and biochemial pathways involved in CD28 is 
crucial to understanding the role played by T lymphocytes in immune regulation.
Interestingly, the addition of SEB alone to antigen-specific T cells resulted either in 
no or very poor proliferative responses which decreased as the dose of SEB 
increased. B7-1 and B7-10 alone stimulated proliferation responses in antigen- 
specific T cells which is in agreement with data from Liu and Janeway 1992. 
Therefore B7-1 was capable of directly stimulating activation , hence emphasising 
the potency of this interaction with CD28. Additionally SEB was demonstrated to 
have an inhibitory effect on B7-1 or B7 -2 stimulated T cell responses. This led to
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the suggestion that SEB was inducing anergy or apoptotic death in activated T 
lymphocytes. Consequently, having examined the requirements for costimulation of 
proliferation in resting and activated T lymphocytes to SEB it was next decided to 






4.1 Apoptosis in T lymphocytes:
Previously, it has been demonstrated that TCR signalling in the absence of APCs 
resulted in a poor proliferative response in resting and activated T cells. The 
proliferation requirements of resting and activated T cells have been examined and it 
is hypothesised that in addition to proliferation , PHA and SEB may also induce a 
death response in these cells. The most common morphological form of T cell death 
in the periphery appears to occur via apoptosis, therefore the ability of SEB and PHA 
to induce apoptotic death in resting and activated T cells was examined.
4.1.1 PHA-induced apoptosis in resting T lymphocytes.
Previously it was shown that PBMCs proliferated vigorously in response to PHA. In 
contrast the addition of PHA to purified T cells did not result in a proliferative 
response, demonstrating the requirement for accessory cell dependent factors for 
PHA responses. Proliferation and IL-2 production was restored in these cells by B7 
or LFA3 costimulation indicating that additional signals were required to fully 
activate PHA stimulated T lymphocytes. Having examined the effect of PHA on T 
cell proliferation it was next decided to determine whether this stimulus induces 
death in these cells. Therefore, PHA (5pg/ml) treated T lymphocytes were examined 
for evidence#of apoptosis by staining DNA with propidium iodide, followed by 
FACS analysis. Apoptosis was measured by the appearance of a sub Go peak 
representing condensed and fragmented apoptotic nuclear DNA. However, PHA 
treatment did not result in the apppearance of an apoptotic sub Go peak in resting T 
lymphocytes (Figure 4.1). Interestingly almost all the treated cells were in the Go (or 
resting) phase of the cell cycle with veiy few in S phase during which cells replicate 
their DNA prior to division. This demonstrated that PHA did not induce a 
proliferative response in resting T lymphocytes, consistent with what has been 
previously demonstrated. One possibility was that these cells were refractory to 
PHA-induced apoptosis because they were not proliferating and were therefore not 
progressing through the cell cycle.
4.1.2 PHA-induced apoptosis in Jurkat T cells
In order to examine this hypothesis further, advantage was taken of the Jurkat T cell line 














Figure 4.1 PHA-induced apoptosis in resting T lymphocytes.
Freshly isolated T lymphocytes (5x 1()4) were cultured for 72 hours in medium with or 
without the addition of PHA (5pg/ml). Cells were fixed with EtOH at 0°C, stained with 
propidium iodide and examined by FACS analysis using a Becton Dickinson FACStar Plus 
for evidence of cells demonstrating sub Go DNA which have undergone apoptosis
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may therefore respond differently to PHA stimulation compared to resting T 
lymphocytes and may be susceptible to PHA-induced apoptosis. Proliferation was 
measured in unstimulated and PHA treated Jurkats and it was seen (Figure 4.2) that 
PHA totally inhibited normal proliferation in these cells. It was possible that PHA 
was inducing apoptosis in these cells. Thus PHA-treated cells were examined for 
evidence of apoptotic cell death by FACS analysis. The appearance of a sub Go peak 
in PHA-treated cells was demonstrated (Figure 4.2) which suggested that PHA 
inhibits proliferation of Jurkat T cells by inducing apoptosis. This indicated that the 
direct outcome of stimulation by PHA in these T cells is apoptotic death. This was in 
contrast to the inability of PHA to induce death in resting T lymphocytes adding 
weight to the hypothesis that resting cells were resistant to PHA-induced apoptosis 
because they were not dividing. Additionally, there must be some cell cycle arrest 
since not all DNA showed apoptotic features. There are check points in the cell cycle 
during which DNA is synthesised where cells may become sensitive to induction of 
the death pathway. Consequently, continuously cycling cells such as Jurkat T cells 
may be more sensitive to apoptosis than resting T lymphocytes which are not 
progressing through the cell cycle.
Therefore, PHA was useful as a model to begin to study apoptosis in T lymphocytes.
One possibility was that PHA-induced apoptosis in Jurkat cells may be the result of 
lack of costi relation, hence it was attempted to provide costimulation using LFA3 
and B7-1 transfectants. Both LFA3 and B7-1 had previously been demonstrated to 
costimulate PHA-dependent proliferation in resting T lymphocytes. The ability of 
B7-1 and LFA3 costimulation to rescue proliferation in PHA treated cells was 
therefore examined. However, in contrast to the costimulation seen in resting T 
lymphocytes, proliferation was not restored by the addition of these factors (Figure 
4.3). The predominant response of Jurkat cells to PHA stimulation was thus apoptotic 
death, which may reflect the fact that these are transformed cells and may exist in a 
preapoptotic state already primed for the induction of apoptosis.
In addition to costimulating T cell proliferation, B7-1 and LFA3 have also been shown to 
be capable of costimulating IL-2 production in resting T cells. It was therefore decided to 
ascertain if costimulation of PHA responses in Jurkats resulted in IL-2 production. 
Interestingly, IL-2 production was increased on costimulation (Figure 4.3), the response to 
B7-1 being more potent than for LFA3. This was consistent with data previously shown 
demonstrating that B7-1 costimulation of resting T lymphocytes resulted in greater 
proliferation and IL-2 production than LFA3 costimulation (Chapter 3). The inability of
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Figure 4.2, PHA effect QP_ Jur.kat T cells.
Jurkat cells were cultured in medium for 18 hours with or without the addition of PHA 
(5pg/ml) and proliferation (A) or apoptosis measured (B). Cell numbers for proliferation 
were 5x10^ and for apoptosis 1x10^. Proliferation was measured by thymidine 
incorporation while apoptosis was measured by staining cells with propidium iodide 
followed by examining DNA by FACS analysis using a Becton Dickinson FACStar Plus. 
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Figure 4.3 Costim ulation of PHA-induced responses in Ju rk a t  cells .
Jurkat cells (5 x 10^) were cultured for 18 hours in medium with or without (none) PHA at 
5|ig/ml. CHO, LFA3 or B7-1 cells (2.5 x 10^) were added to PHA stimulated cells, and 
proliferation (A) or IL-2 responses (B) determined. Proliferation was measured by ^H 
thymidine incorporation while IL-2 prodction was measured using a CTLL-2 bioassay. 
Data are representative of 4 experiments.
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costimulation of IL-2 responses to rescue proliferation was interpreted by the fact that 
Jurkat T cells do not express IL-2 receptors, and were thus incapable of responding to 
the IL-2 produced.
PHA therefore induced apoptosis in Jurkat T cells while proliferation was inhibited 
and could not be restored by LFA3 or B7-1 costimulation. B7-1 was demonstrated to 
be a more potent costimulator of IL-2 responses which was consistent with the 
importance of CD28 signalling in IL-2 production and the effector function of T 
lymphocytes.
4.2. Dose reponse of Jurkats to PHA-induced apoptosis.
In order to look at the requirements for PHA-induced apoptosis, death in Jurkat T 
cells was examined in greater detail. Jurkat T cells treated with various 
concentrations of PHA were examined using FACS analysis, the cells being stained 
with both propidium iodide and the fluorochrome Hoechst 33342 (Figure 4.4 and 4.5) 
to establish a useful dose range of PHA. It can be seen by FACS analysis of 
propidium iodide .stained cells (Figure 4.4) that even at doses of PHA as low as 
0.5pg/ml there was a proportion of cells induced to die by apoptosis, which increased 
as the concentration increased. Further evidence of the dose dependency of PHA- 
induced apoptotic death was investigated using the fluorochrome Hoechst 33342 
(Figure 4.5), with increasing amounts of this dye being taken up as the dose of PHA 
was increased.The advantages of using this dye are that live cells can be used and the 
staining procedure is faster than for propidium iodide. Conversely, a FACS machine 
equipped with a uv laser must be used to analyse results which is slightly 
disadvantageous.
Together these results demonstrated that PHA induced dose dependent apoptosis in 
T lymphocytes. From these experiments the working concentration of PHA to be 
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Figure 4.4 PHA-induced apoptosis ; dose response in Ju rk a ts
Jurkat cells (lxlOfy were treated for 18 hours with PHA at indicated concentrations. Cells 
were fixed at 0°C  using EtOH, stained with propidium iodide and DNA content examined 




Figure 4.5 PHA-induced apoptosis in Ju rk a ts  : dose response m easured using 
Hoechst staining.
Jurkat cells ( 1x 106) were treated for 18 hours with PHA at various concentrations (A = 0,
B = 0.5, C = 1, D = 5, E = 10 flg/ml). Cells were stained with the fluorochrome Hoechst 
33342 and examined by FACS analysis using a FACS Vantage equipped with a 50mW uv 
laser. Necrotic cells were eliminated by simultaneously staining cells with propidum iodide 
and gating using FL-2. Data are representative o f 2 experiments
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4.3 Fas expression and apoptosis in Jurkat T cells.
It was next decided to examine the mechanism involved in PHA-induced apoptosis. 
One pathway by which apoptosis of T cells occurs is via ligation of the Fas receptor. 
Jurkat T cells express Fas (Figure 4.6), consequently, one possibility was that PHA- 
induced death might be mediated via a Fas-dependent pathway. In order to examine 
whether these cells were susceptible to Fas-induced apoptosis induction of apoptotic 
death using an anti-Fas mAb (CHI 1) was examined. Jurkats were treated with 
CHI 1, stained with propidium iodide and examined by FACS analysis. A substantial 
increase in the number of cells appearing in the sub Go region was observed 
indicating loss of DNA stainability with propidium iodide due to condensation of 
chromatin and DNA degradation (Figure 4.6D). Jurkat T cells thus underwent 
apoptotic death in response to ligation of Fas receptor. Interestingly however, 
apoptosis seen in these cells was of much greater magnitude than that seen in PHA- 
induced death. This suggested either that the antibody treatment was much more 
potent than PHA treatment or alternatively that PHA-induced death may be Fas- 
independent
4.4 Kinetics of PHA-induced apoptosis.
In order to further dissect PHA-induced death of Jurkats the kinetics of induction of 
apoptosis was determined. Cells were taken at various time points after the addition 
of PHA and their DNA examined for apoptosis. Surprisingly, very little death was in 
evidence up to 8 hours while significant amounts of apoptotic death only occured 
after 18 hours (Figure 4.7), PHA therefore induced slow time-dependent apoptotic 
death in Jurkat T cells. In order to determine whether PHA death could be mediated 
via ligation of Fas the kinetics of Fas- induced apoptosis in Jurkats was also 
examined (Figure 4.7). A large number of apoptotic cells were seen as early as 2 
hours post addition of CHI 1 followed by a rapid rise in apoptotic cell numbers 
increasing to almost 70% by 18 hours. The kinetics of these systems were therefore 
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Figure 4.6 Fas expression on Jurkat cells and Fas-induced apoptosis.
Jurkat cells (5x10^) were stained for 45 minutes at 0°C with a control Ig (A) or an 
anti-Fas mAb M3 (l|ig /m l) (B) followed by 45 minutes at 0°C with anti-mouse FITC 
conjugated Ig and examined by FACS analysis. In order to look at Fas-induced 
apoptosis, Jurkat cells ( lx l  0^) were treated for 18 hours with control Ig (C) or anti- 
Fas mAb CHI 1 (0.1 pg/ml) (D), fixed with EtOH at 0°C  and stained with propidium 
iodide. DNA was then examined by FACS analysis for evidence of sub Go apoptotic 
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Figure 4.7 Kinetics of PHA and Fas- induced apoptosis.
PHA (5|ig/ml), anti-Fas mAb CHI 1(0.1 fig/ml) or medium alone was added to Jurkat cells 
(1x106) and cells incubated at 37°C. At time points indicated cells were fixed, DNA 
stained with propidium iodide and% apoptotic cells determined by measuring cells with 
DNA in the subGo region by FACS analysis using a Becton Dickinson FACStar Plus. Data 
are representative of 4 experments.
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4.5 Modulation of PHA induced apoptosis.
The signals involved in apoptosis have yet to be completely elucidated although there 
are indications that a calcium-dependent endonuclease is involved in DNA 
fragmentation. In order to determine whether the mechanism of death induced by 
PHA involved a calcium signal, cyclosporin A(CsA) was utilised in an attempt to 
inhibit apoptosis. CsA appears to modulate T cell functions by blocking Ca 
-dependent signalling via the calcineurin dependent second messenger pathway, 
therefore the effect of CsA on PHA induced death was examined. A small amount of 
inhibition of PHA-induced apoptotic death was seen using CsA even at doses of PHA 
as high as 10pg/ml (Figure 4.8) although inhibition was not complete. This suggested 
that although calcium signalling was involved in PHA-induced apoptosis it may not 
be a critical factor.
To examine whether other receptor-ligand interactions were involved in PHA- 
induced apoptosis, antibody blocking experiments were performed in an attempt to 
prevent death. None of the antibodies tested substantially inhibited the apoptotic 
death induced in Jurkats by PHA (Figure 4.9). Binding of these antibodies to the 
appropriate cell surface receptor would occur before onset of apoptosis as suggested 
by the kinetics of PHA-induce death consequently, the antibodies would have access 
to their ligand. Interestingly, the antibody which had some effect on PHA- driven 
apoptosis wa$ an anti-CD28 antibody, (9.3) indicating that the CD28-B7-1 
interaction may be involved in the induction of apoptosis. This was in contrast to the 
inability of B7-1 molecules to rescue the proliferative response in PHA-treated 
Jurkats but reflected the ability of B7-1 to costimulate EL-2 production in PHA- 
treated cells.
Together these results suggested that there was minimal requirement for cell contact 
in PHA-induced apoptosis. However as expected from the definition of PHA as a 
lectin, microscopic examination PHA treated T cells appeared clustered, therefore 
one of the characteristics of PHA was to cause aggregation of T cells in culture. This 
may not however be a necessary event for the induction of apoptosis.
4.6 Involvement of Fas in PHA-induced apoptosis o f Jurkats.
The different kinetics of PHA-induced death compared to Fas-induced apoptosis 
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Figure 4.8 Effect of cyclosporin A (CsA) on PHA-induced apoptosis.
Jurkat T cells (lx  106) were treated with PHA at concentrations indicated and the effect of 
varying concentrations of CsA on PHA-induced apoptosis was determined by measuring 
the % of apoptotic cells using FACS analysis of fixed propidium iodide stained cells . Data 





Figure 4.9 Modulation of PHA-induced apoptosis.
The effect of antibodies to various cell surface molecules on PHA-induced apoptosis 
in Jurkat cells ( lx  1()6) was determined by measuring % apoptotic cells by propidium 
iodide staining and FACS analysis. Antibodies used were to CD2 (OKT11), CD3 
(OKT3), CD25 (CD25), CD28 (9.3) class II MHC (L243) or control antibody 
(control Ig). Data are representative of 3 experiment
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definitively investigate whether PHA induced death occured independently of Fas 
receptor engagement, an anti-Fas blocking antibody (M3) was used in an attempt to 
block apoptosis. Very little inhibition of PHA-induced apoptosis was seen (Figure 
4.10) indicating that PHA-induced apoptosis did not depend on Fas engagement. 
Overall, these finding suggested that Fas was not involved in PHA-induced apoptosis 
in Jurkats. There are many other possibilities for the death pathway induced by PHA 
in these cells including the involvement of TNF, the activation of an ICE-like 
cysteine protease or engagement of as yet unidentified receptors. Further work is 
needed to determine the pathway utilised in PHA-mediated death of Jurkat T cells.
4.7 Summary.
T lymphocytes have been examined for evidence of PHA-induced apoptotic death,
and it was observed that resting T cells were resistant to death. Lack of proliferation
in these cells was hypothesised to be one factor determining resistance to death.
Evidence for this hypothesis was provided by the demonstration that PHA induced
apoptosis in continuously proliferating Jurkat cells. Jurkat cells are transformed and
may therefore be in a preapoptotic state expressing altered levels of bcl-2 or c-myc.
Much evidence has accumulated to support the hypothesis that activated T cells are
more susceptible to apoptosis than resting cells. It has been shown that IL-2 treatment 
$
can render cells sensitive to apoptosis by driving them into a proliferative state 
(Leonardo 1991) during which the cells synthesise DNA and may become more 
susceptible to death.
PHA induced dose- and time- dependent apoptosis in Jurkat T cells, however the 
kinetics of death were very different to that seen during Fas-dependent death. 
Consequently, it was predicted that Fas-mediated apoptosis was not involved in the 
death induced in Jurkats by addition of PHA. More importantly, PHA-induced death 
was not inhibited by an anti-Fas blocking antibody which lead to the conclusion that 
PHA-induced death was independent of Fas.
Interestingly, an antibody to CD28 had some inhibitory effect on PHA-induced death, 
indicating the involvement of the CD28 signalling pathway in the prevention of PHA 
death. In contrast, the addition of B7-1 transfectants did not restore proliferation in
109
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Figure 4.10 Effect of anti-Fas blocking antibody on PHA induced apoptosis of Jurkat 
T cells.
Jurkat T cells ( lx  10^) were treated with PHA at indicated concentrations with (black) or 
without (white) the addition of M3 (5pg/ml) anti-Fas blocking antibody. Apoptosis was 
evaluated by FACS analysis of fixed, propidium iodide stained cells by measuring the 
number of cells displaying DNA as a sub Go peak. Data are representative of 3 
experiments.
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these cells, which indicated that costimulation did not restore a proliferative response 
in these cells. However, IL-2 production was costimulated by the addition of B7-1 
transfectants. It will be interesting to examine the effect of B7-2 transfectants on this 
response.
Apoptosis induced by PHA was sensitive to CsA indicating the involvement of 
calcium in cell death. In addition the inability of anti-MHC antibody to block PHA- 
induced death was demonstrated. Previously MHC-dependent responses were 
investigated using the superantigen SEB, therefore induction of apoptosis using this 
MHC-dependent antigen was investigated.
i l l
4.8 Induction of apoptosis by SEB
The superantigen SEB has been shown to have pleiotropic effects on specific Vb8 
expressing T cells when administered in vivo to mice (Callahan et al 1989). In 
addition it has been established in this study that PBMCs respond to SEB by 
proliferating, however concomitant with proliferation other events such as anergy 
and/or apoptosis may be taking place. It was therefore decided to examine human 
peripheral T cells for evidence of SEB induced apoptosis.
4.8.1 SEB induced apoptosis in PBMCs
Initially it was decided to investigate SEB-treated PBMCs for evidence of apoptosis. 
SEB was added to freshly isolated PBMCs over a period of 7 days during which cells 
were taken, their DNA stained with propidium iodide and examined for evidence of 
apoptotic death by FACS analysis (Figure 4.11 day 5). As early as day 1 post SEB 
addition, apoptosis as evidenced by the appearance of DNA with a sub GO peak was 
demonstrated (Figure 4.11) which was followed by an increase in amounts of 
apoptotic cell numbers peaking at day 5 and decreasing from day 7. Therefore in 
addition to eliciting a proliferative response SEB also induced death in PBMCs. This 
emphasised the ability of this antigen to bring about both proliferation and apoptosis, 
underscoring {he dual nature of SEB stimulation. TCR engagement may therefore 
result in more than one outcome in human peripheral T lymphocytes.
112


















Figure 4.11 Time course of SEB induced apoptosis in PBMCs.
SEB (l(ig/ml) was added to freshly isolated PBMCs ( lx  10^) which were taken at day 5 
(A) or at time points indicated (B), fixed with EtOH, stained with propidium iodide and 
DNA analysed by FACS for evidence of apoptosis. % apoptotic death was determined by 
measuring the number of cells whose DNA appeared as a sub Go peak. Data are 
representative of 4 experiments.
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4.8.2 SEB-induced death in antigen specific T cells
In order to examine apoptosis in activated T cells SEB specific T cells were used. 
These were generated by stimulating PBMCs with SEB followed by rIL-2 addition 
and restimulation using SEB presented on DR4/LFA3/B7-1 transfetcants. These cells 
were demonstrated to express MHC class II in contrast to resting cells which do not 
express class II and have upregulated CD28 expression. Previously it was shown that 
SEB in the absence of APCs did not induce proliferation of activated T lymphocytes 
and inhibited B7-1- and B7-10- induced proliferation in antigen specific T cells .
One possibility is that SEB alone may be inducing death in these cells, consequently 
it was decided to study SEB specific T cells for evidence of SEB-induced apoptosis.
Superantigen specific T cells were treated with SEB, their DNA stained with 
propidium iodide and examined by FACS analysis for evidence of apoptosis. A 
striking increase in cells whose nuclei showed signs of apoptosis as a result of the 
addition of SEB was observed (Figure 4.12). Apoptotic features such as 
accumulation of DNA staining in the sub-GO region of the DNA histogram, reflecting 
loss of DNA stainability due to condensation and fragmentation of the nuclear DNA 
were seen. Hence SEB induced apoptosis in antigen specific T cells whereas it did 
not produce a significant proliferative response in these cells. The predominant 
outcome demonstrated upon SEB addition to antigen-specific cells thus appears to be 
apoptosis in the absence of APCs.
4.9 Kinetics of SEB-induced apoptosis
It was next decided to determine the requirements for SEB-induced death. The 
kinetics of SEB-induced apoptosis in antigen specific T cells was examined initially. 
Cells were incubated with SEB over a period of 24 hours and at various time points 
were examined for evidence of apoptotic death by FACS analysis. The kinetics of 
this response revealed that nuclear changes were apparent as early as 1 hour 
following addition of SEB reaching almost maximal response after as little as 4 hours 
(Figure 4.13). Therefore a rapid response resulting in apoptosis of previously 
activated T cells was produced by SEB addition. These kinetics are very similar to 
those measured when Fas-mediated death was induced in Jurkats, leading to the 
suggestion that SEB may induce Fas-L expression and thus Fas/Fas-L interaction 








Figure 4.12 SEB-induced apoptosis in antigen specific T ceils.
SEB (0 or lpg/ml) was added to SEB-specific T cells (lxlO fy for 8 hours at 37oC Cells 
were examined for evidence of apoptotic death by propidium iodide staining followed by 
FACS analysis of DNA content. Data are representative of 4 experiments
115
O o  n-
M 1



















1 I I 1




o  J M ...... ..
200 400 600
FL2-Height












Figure 4.13 Kinetics of SEB-induced apoptosis in antigen-specific T cells.
SEB (lpg/m l) was added to antigen specific T cells(lx 10^) and DNA examined for 
apoptosis at various time points following addition. Percentage apoptosis was 
measured as accumulation of DNA in the sub GO region (M l). A=0 hour, B = lhour, 
C= 2hour, D= 4 hour, E= 8 hour and F= 24 hours.. FL-2 = PI staining, counts + 
relative cell number. Data are representative of 4 experiments.
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4.10 SEB-induced apoptosis: dose response of SEB specific T 
cells
In order to determine the effective dose of SEB at which apoptosis was induced the 
response of these SEB T cell lines at various doses of antigen was also measured. 
Increasing amounts of apoptotic death were seen as the dose of SEB increased, 
leading to apoptosis of 40-50% of the T cells at lpg/ml (Figure 4.14). These features 
were highly consistent with an apoptotic response and it was therefore concluded that 
the addition of SEB to these T cell lines caused the rapid induction of apoptosis. One 
possibility is that presentation of SEB by DR4/B7-1 transfectants prevented induction 
of apoptosis so that in the presence of an APC SEB may induce proliferation.
The death induced by SEB may reflect the involvement of Fas, as a similar high 
percentage of cells were induced to die on engagement of Fas in Jurkat cells. SEB- 
induced death in these cells was therefore time and dose dependent in a manner 
similar to that seen in Fas-induced apoptosis in Jurkats.
4.11 The death signalling pathway induced by SEB
Whilst SEB is known to bind to MHC class II it has also been suggested that SEB 
may bind directly to the TCR and induce activation signals via engagement of this 
receptor (Hewitt et al 1992). It was therefore decided to establish whether apoptosis 
induced by SEB in these T cells was occurring via this pathway. CsA was used to 
investigate the calcium dependence of SEB- induced apoptotic death. Results are 
shown as percentage inhibition of apoptotic death as measured by FACS analysis. It 
was clearly seen (Figure 4.15) that SEB-induced apoptosis was almost completely 
abolished by the addition of increasing concentrations of CsA. This indicated an 
important role for a calcium/calcineurin- mediated signal in SEB-induced apoptosis 
which may support the involvement of TCR signalling in the death process. In 
addition this was consistent with a role for Fas-dependent responses in SEB-mediated 
apoptosis as Fas-L expression has also been demonstrated to be inhibited by CsA 
(Vignaux et al 1995). Inhibition of Fas-L expression might thus be a possible cause 
of inhibition of SEB-mediated death by CsA if the interaction of this ligand with Fas 













Figure 4.14 Dose response of SEB-induced apoptosis in specific T cells to SEB.
SEB specific T cells were incubated for 16 hours with indicated concentrations of SEB. 
Apoptosis was measured by staining cells with propidium iodide followed by examining 
DNA content by FACS analysis measuring the amount of cells displaying DNA in the 




















Figure 4.15 (A) Effect of cyclosporin A on SEB induced apoptosis.
CsA was added to SEB specific T cells (lxlOfy 30 minutes prior to SEB (lpg/ml) and cells 
incubated for 18 hours.
fB) Effect of ionomvcin on the induction of T cell apoptosis.
Ionomycin at indicated concentrations was added to SEB specific T cells (lx l 0^) and cells 
incubated for 18 hours.
Apoptotic DNA was measured by FACS analysis of fixed propidium iodide stained 
cells and % apoptotic cells determined. Data are representative of 3 experiments.
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In order to further investigate the ability of calcium signalling to mediate an apoptotic 
response in SEB specific T cells the calcium ionophore ionomycin was used. A dose 
dependent apoptotic response was elicited in SEB T cell lines with ionomycin (Figure 
4.15). Therefore SEB-induced apoptosis could be mimicked by the addition of the 
calcium ionophore to the SEB T cell lines. These experiments were consistent with 
the involvement of an intracellular calcium signal in SEB-induced apoptosis of 
activated T cells. In addition these results correlated well with the hypothesis that 
direct binding of the TCR by SEB occurred during the apoptotic death induced by 
this antigen.
Antibody blocking experiments were carried out to determine if SEB-induced
apoptosis was dependent on T-T cell contact. None of the antibodies used were
particularly effective in inhibiting cell death (Figure 4.16). The most effective were
those against the adhesion molecules LFA1 (38.1) and LFA-3 (TS2/9) indicating only
the involvement of cell to cell contact in the induction of apoptosis in this system. An
antibody against the HLA-DR molecules was also ineffective in blocking the death
response, indicating that MHC presentation of SEB is not required to induce
apoptosis. This suggested that MHC presentation of SEB to the T cells was not
necessary and that activation of the T cells via direct interaction of SEB with the
TCR resulted in a calcium signal which is intimately involved in the apoptotic death #
process induced by SEB.
4.12 The role of the Fas/Fas-L interaction in SEB induced 
apoptosis.
SEB presentation occurs primarily via MHC class II although it can costimulate the 
TCR in the absence of class II (Hewitt et al 1992) whilst death induced via the TCR 
has been shown to be dependent on the Fas pathway (Vignaux et al 1995). Also 
apoptosis induced in antigen-specific T cells by SEB and by Fas engagement of 
Jurkats has been demonstrated to display similar kinetics. These data indicated that 
Fas-mediated death pathway may be responsible for apoptosis induced by SEB. 
Consequently it was decided to investigate the role played by Fas in SEB induced 
apoptosis.
The expression of Fas-L on the surface of activated T cells as a result of antigen 












Figure 4.16 Effect of antibody blocking on SEB-induced apoptosis.
Monoclonal antibodies (10|ig/ml) to the following cell surface molecules : HLA-DR 
(L243), LFA-1 (38.1), ICAM1 (15.2), CD2 (OKT11), LFA-3 (TS29) were added to 
SEB-specific T cells (lxlOfy at the start o f the experiment and incubated for 18 hours 
in the presence o f SEB (lpg/m l). Apoptosis was measured by propidium iodide 
staining followed by FACS analysis and determination o f % apoptotic cells 
displaying DNA in subGO region of the histogram. Data are representative of 2 
experiments.
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induced death. It has previously been established that Jurkat T cells express Fas on 
theirsurface and that ligation of Fas by an anti-Fas mAb leads to apoptosis in these cells. 
Consequently, it was decided to use these cells as targets for killing in a 
sensitive bioassay for Fas-L expression. In order for killing of Fas sensitive targets to 
occur, the cytotoxic effector cells must express Fas-L which may be induced by 
activating T cells using PMA and ionomycin. Therefore killing of Jurkats by 
unstimulated and PMA/ionomycin activated SEB T cells was initially examined 
using a sensitive 51Cr release assay. As expected no killing was detectable by 
unstimulated cells as evidenced by 51Cr release (Figure 4.17). In contrast, activating 
T cells by the addition of PMA and ionomycin resulted in the death of the Fas 
sensitive Jurkat cells, which released SlCr into the culture medium. Therefore 
activation may have induced Fas-L expression on SEB specific effector T cells, 
followed by ligation of the Fas receptor on the surface of Jurkat T cells leading to the 
death of Jurkat cells . To prove that this death was due to the interaction of Fas-L 
with Fas receptor, a blocking anti-Fas antibody (M3) was used. Cytotoxic killing of 
Fas sensitive cells by Fas-L expressing SEB T cells was inhibited by this antibody 
(Figure 4.17), thereby confirming that death in this sytem is due to engagement of 
the Fas receptoron the Jurkat T cells by activation induced Fas-L on SEB specific T 
cells.
These experiments demonstrated indirectly that expression of Fas-L was up- 
regulated on SEB T cells by activation. These Fas-L-expressing cells were then 
capable of killing Fas sensitive targets. It was next determined whether SEB 
stimulation was also capable of increasing Fas-L expression and inducing cytotoxic 
killing. When SEB was used to induce Fas-L expression, killing of the Jurkat T cells 
was also demonstrated (Figure 4.18). Furthermore, the M3 anti-Fas blocking 
antibody and in addition a recombinant Fas-Fc protein clearly inhibited SEB induced 
death of the Fas-sensitive target cells . This Fas-Fc lusion molecule acts as a receptor 
decoy for Fas and therefore blocked the interaction of Fas-L with Fas expressed on 
Jurkat cells thus preventing induction of killing. This confirmed that cytotoxicity was 
due to engagement of Fas by SEB induced Fas-L expressed on antigen specific T 
cells. Therefore SEB induced T cell death occurred via interaction of the Fas 
receptor with Fas-L expressed on antigen specific effector cells. SEB-induced 
apoptosis was therefore dependent on the Fas mediated death pathway. These 
experiments demonstrate that Fas is intimately linked with SEB-induced apoptosis of 
antigen specific T lymphocytes.
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Figure 4.17 Effect of PMA and ionomycin on Fas-L expression in SEB-specific T 
cells.
SEB T cells were assessed for their ability to induce cytotoxicity via apoptosis in SlCr 
labelled Fas sensitive Jurkat cells at various effector to target ratios. Labelled Jurkats were 
co-incubated with T cells in the presence or absence of PMA and ionomycin. The blocking 
effect of 3pg/ml of an anti-Fas antibody, M3 on cell death was measured. Data are 
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Figure 4. 18 Fas-L expression on SEB specific T cells.
Two independent T cell lines (panels A and B) were assessed for their ability to induce 
apoptosis in 5 lCr labelled Fas sensitive Jurkat cells at various effector to target ratios. 
Labelled Jurkat cells were co-incubated with T cells in the presence or absence of SEB. 
The blocking effects of 3|ig/ml of an anti-Fas antibody, M3 or 1/10 dilution of a 
recombinant Fas-Fc protein (panel B only) on induction of death were measured. Data are 
representative of 3 experiments
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An independent SEB-specific T cell line was investigated and interestingly it was 
seen that there was a basal expression of Fas-L in this line as well as upregulation of 
expression induced by SEB (Figure 4.18). Both death induced by unstimulated T 
cells expressing basal Fas-L and SEB stimulated T cells with upregulated Fas-L was 
inhibited by blocking the Fas/Fas-L interaction using both M3 and the Fas-Fc fusion 
molecule. It was therefore concluded that SEB activation resulted in Fas-L up­
regulation on SEB T cells which induced cell apoptosis in Fas positive target cells.
This supported the hypothesis that the Fas/Fas-L interaction is intimately involved in 
SEB mediated T cell death. This was in contrast to the death induced by PHA in 
Jurkat T cells demonstrated earlier.
The involvement of Fas-mediated death in SEB-induced apoptosis was further 
examined using FACS analysis of SEB-specific T cells which underwent apoptosis in 
response to SEB. It can be seen (Figure 4.19) that the appearance of SEB-induced 
apoptotic DNA was inhibited in these cells by M3 confirming that SEB-induced 
death occurred via a Fas-dependent pathway. SEB death and Fas dependent death 
were therefore hypothesised to be intimately linked. This led to the prediction that 
activation would result in the up-regulation of Fas-L mRNA expression in SEB 
specific T cells.
4.13 Kinetics of Fas-L expression
The kinetics of SEB stimulated regulation of Fas-L mRNA was examined using RT 
PCR. SEB specific T cells were stimulated with SEB (lpg/ml) and mRNA analysed 
at various times following stimulation by using primers specific for Fas-L (Figure 
4.20). Fas-L mRNA was not detected in unstimulated cells. However, following 
activation with SEB, mRNA for Fas-L was detectable by 1 hour and expression 
increased up to 4 hours. Levels of mRNA were compared by using a GAPDH 
control. These data confirmed the ability of SEB T cells to rapidly upregulate Fas-L 
mRNA in a manner consistent with the expression of this molecule in T cells 
undergoing apoptosis.
Previously SEB was demonstrated to induce apoptosis in PBMCs over a period of 7 days. 
Therefore Fas-L expression on SEB treated PBMCs was measured during this time period. 
RNA isolated from PBMCs incubated with or without SEB at various time points was 
subjected to RT PCR for Fas-L and the PCR product probed for expression of Fas-L by 




Figure 4.19 Involvement of Fas/Fas-L interactions in SEB-induced apoptosis.
SEB-specific T cells (lxlOfy were incubated with SEB (l|ig/m l) for 18 hours and the effect 
of addition of an anti-Fas blocking antibody (M3 at 3|lg/ml) on apoptosis was determined. 
Cells were stained with propidium iodide and examined by FACS analysis. Data are 
representative of 3 experiments
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Figure 4.20 Induction of Fas-L mRNA expression in SEB specific T cells.
T cells were stimulated with SEB (1/Ug/ml) for 0 hr (lanes 2 and 8), 1 hr (lanes 3 and 9), 
2hr (lanes 4 and 10), 3 hr (lanes 5 and 11) and 4hr lanes 6 and 12). Lane 7 contains a PCR 
amplified Fas-L cDNA control while lane 13 contains a GAPDH cDNA control. Samples 
were subjected to reverse transcriptase PCR for Fas-L (lanes 2-7) or GAPDH (lanes 8-13). 
Lane 1 contains <J)X174 /Hae III markers.
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Figure 4.21 SEB induction of Fas-L mRNA expression in PBMCs.
Panel A Southern blot hybridised with Fas-L probe, panel B GAPDH controls.
PBMCs were treated with ( A lanes 2,4, 6 and 8, B lanes 3, 5, 7and 9) or without lpg/ml 
SEB (A lanes 1. 3. 5 and 7, B lanes 2, 4, 6 and 8)) and RNA isolated at various time points 
from day 1 (panel A lanes 1 and 2, panel B lanes 2 and 3), day 3 (panel A lanes 3 and 4. 
panel B lanes 4 and 5 ) ,  day 5 (panel A lanes 5 and 6, panel B lanes 6 and 7) and day 7 
(panel A lanes 7 and 8, panel B lanes 8 and 9). Panel A lane 9 is Fas-L cDNA control , all 
samples were southern blotted and probed for Fas-L expression, autoradiograph was 
exposed for 2 hours. Panel B samples were subjected to reverse transcriptase PCR for 
GAPDH Panel B lane 1 0X174 markers
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GAPDH primed expression. Fas-L mRNA was rapidly induced by day 1 in SEB- 
treated PBMCs, which increased to a maximum at day 5 and rapidly declined at day 
7. This expression correlated well with the kinetics of death induced by SEB in these 
cells, providing further evidence for the involvement of the Fas/Fas-L interaction in 
SEB induced apoptosis. The kinetics of Fas-L mRNA expression thus reflected the 
regulation of SEB-induced apoptosis demonstrated earlier in PBMCs. Consequently 
these results highlight the critical role played by the Fas/Fas-L interaction in SEB- 
mediated apoptosis of T lymphocytes.
These experiments led to the hypothesis that SEB can induce apoptosis in both 
resting and activated T lymphocytes and that Fas-L is upregulated by SEB 
stimulation. SEB-induced death can be blocked by inhibiting the Fas-Fas-L 
interaction which showed that SEB death is mediated via Fas/Fas-L interactions. Fas- 
L upregulation appears to be intimately associated with activation induced death of T 
cells.
4.14 Induction of apoptosis by ligation of Fas on activated T 
cells.
When a number of SEB-specific T cells were examined by FACS analysis, Fas 
expression was seen (Table 4.1) as would be expected on activated T cells. These T 
cell lines were examined for evidence of Fas-induced apoptosis. Surprisingly 
however, in no case was death of these cells demonstrated on ligation of Fas by 
CHI 1 (Table 4.1). This was quite an unexpected finding as many of the SEB specific 
T cell lines had been repeatedly activated during restimulation and would thus be 
predicted to be sensitive to death upon engagement of Fas. Fas-dependent death 
may not occur in these cells for a number of reasons. One possibility to explain this 
finding was that signals in addition to Fas ligation were required to induce death in 
these cells. Death mediated by the Fas pathway may be due to trimerisation of this 
receptor on the cell surface which may not be occurring. Alternatively, the secretion 
of Fas-L by these cells which can bind to the antibody may inhibit death.
Engagement of the TCR, which occurs during SEB-induced responses, may also be 
required in conjunction with engagement of Fas in order to induce apoptosis.
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CELL LINE FAS STAINING % APOPTOTIC DEATH
MEI %-CELLS ANTI-FAS SEB(0.5 ng/ml) (lUg/nd)
LW.l 51.2 83.4 1.9 3.68
LW.2 26.8 95.8 1.33 2.35
SE.l 24.4 92.3 3.81 0.5
SE.2 56.5 81.3 5.5 4.08
MB.l 55.1 89.3 0.2 3.67
PI.l 83.9 98.0 0.6 N.D.
TABLE 4.1
6 independent SEB lines were assayed for Fas expression and susceptibility to anti- 
Fas induced or SEB-induced apoptosis. Cells (2xl05/antibody) were removed from 
culture and washed with PBS, followed by suspension in M3 for 45 minutes at OoC. 
Having washed with PBS antibody was detected using anti-mouse FITC conjugated 
Ig. Stained cells‘were analysed for Mean Fluorescence Intensity (MFI) and % 
positivity.To determine apoptotic death cells were cultured for 18 hours with or 
without an anti-Fas killing antibody (0.5pg/ml) or SEB (lpg/ml) and apoptotic cells 
determined by propidium iodide staining and examination of hypoploid DNA by 
FACS analysis.
As it has been demonstrated that SEB-induced death was dependent on Fas, it was 
also interesting to examine these Fas-resistant cell lines for SEB-induced apoptosis 
Interestingly all of the Fas-resistant SEB lines examined were also resistant to SEB- 
induced apoptosis(Table 4.1). It was therefore observed that various cell lines were 
resistant to Fas-mediated death using anti-Fas antibodies while a number of SEB 
lines were also refractory to SEB-induced death. This may reflect the inability to 
induce Fas-triggered death in these ceils, as it is hypothesised that SEB death is 
intimately associated with triggering of the Fas-death signal. These cells may have an 
intrinsic defect in their Fas signalling pathway or may be deficient in the factors that 
contribute to Fas-induced death. It is possible that Fas-mediated death requires 
additional “costimulation” signals such as CTLA-4. Consequently the effect of Fas 
ligation on CD28 responses were examined. Interestingly, the anti-Fas antibody,
CHI 1 was demonstrated to inhibit the proliferative response induced by CD28 
costimulated SEB driven proliferation (Figure 4.22). CHI 1 also blocked proliferation 
in response to DR4/B7-1 transfectants . This suggested that in order for engagement 
of Fas to induce a death signal in T cell lines they must first receive activation 
signals to proliferate.
Alternatively, a feature of T cell lines may be regulation of factors which modulate 
apoptotic death. One of these death modulator-factors is the bcl-2 family which 
includes the bcl-2 and bax molecules. Therefore, the expression of bax was 
investigated as a preliminary step to determine whether resistance to apoptotic death 
was due to modulation of death influencing factors. An SEB specific T cell line 
which constitutively expressed Fas-L was examined for effect of SEB activation on 
bax expression. In addition to constitutive expression of Fas-L this cell line also 
expressed bax (Figure 4.23). However, the addition of SEB down regulated the 
expression of bax in this cell line (Figure 4.23). When bax is in excess, cell death is 
accelerated. Therefore, as SEB downregulates bax expression, these cells are 
suggested to increase their resistance to SEB/Fas induced apoptotic death. The 
balance between bcl-2/bax expression and Fas-L expression may determine the 
outcome of Fas receptor engagement in these cells. Therefore SEB-specific T cells 
may become resistant to death upon SEB addition by the down-regulation of death 
enhancing factors. The balance between expression of factors which influenc 







Figure 4.22 Effect of Fas ligation on CD28 costimulated SEB proliferation.
SEB specific T cells (5x10^ ) were stimulated by presenting SEB on DR4/B7-1 cells 
(2.5x104) and the effect of addition of CHI 1 (O.lpg/ml), an anti-Fas antibody was 
determined by measuring proliferative responses. The response to DR4/B7-1 cells 
with and without CHI 1 is also shown. Proliferation was measured by ^H thymidine 
incorporation. Data are representative o f 2 experiments.
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Figure 4.23 SEB effect on bax mRNA expression in SEB specific I cells.
Panel A southern blot hybridised with bax probe. B GAPDH controls.
Panel A SEB specific cells were treated with SEB and RNA isolated at 0 (lane 2), 4 hours 
(lane3) and 18 hours(lane 4), reverse transcribed, separated by agarose gel electrophoresis 
southern blotted and autoradiograph exposed for 24 hours. Lane 1 bax cDNA control 
probed with bax.
Panel B samples were subjected to reverse transcription PCR for GAPDH, 0 hrs (lane 2) 4 
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Figure 4.24 Effect of Fas ligation on CD3 stimulated proliferation.
Freshly isolated T lymphocytes (5x10^) were stimulated for 3 days with or without anti- 
CD3 (1 p.g/ml). The effect of addition of various concentrations of CHI 1, an anti-Fas 
antibody on proliferation responses was determined. Proliferation was measured by 
thymidine incorporation. Data are representative of 2 experiments.
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4.15 Fas-L ligation may result in costimulation in addition to 
inducing death in T cells.
Interestingly, it was demonstrated that Fas ligation in addition to signals induced 
upon TCR engagement using an anti-CD3 antibody resulted in enhanced proliferative 
responses in PBMCs (Figure 4.24). Therefore in addition to death signals Fas 
receptor engagement may also result in synergy with the signals that elicit a 
proliferative response. Consequently, a simple definition of Fas as a death inducing 
molecule needs some elaboration.
4.16 Discussion.
Having explored some of the factors necessary for productive T cell activation, it was 
decided to examine the possibility that apoptosis was also occurring in PHA or SEB- 
treated T cells. Resting T lymphocytes were found to be resistant to PHA-induced 
apoptosis, however when Juikat T cells were examined for PHA-induced death a 
substantial apoptotic response was demonstrated. The different outcome of PHA 
treatment in Jurkat T cells may reflect the observation that they are continuously 
proliferating and thus may be constantly susceptible to apoptosis. The continuous 
progression of these cells through the cell cycle may lead to production of DNA 
strand breaks during mitosis resulting perhaps in irreparable DNA damage 
committing the cell to the apoptosis pathway. Alternatively, these T cells may be in a 
pre-apoptotic state because they are transformed and express altered levels of factors 
such as bcl-2 or c-myc or p53 which .may render the cell susceptible to the induction 
of death by PHA. It is suggested therefore that PHA triggers a death signal in 
previously activated (transformed) T cells which are highly susceptible to apoptosis 
when they are in a proliferative phase of the cell cycle. This is in agreement with data 
demonstrating that pretreatment of T cells with IL-2 which drives them towards 
proliferation renders these cells susceptible to the induction of apoptosis. (Lenardo 
1990). Transformed cells and activated T cells appear to be much more susceptible to 
apoptosis than resting T lymphocytes (Nishioka et al 1994, Russell et al 1991,
Salmon et al 1994) and it is suggested that together with an apoptotic signal T 
lymphocytes must also receive a further signal in order for death to occur. This may 
well involve similar signals to those which T cells receive in order to become 
activated or proliferate. The death pathway therefore appears to be more complicated
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than requiring one signal and may have similar requirements to T cell activation in 
agreement with the two signal model first proposed by Bretscher and Cohn (1970).
Many mechanisms for the induction of cell death have been identified, one involving 
Fas/Fas-L interactions. This was not the mechanism induced by PHA stimulation as 
the kinetics of PHA-dependent apoptosis and death induced by ligation of the Fas 
receptor on Jurkats were remarkably different. More importantly, anti-Fas blocking 
antibody did not prevent PHA-induced death of Jurkats indicating that Fas was not 
involved in PHA-induced apoptosis. The apoptotic pathway induced by PHA remains 
unknown but may involve ligation of as yet undiscovered receptors. Alternatively, 
TNF-dependent cell death may be triggered by PHA in Jurkat cells which warrants 
investigation. Additionally activation of cysteine proteases such as ICE may be 
involved and the once surface molecules have been triggered to initiate apoptosis the 
intracellular pathway of PHA induced apoptosis and Fas-induced apoptosis may 
intersect.
The involvement of a calcium signal in PHA-induced apoptosis was demonstrated 
using CsA which partially blocked apoptosis. This may reflect the involvement of a 
Ca-dependent endonuclease and/or the importance of TCR mediated signals in PHA- 
induced death of Jurkat T cells. However, in this case triggering of the TCR did not 
lead to Fas mediated death as reported in Vignaux et al (1995). Alternatively, PHA 
may not signal through the TCR and other receptors such as CD2 may be incvolved 
in PHA-induced death.
In this study use was also made of the superantigen SEB to look at induction of 
apoptosis in human peripheral T cells. Previously it was demonstrated that SEB 
induced proliferation in PBMCs while SEB alone was insufficient to induce 
proliferation in antigen-specific T cells. However, when costimulation was provided 
by B7-1 or LFA3 these cells were capable of proliferating in response to SEB. 
Interestingly it was also found that increasing the dose of SEB in some antigen- 
specific T cells lead to a decrease in their proliferation. Additionally, proliferation 
induced in response to B7-1 or B7-1-2 stimulation was inhibited by the addition of 
SEB to these cultures. Consequently, it was predicted that not only was SEB capable 
of stimulating a proliferative response but was also capable of inducing apoptosis in 
T lymphocytes. SEB was indeed demonstrated to induce apoptotic death of PBMCs 
providing evidence for the dual outcome of TCR engagement. SEB stimulation of 
PBMCs can therefore result in either proliferation and IL-2 production or apoptosis.
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Additionally it was demonstrated that antigen-specific T cells underwent apoptosis 
when treated with SEB. This is in direct agreement with data from Damle and his 
colleagues who showed SAg-induced death of antigen-specific T cells (Damle et al 
1993). Therefore the predominant effect of SEB on activated T cells appeared to be 
death. It is intriguing however that in some cases low levels of proliferation were also 
seen, implying perhaps that activation signals were necessary in addition to apoptotic 
signals to induce death of these T cells.
SEB-induced apoptosis was completely inhibited by the addition of CsA indicating 
the involvement of calcium signalling in death. This death could be mimicked by the 
addition of tjie calcium ionophore ionomycin. Again these data are in aggreement 
with recently published data (Damle et al 1993a). This is in contrast to the 
enhancement of T cell deletion seen in mice using SEB and CsA (Vanier and 
Prud’homme 1992). CsA was demonstrated to block the the expansion phase of 
targeted T cells. The work of Shi et al (1989) demonstrated that CsA blocks anti-CD3 
induced apoptosis in the thymus which support the hypothesis of calcium signalling 
playing a role in apoptosis and the direct involvement of TCR ligation in 
programmed cell death.
The failure of anti-Class II antibody to block SEB death led to the hypothesis that 
MHC presentation of this superantigen to the TCR was not necessary and death 
occurred via a direct interaction of SEB with the TCR. Anergy induced by SEB has 
also been demonstrated to occur via MHC-independent pathways (Hewitt et al 1992) 
by direct binding of SEB to the TCR which induces a calcium signal. These data are 
in direct agreement with the experiments seen here and it is therefore concluded that 
SEB interaction with the TCR on antigen-specific T cells results in apoptosis. T cells 
undergo apoptosis in response to SAg in mice but do not express MHC class II which 
supports the concept of SEB directly interacting with the TCR and causing a calcium 
signal.
Although not directly demonstrated here it may be suggested that in addition to 
apoptosis SEB may also be inducing anergy in antigen-specific T cells as in no case 
was 100% apoptosis shown. Additionally, there are many reports of SEB-induced 
anergy in the literature to support this hypothesis (Hewitt et al 1992). Interestingly 
most demonstrations of apoptosis occur in less than 100% of cells opening up the 
possibility that other events such as anergy and proliferation are occurring 
simultaneously.
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The ability of an antibody to LFA1 (CD11 a/CD 18) to block SEB-induced apoptosis 
is consistent with recently published data (Damle et al 1993) which demonstrated that 
SAg-induced antigen specific death was inhibited by blocking the interaction of 
LFA1 with its ligands. Additionally, it has previously been demonstrated that 
proliferation of resting T cells with SAg is efficiently inhibited by anti-LFAl 
antibody (Damle et a ll992). One explanation for these results is that CD 11 a/CD 18 
plays an important role in the interaction of SAgs with T cells and the consequent 
results. Alternatively, the binding of antibodies to LFA1 may induce steric hindrance 
thus preventing SEB binding to the TCR. Another possibility for the role of LFA1- 
mediated cell adhesion is that it may facilitate the interaction of Fas with Fas-L 
thereby allowing this interaction to exert its death promoting activity. In contrast to 
data seen here these authors demonstrated that antibody to LFA3 had no such effect 
(Damle et al 1993) .The interaction of LFA3 with CD2 may transduce a signal which 
when blocked by anti-LFA3 antibody interferes with SEB-induced death implying 
perhaps that CD2 signalling may be involved in SEB-induced apoptosis.
SEB-induced death was shown to be rapid and occurred with similar kinetics to Fas- 
dependent death in Jurkats. More importantly, inhibition of SEB-induced killing of 
Fas-sensitive Jurkats was demonstrated using an anti-Fas blocking antibody. SEB up- 
regulation of Fas-L in this system lead to ligation of Fas receptor resulting in the 
death of the Jurkats. SEB induced apoptosis was therefore dependent on the 
interaction of Fas-L with its receptor. Fas-L mRNA expression was further 
demonstrated to be upregulated in SEB-specific T cells upon activation consistent 
with the involvement of this molecule in AICD. This is in complete agreement with 
recently published data demonstrating a role for the Fas/Fas-L in SEB induced T cell 
death (Ettinger et al 1995). It was demonstrated that SEB induced apoptosis was 
linked to the rapid induction of Fas-L expression in cells constitutively expressing 
high levels of Fas. In addition blocking of death was seen using a Fas-Fc fusion 
molecule which is consistent with data presented here.
The ability of SAgs to induce apoptosis via direct up-regulation of Fas-L has 
potential implication in the pathogenesis of AIDS. One of the symptoms of HIV+ 
patients is their susceptibility to a wide variety of infections during which they are 
exposed to an array of diverse micro-organisms including those expressing SAgs 
such as SEB. Direct exposure of antigen-specific T cells to SAg may lead to 
apoptosis via up-regulation of Fas-L and thus may contribute to the depletion of T
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cells associated with AIDS pathogenesis. Therefore an understanding of the ability of 
SEB to influence Fas-L expression has implications for therapeutic intervention in 
AIDS. Moreover recently Fas induced T cell apoptosis in HIV-infected individuals 
has recently been demonstrated (Katsikis et al 1995). Anti-Fas induced apoptosis 
involved both CD4+ and CD8+ T cells and correlated with disease severity. These 
results emphasise the crucial role apoptosis plays in the maintenance of a fully 
functional immune system and the prevention of disease.
The inability of anti-Fas antibody and in some cases SEB to induce death in Fas 
positive T cells indicated that, while levels of Fas expression may be sufficient, there 
are other factors required to initiate the death outcome in response to Fas ligation in T 
cells. One possibility is that the differentiation state of the T cell influences its 
susceptibility to death via Fas engagement. It has been demonstrated (Miyawaki et al 
1992), that viability of in vitro stimulated T cells was not significantly altered after 
treatment with anti-Fas antibody in contrast to Fas-expressing cultured cell lines, 
indicating that additional cellular conditions to Fas expression might be required for 
Fas-induced apoptosis. Additionally differential sensitivity of activated T cells to 
anti-Fas mediated apoptosis independent of Fas epitope density on activated T cells 
has also been demonstrated (Klas et al 1992). It may therefore be concluded that 
activation signals interfere with the Fas pathway thus preventing apoptosis.
f
Alternatively, Fas-mediated apoptosis may involve a delicate balance of receptor 
-ligand interaction and the possibility must be considered that this can be modulated 
by soluble proteins. Indeed, three human Fas variants have been identified and 
characterised which encode soluble Fas molecules which are capable of inhibiting 
antibody induced apoptosis (Cascino et al 1995). In addition elevated levels of 
soluble Fas observed in some patients with SLE may block apoptosis resulting in 
accumulation of self-reactive T and B lymphocytes, and perhaps accounting for the 
presence of increased mutations observed in the lymphocytes of SLE patients 
(Gmelig-Meyling et al 1992). The identification of such soluble forms of Fas implies 
that the simple model of Fas/Fas-L interaction as an apoptosis transducing complex 
needs some enrichment.
Engagement of receptors by specific Ligands or crosslinking by specific mAbs causes 
receptor dimerisation or oligomerisation which promotes recruitment of mediators 
that trigger a signalling cascade. The apoptotic signal through Fas is induced by the 
binding of anti-Fas antibodies or the Fas-L to Fas. These tend to be IgM antibodies or
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IgG3 antibodies which lead to aggregation of Fas. It has also been shown that the 
F(ab’)2 fragment or other isotypes of the anti-APO-1 antibody hardly induce 
apoptosis (Dhein et al 1992). These results suggested that oligomerisation of at least 
three Fas molecules is a biologically relevant complex in generating an intracellular 
signal. The fact that Fas-L is a TNF-related molecule which exists as a trimer (Boldin 
et al 1995) agrees with this idea. Furthermore a functional soluble form of human 
Fas-L has been identified in the supernatant of activated lymphocytes and shown to 
have a trimeric structure (Tanaka et al 1995). Thus it is likely that Fas-L as a 
homotrimer binds to three Fas receptors and induces its trimerisation to transduce the 
apoptotic signal. The threshold of sensitivity to Fas-mediated cell death in partially 
resistant clones was reduced by the addition of cycloheximide (Tanaka et al 1995). 
This suggested that there are factors being produced in these clones which protect 
against Fas-induced death, and protein synthesis inhibition prevents these factors 
from being produced. Cytotoxic signalling is therefore subject to the inhibitory action 
of intracellular proteins. The efficacy of Fas cytotoxic signals may be dependent on a 
critical level of receptor surface expression. Optimal signal transduction presumably 
requires interaction between a critical fraction of receptors forming the ligand 
mediated clustering of cells and specific second messenger molecules.
The simple definition of Fas as a death inducer needs elaboration in light of the data 
presented here showing that Fas engagement can enhance CD3 stimulation which is 
in agreement with data recently published (Alderson et al 1993). These authors 
demonstrated that ligation of Fas on freshly isolated T cells by a mAb in conjunction 
with anti-CD3 stimulation lead to enhance proliferation, increased expression of the 
EL-2 receptor CD25 and the activation marker CD69 and also enhanced expression of 
cytokines including IL-2. Additionally similar results have also been obtained using 
recombinant Fas-L (Lynch et al 1995). It has been hypothesised that Fas might act as 
a costimulatory molecule during the early part of an immune response while as cells 
become activated Fas may then become important to suppress the immune response 
by eliciting apoptotic death of Fas positive activated T cells (Lynch et al 1995). In 
addition, antibodies have been raised to the Fas receptor which inhibit anti-Fas 
induced apoptosis and it is speculated that these antibodies bind to determinants on 
Fas which interfere with the formation of the trimolecular complex required to 
transduce the apoptotic signal (Alderson et al 1994). The idea of Fas as an 
immunomodulatory molecule rather than simply a death inducing molecule becomes 
more valid in light of these data. The immune system has developed an intricate way
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of regulating life and death of T cells which is not yet fully understood but its 
complexity is no longer surprising.
It is possible that Fas-mediated signals may include both apoptosis and cellular 
activation depending on the activation state of the target cell. Thus conversion of Fas- 
mediated signals from activation to apoptotic may be an integral component of the 
transformation process and represents a safety mechanism by which the immune 
system can eliminate transformed ceils from the host by stimulation through Fas. 
Freshly isolated T cells are not susceptible to Fas-mediated death signals and it takes 
multiple rounds of stimulation before a cell becomes susceptible to Fas-mediated 
apoptosis. This may reflect the use of antigenic stimulation as a mechanism to control 
lymphocyte homeostasis. The immune response may be regulated by the type and 
anatomical location of APC, which plays a role in determining whether the T cell 
responding to antigen remains capable of further proliferation or dies.
Induction of death by Fas-L requires the cell to have received more than one signal. 
Previous signals by antigen or signals occurring simultaneously may be required for 
the death signal to be triggered by Fas engagement. The signal induced by Fas has 
been intimately linked with ligation of the TCR (Vignaux et al 1995). It is suggested 
therefore that rather similar to CD3 Fas mediated death requires costimulation. 
Consequently, Fas is a neccesary component of the death pathway but is dependent 
on the integration of other stimuli for transduction of the death signal. This is 
supported by the recent isolation of death associated molecules (FADD, TRADD and 
RIP) (Hsu et al 1995, Stanger et al 1995, Chinnaiyan et al 1995). These results firmly 
place the Fas/Fas-L interaction as an important regulator of immune responses and 
suggest a role for expression of these molecules in harnessing T cell proliferative 
responses and terminating a T cell response once it has completed its function.
Ligation of Fas by a mAb was shown here to inhibit the proliferative response 
induced by CD28 costimulated SEB-driven stimulation. Additionally the proliferative 
response induced in activated T cells by class II MHC and CD28 stimulation was also 
inhibited by Fas ligation. These data demonstrate the ability of Fas signals to 
modulate CD28 induced costimulation. T cell activation, which is intimately 
dependent on CD28 costimulation, may therefore also involve Fas regulation. CD28 
costimulation has been demonstrated to enhance the expression of the survival factor 
bcl-xL (Boise et al 1995). Cells which express bcl-xL at levels comparable to that of 
CD3/CD28 stimulated T cells were found to be resistant to the induction of cell death
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by antibodies crosslinking Fas. Thus costimulation appears to prevent Fas-induced 
cell death. Together these data appear to imply that CD28 and Fas expression are co- 
ordinately regulated and the outcome may be determined by which signal 
predominates.
Down-regulation of bax mRNA expression due to SEB activation led to the 
hypothesis that in some cases addition of SEB actually protects the cells from 
apoptosis. Co-ordination of the expression of death repressor factors and death 
inducing factors may ultimately determine whether a stimulus results in proliferation, 
anergy or death of a T lymphocyte.
The involvement of B7-1-CD28 interactions in the inhibition of tolerance in the 
lpr/lpr mice has also been examined (Ettinger et al 1995). CD28 and CTLA4 mRNA 
were found to be overexpressed in the lymph nodes of Ipr mice. Results from these 
studies suggested that the CD28/CTLA4 interaction with B7-1 is critical to the ability 
of lpr T cells to respond to SEB stimulation. By blocking the CD28 interaction it was 
demonstrated that TCR stimulation in the absence of costimulation reanergises the T 
cells and restores tolerance. This confirms that CD28 can block the induction of 
anergy . In addition these mice demonstrate a failure to undergo AICD in response to 
SAgs in vitro (Bossu et al 1992).This was demonstrated to be due to the defect in Fas 
expression an0 it has been shown that Fas-L mediated cytotoxicity is crucial in the 
apoptotic response to SEB (Ettinger et al 1995). The results in these mice suggested 
that the CD28/B7-1 interaction may be interlinked with the Fas/Fas-L interaction in 
mediating tolerance in the immune system and further strengthen the hypothesis that 
CD28 and Fas expression may be co-ordinately regulated.
In summary the Fas/Fas-L has been demonstrated to be intimately involved in the apoptotic 
death process induced by SEB in antigen-specific T cells. Additionally, the induction of 
apoptosis appears to require more than Fas ligation and elucidation of the factors which 
determine susceptibility to SEB- or Fas-induced apoptosis remain a matter of speculation 





A major focus of attention in this study has been to address the factors necessary for 
T cell activation . One initial finding was that TCR triggering alone did not stimulate 
proliferation in resting T lymphocytes and that additional APC-derived signals were 
required. CD28 costimulation using B7-1 or B7-2 was shown to synergise with TCR 
signals to induce T cell proliferation, highlighting the importance of the B7-1/CD28 
interaction in T cell effector function. This agrees with the current consensus of 
opinion of the critical role played by CD28 signalling in T cell activation and 
production of IL-2 (Harlan et al 1995). Additionally, it has also been demonstrated 
that CD28 can provide costimulation for Th2 proliferation by increasing 
responsiveness to IL-4 and can costimulate CD8+ cytotoxic cells (McArthur et al 
1993, Azuma et al 1993). Collectively, these results demonstrate that the CD28 
pathway plays a central role in the activation and proliferation in both Thl and 1112 
classes of T lymphocytes.
It is intriguing to speculate that the B7-1/CD28 interaction might be a target for 
immune intervention. The demonstration that B7-1 transfection of tumour cells 
resulted in improved detection and elimination of these cells (Harlan et al 1995) and 
the ability of CD28 to costimulate CD8+ cytotoxicity (Harding and Allison 1993) 
indicates opportunities for tumour therapy. Additionally, CTLA-4-Ig induced long­
term survival of pancreatic islet grafts (Lenschow et al 1992) suggesting that 
blocking the CD28/B7-1 interaction may have applications in human organ 
transplantation and provide an approach to improve transplant success. Interestingly, 
recent data has also showed that B7-1 induced Thl cells whereas B7-2 induced Th2 
cells (Freeman et al 1995, Kuchroo et al 1995). Another conclusion from these and 
other studies in NOD mice (Lenschow et al 1995) was that differential administration 
of anti-B7-l/B7-2 antibodies had opposing effects on disease progression. 
Collectively, these studies lead to the hypothesis that B7 regulation plays a vital role 
in T cell function and provides exciting possibilities for immunoregulation of 
autoimmune diseases.
Another stimulating finding was that LFA3 also costimulated PHA-driven 
proliferation and IL-2 production. Thus PHA and LFA3 together provided the T cell 
with all the necessary signals to become fully activated, produce cytokines and
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expand. Knowing that LFA3 binds to its ligand CD2 on T lymphocytes, one possible 
interpretation is that PHA can also interact with this ligand. Both these interactions 
could then be said to mimic the effect of pairs of anti-CD2 mAbs which have been 
demonstrated to induce T cell proliferation (Moingeon et al 1992). CD2 has two 
binding moieties which may both need to be triggered in order that T cell activation 
occur. CD2 signalling may then be sufficient to induce proliferation and IL-2 
production. PHA and CD28 signals synergise to result in T cell activation, thus it is 
also possible that LFA3 uses the same pathways as CD28, or in some way triggers 
CD28 signalling although this seems highly improbable. PHA signalling may 
however intersect the CD28 signalling pathway via PI3K for example which perhaps 
synergises with CD2 signalling. However, it has yet to be determined exactly what 
second messenger system is triggered in T cells by PHA.
It was also found that B7-1 or B7-2 alone was capable of inducing proliferation in 
activated T cells but not resting cells, leading to the hypothesis that resting cells and 
activated T cells differ in their requirements for proliferation. One attractive idea to 
explain this difference is that activated T cells have an active TCR signalling 
pathway which can synergise with CD28 signalling. Consequently, activated T cells 
are more receptive to B7-1 or B7-2 stimulation than resting cells. This correlates well 
with experiments showing that CD28 ligation in SAg specific T cells leads to 
induction of the SMase pathway minutes following addition of either B7-1 
transfectants or anti-CD28 antibody (Dr Y. Patel personal communication), reflecting 
the idea that signal transduction occurs more readily in activated T cells.
Even more interesting was the observation that addition of free SEB to B7-1 or B7- 
10 stimulated T cells resulted in inhibition of the proliferative response. Evidence has 
been provided here that SEB in the absence of APCs induces apoptosis in activated T 
cells, which is in aggreement with work carried out by Damle and colleagues (1993a) 
which showed that SAg induced PCD in antigen specific T cells. Thus one possibility 
was that SEB was inducing apoptosis in these cells. Interestingly, proliferation was 
not totally inhibited which can be interpreted as the occurence of a number of events 
simultaneously. Therefore some cells may be triggered by B7-1 or B7-2 to proliferate 
and at the same time cells may be triggered by SEB to die. Alternatively,the majority 
of cells may receive CD28 signals to progress through the cell cycle where they 
become susceptible to SEB induced death and consequently die. The signals which 
result in AICD and proliferation may overlap and are still a stimulating focus of
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research and so it is not surprising that there may be more than one interpretation of 
what may occur during the decision between life and death of T cells.
Progressing from the observation that SEB can inhibit T cell proliferation and 
induces apoptosis in activated T cells it was also found that not all activated T cells 
examined were induced to apoptose with SEB or with Fas. This begged the question; 
what are the factors which control cell death and why do some cells die while others 
survive and proliferate? One explanation could be that protective factors such as the 
bcl-2 family of proteins plays a role in determining survival. Bcl-2 plays a crucial 
role in determining survival of lymphocytes (Nakayama et al 1993) while expression 
of bcl-2 or bclxl may dictate whether a stimulus induces T cell death (Boise et al 
1995, Chao et al 1995). Preliminaiy data demonstrated the involvement of bax in 
determining susceptibility to SEB-induced apoptosis, as SEB induced down- 
regulation of this death enhancing factor in activated T cells . Interestingly, some 
aspects of T cell survival appear to be linked to the state of activation of the T cell. It 
has recently been shown that costimulation through CD28 enhances the survival of T 
cells activated through the TCR not only by enhancing IL-2 production but also by 
regulating expression of bclxl (Boise et al 1995). By augmenting lymphokine 
production, CD28 costimulation is likely to effect the survival of T cells while bclxl 
transfected Jurkatts survived Fas-induced PCD, thus suggesting that bclxl is likely to 
play a role in the ability of CD28 to enhance T cell survival. These results reflect the 
importance of the activation state in regulating survival of T cells and the inter­
relationship between factors that control proliferation and those that regulate death.
Another intriguing observation is that CD28 results in the generation of ceramides 
and induction of the SMase pathway, which has also been shown to be a signal for 
apoptotic death upon ligation of Fas or TNF. (Cifone et al 1993, Boucher et al 1995). 
How then does CD28 signalling result in costimulation rather than apoptosis? It can 
be proposed that the involvement of other signals such as PI3 kinase in the CD28 
pathway may provide an answer to this question as it has also recently been found 
that PI3 kinase prevents apoptosis induced by NGF (Yao and Cooper 1995) 
.Consequently, the difference between life and death may reside in the interaction of 
the two pathways, and which predominates, which may in turn depend on the overall 
activation state of the T cell. The CTLA-4 signalling pathway has yet to be 
elucidated and it is intriguing that there is conflicting evidence as to whether 
PI3kinase is involved (Stein et al 1994, Schneider et al 1994). The finding that an 
antibody to CTLA-4 can induce apoptosis and that CTLA-4 knockout mice have
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amino acid carboxyl terminus of Fas was shown to associate with a protein 
phosphatase that had previously been identified in basophils. Cells that were resistant 
to Fas-L killing expressed this phosphatase whereas susceptible cells did not. 
Resistance could be conferred by introducing the phosphatase into sensitive cells .It 
will be interesting to examine the SEB T cell lines produced here for expression of 
this phosphatase. Co-ordination of signals received from kinase and phosphatases 
may ultimately determine the outcome of Fas ligation in T lymphocytes.. This is 
reminiscent of the crucial role phosphorylation and dephosphorylation play in TCR- 
mediated signalling and substantiates the hypothesis of interaction of the pathways 
which determine life and death of T cells.
One final interesting observation was that the death domains of Fas and the recently 
isolated associated death molecules, FADD, TRADD and RIP revealed a significant 
homology to the family of ankyrins that mediate interaction between integral 
membrane components and cytoskeletal elements (Chinnaiyan et al 1995, Stanger et 
al 1995). Cytoplasmic molecules including IkBa and NFkB are ankyrin containing 
molecules which have been shown to be down-regulated by CD28 signalling leading 
to IL-2 gene expression . It is intriguing to infer from this that ankyrin molecules 
express a death domain which is important in suppressing IL-2 production which can 
lead to cell death. This demonstrates further similarities between the downstream 
events involved in CD28 signalling and the signalling involved in Fas-mediated 
apoptosis.
This work has examined two of the most exciting interactions in T lymphocyte 
immunology today, that of B7-1 and CD28 and Fas and its ligand Fas-L. The 
importance of these molecules in T cell function has been demonstrated and it has 
become obvious over the last year that the fate of a T lymphocyte is dependent on 
co-ordination of the signalling pathways involved in these interactions. The 
underlying message suggested by the results presented is that life and death of a T 
lymphocyte are complicated phenomenon.The requirements for T cell activation 
and apoptosis appear to be similar in that more than one signal is necessary for 
either to occur and that their signalling pathways may intersect or use similar 
second messenger systems.
An understanding of the molecular events which regulate T cell effector function 
is vital in order to facilitate prevention and cure of disease. The treatment of 
autoimmune diseases such as rheumatoid arthritis , insulin dependent diabetes
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mellitus has improved enormously due to studies addressing the structure of the 
immune system. Equally significant has been the strides made in our 
understanding of cancer and relatively new diseases such as AIDS due to 
investigation of the mechanisms involved in expansion, regulation and deletion of 
immune effector cells. However, it has become increasingly apparent that the 
complexity of regulation of the immune system dictates that immunomodulatory 
intervention may not be as simple as once thought. It is hoped that this study has 
contributed to a further awareness of the role T cell activation and apoptosis plays 
in immune homeostasis .
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